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Abstract 
 
Hypothesis: It is possible to safely increase the conventional limits of corneal laser refractive surgery for high 
ametropia and irregular astigmatism using ablation profile modifications, pre and postoperative safety 
screening and monitoring, surgical technique improvements such as centration, introduction of the small 
incision lenticule extraction (SMILE) surgical procedure as an alternative to laser in-situ keratomileusis (LASIK), 
and the use of therapeutic options including topography-guided custom ablation and trans-epithelial 
phototherapeutic keratectomy. 
 
Results: A method for the safe treatment of high myopia up to -14.00 D by corneal laser refractive surgery was 
described through the use of aspherically optimized ablation profiles, residual stromal thickness mapping by 
VHF digital ultrasound for safe retreatment planning, a two-stage treatment protocol for high corrections and 
thin corneas, and flap creation by a femtosecond laser enabling the use of thinner flaps. Results were found to 
be comparable to those achieved by intraocular surgery, while avoiding the catastrophic risks of intraocular 
surgery. 
 
A method for the safe treatment of high hyperopia up to +7.00 D by corneal laser refractive surgery was 
described through the use of large optical zones and transition zones to maximize refractive stability, residual 
stromal thickness mapping by VHF digital ultrasound for safe retreatment planning, and a two-stage treatment 
protocol for high corrections. The safety of retreatments was also assessed by monitoring the epithelial 
thickness by VHF digital ultrasound as a more reliable parameter to avoid apical syndrome than using corneal 
curvature. This enabled retreatment to be safely performed in eyes with relatively thick epithelium but steep 
corneal curvature, and no retreatment performed in eyes with thin epithelium but otherwise flat corneal 
curvature. Results were found to be comparable to those achieved by intraocular surgery, while avoiding the 
catastrophic risks of intraocular surgery. 
 
The influence of ocular residual astigmatism on refractive predictability was evaluated and compared to prior 
publications to investigate potential methodological flaws. The method of grouping by a ratio was found to 
bias the results towards lower predictability in the high ocular residual astigmatism group due to the treated 
cylinder not being matched between groups. However, a small difference was still found after matching for 
treated cylinder with a slightly lower predictability in the group of eyes with high corneal astigmatism, high 
refractive cylinder, and high ocular residual astigmatism. But this result must take into account the potential 
for bias in this group due to potential errors in the manifest refraction, poor scan quality of the topography 
measurement, or the presence of non-orthogonal corneal astigmatism or other higher order aberrations. This 
study highlighted the importance of comparing the manifest refraction with the corneal astigmatism before 
surgery and to re-refract the patient if the ocular residual astigmatism is abnormally high. 
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The ability to repair the complications of corneal laser refractive surgery is a critical component of achieving 
optimal outcomes. Quality of vision can be compromised by optical zone decentration or a small topographic 
optical zone. Topography-guided custom ablation was shown to be effective at improving the optical zone 
centration relative to the corneal vertex and enlarging the topographic optical zone. These topographic 
changes were associated with a significant reduction in corneal higher order aberrations. 
 
The last chapter introduced small incision lenticule extraction (SMILE) as a potential procedure that might be 
suited for the correction of high ametropia due to the preservation of the anterior stromal lamellae and 
Bowman’s layer by not requiring a LASIK flap. A number of aspects of SMILE were evaluated. 
Firstly, cylinder predictability was found to vary according to the cylinder axis indicating the need for an 
angular dependent nomogram. Secondly, spherical aberration induction was shown to decrease for larger 
optical zones, with SMILE achieving greater spherical aberration control compared to aspherically-optimized 
LASIK. Thirdly, it was demonstrated that there was clinically negligible astigmatism effect due to the small 
incisions. 
 
Conclusion: Corneal laser refractive surgery can offer safe and effective treatment for a wide range of myopia, 
hyperopia, and astigmatism by using optimized ablation profile design, residual stromal thickness mapping, 
and a two-stage treatment protocol. Consideration of the epithelial thickness as the risk factor for apical 
syndrome in hyperopia also offers greater safety than that provided by corneal curvature. The methods 
described in this thesis may facilitate corneal laser refractive treatment in a cohort of patients in which 
intraocular surgical techniques have traditionally been preferred. 
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Chapter 1 Introduction 
 
1.1 Keratomileusis 
The concept that refractive error could be corrected by sculpting corneal stromal tissue to change corneal 
curvature was the brainchild of Jose Ignacio Barraquer Moner in 1948.
1-3
 Barraquer developed a procedure he 
coined as keratomileusis
4
 which involved ressecting a disc of anterior corneal tissue which was then frozen in 
liquid nitrogen, placed on a modified watchmaker’s lathe and turned to change corneal curvature. The word 
“keratomileusis” literally means “sculpting” of the “cornea”. 
 
The resection was achieved using a manually driven microkeratome that he designed specifically for this 
purpose based on a carpenter’s plane. Barraquer then used trigonometric calculations to derive the volume of 
tissue removal required for a particular refractive error correction. In his 1964 thesis on the ‘Law of 
Thicknesses”
5
 he described that “the cornea flattens when tissue is removed from the centre and steepens 
when tissue is removed from the periphery.” 
 
Several thousand keratomileusis procedures were performed at the Barraquer Instituto de America in the 
1970s and early to mid 1980’s and surgeons from around the world came to learn this technique. The long 
term outcomes of 1,606 eyes treated by cryolathe keratomileusis have been published by Dr Carmen 
Barraquer.
6
 The treated myopia ranged from -4.50 to -27.00 D, with a correction of more than -7.00 D in 86% 
of eyes. Refractive predictability was acceptable given the novel procedure, lack of nomograms, no correction 
of cylinder, and high myopia treated: 58% of eyes were within ±2.00 D of the intended target 1 year after 
surgery, which decreased to 44% at 5 years and 27% at 10 years. The correction was found to be more 
predictable and stable when the resection was more anterior, leaving a total minimal corneal thickness of two 
thirds the initial thickness. Less refractive regression was also found in older patients, which may be partly 
explained by myopic progression in younger patients, but this could not be confirmed due to lack of axial 
length data. 
 
This early cohort of eyes also led to the first described cases of iatrogenic ectasia, which occurred in 45 (2.8%) 
cases. Corneal ectasia following keratomileusis was originally defined by Barraquer as “progressive 
myopisation due to reduction of the corneal radius” and noted that patients with steep keratometry (possibly 
keratoconus) and deep resections were at greater risk. 
 
1.2 Stromectomy 
Around that time others were experimenting with Barraquer’s ideas. Krwawicz
7-9
 in Poland, published a paper 
in 1964 describing a series of 3 highly myopic eyes in which he had performed a “stromectomy”. He manually 
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made two stromal cuts at different depths with a flat knife and removed the thin lamella of intervening 
stroma.  
 
Pureskin
9
 in Russia described in 1967 the concept of an incomplete anterior corneal resection in order to leave 
a naturally hinged flap, after which a stromal disc was removed by trephination. He reported a series of 71 
rabbit eyes and described the power change achieved for discs with different diameters. 
 
1.3 Barraquer-Krumeich-Swinger Technique 
Two of Barraquer’s disciples, Krumeich and Swinger, worked on a refinement of the technique to perform 
keratomileusis without freezing referred to as the Barraquer-Krumeich-Swinger (BKS) technique which was 
published in 1986.
10, 11
 This BKS non-freeze technique involved placing the ressected disc epithelial side down 
on to a curved suction die or mould where a second pass of the microkeratome removed tissue from the 
exposed posterior stromal surface according to the shape of the die. The BKS technique aimed to reduce 
surgical trauma to the tissues and improve visual recovery time.  
 
1.4 In-Situ Keratomileusis 
At around the same time, another non-freeze technique called in-situ keratomileusis
12
 was developed. The 
procedure was first performed by Ruiz, who having completed his residency at the Barraquer Institute was 
performing up to twenty keratomileusis procedures in a day. Ruiz was interrupted in his flow by a corneal disc 
resection which was found to be too thin for the required tissue removal – with the patient on the table he 
came up with the idea of passing the microkeratome a second time using a different suction ring with the 
height adjusted to resect the required lenticule directly from the stromal bed. This was called in-situ 
keratomileusis.  
 
1.5 Automated Lamellar Keratoplasty 
Ruiz was then responsible for designing a gear system to automate the passage of the microkeratome head. 
This eased the technical challenges of using a manual microkeratome as the head could be passed with a 
constant and reproducible speed, therefore avoiding irregular resections and greatly improving the accuracy. 
The procedure became known as Automated Lamellar Keratoplasty or ALK. ALK was further refined by 
replacing the disc without a suture and adhesion was aided by drying, after which the eye was patched over-
night until the epithelium sealed the disc into place. 
 
In 1989 Ruiz presented a paper demonstrating how a flap could be produced by stopping the microkeratome 
before the end of the pass.
13
 The flap would then be tucked under the second microkeratome ring applied for 
the stromal resection thus leaving a hinge to simplify the replacement of the cap and reduce cap related 
complications. This was the first description of a hinged flap, which would go onto become an integral 
component of laser in-situ keratomileusis (LASIK). 
Fig 5 
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1.6 Excimer Laser and Phototherapeutic Keratectomy 
However, it was unlikely that any of these techniques would ever reach the mainstream due to the 
inaccuracies associated with removing tissue by blade-based methods. The next step in the evolution of 
corneal refractive surgery was to introduce the excimer laser as a more accurate method for tissue removal. 
 
This process began in 1981 when Srinivasan, Wynne and Blum, researchers at IBM, used an Argon-Fluoride 
excimer laser (193 nm) to make an incision in the leftover cartilage of a Thanksgiving dinner. They found no 
evidence of damage to the surrounding tissue unlike the charring seen around an incision made with a solid-
state laser with a wavelength of 532 nm, presenting their results at the Conference on Lasers and Electro-
Optics in May 1983.
14, 15
 They demonstrated that complex patterns could be made at a sub-micron level with 
each pulse removing a fraction of a micron.  
 
At the same time, Taboada, also found no thermal damage to the remaining tissue after a 248-nanometer 
excimer laser pulse onto corneal epithelium.
16
 Thus it was established that excimer laser-tissue interaction was 
effectively non-thermal, but rather one of direct splitting of molecular bonds with minimal adjacent heating. 
This process was coined in the term “photo-ablation”.
17
 
 
Trokel had been looking at the possibility of using different lasers (such as CO2 and Nd:YAG lasers) for radial 
keratotomy incisions, but none that he had tried were suitable for corneal application. On learning of the 
restuls with excimer lasers, he approached Srinivasan at IBM to investigate the potential of using an excimer 
laser to improve the accuracy of radial keratotomy incisions.
18, 19
 Trokel later began working with Marshall to 
study the ultrastructural aspects of corneal photoablation.
20
 They compared the quality of the wounds made 
by an excimer laser at 193 nm with one at 248 nm as well as made by steel and diamond blades and found the 
quality of the wounds was best with 193 nm.
21
 This finding was in agreement with similar studies by other 
groups
22-25
 at that time.  
 
The wound quality suggested to Marshall that large area ablation could be performed in the central cornea, 
rather than just for peripheral linear incisions, and he described this in 1986 as photorefractive keratectomy 
(PRK).
26
 For PRK to become a feasible procedure in human eyes, the following criteria needed to be satisfied. 
First, the depth of tissue removal required for a given refraction change must be known. Munnerlyn proposed 
an algorithm adapted from Barraquer’s earlier formulae to calculate the ablation profile as a function of 
refractive error and optical zone diameter.
27
 Second, the quality and clarity of the ablated surface must be 
preserved. Earlier studies in rabbit corneas demonstrated only limited haze after a large area ablation.
26
 
Myopic ablation on a donor eye also showed that the ablated surface was clean and smooth.
28
 Third, the 
wound healing process must not result in scarring. It was already known that there was no scarring after radial 
incisions.
29, 30
 Then, Marshall demonstrated no changes in corneal transparency 8 months after PRK in 12 
Fig 9 
Fig 10 
Page | 4 
monkey corneas,
31
 and McDonald reported stable dioptric change in a primate cornea with good healing and 
long-term corneal clarity up to one year after PRK.
32
 
 
In 1985, Seiler
29
 performed the first large area ablation in a human eye to remove a corneal dystrophy scar 
having previously performed T-incisions earlier that year with an excimer laser to correct for astigmatism. This 
led to PRK being performed in humans. In early 1988 McDonald performed the first PRK on a sighted eye due 
for enucleation, while at around the same time L’Esperance
33
 and Seiler
34
 also began performing PRK, but in 
blind eyes.  
 
Central ablation of the cornea was performed using different methods. L’Esperance suggested small scanning 
spot excimer lasers which could be controlled to ablate in specific patterns.
35
 Marshall proposed using a broad 
beam laser and a moving iris diaphragm to shape the area to be ablated. For a myopic correction, initially the 
aperture was sequentially reduced in diameter to create steps on the corneal surface. The number of steps 
was gradually increased to improve the smoothness of the curved surface.
36
 Hanna used a rotating-slit laser 
delivery system; the shape of the slit was determined mathematically to obtain a parabolic ablation profile 
that resulted from the slit rotation,
37
 as previously proposed by Barraquer.
38
 
 
Larger clinical trials followed with commercially available lasers given the encouraging results from the first 
cases. In 1991, McDonald
39
 reported that myopic PRK treatment with the VISX 20/20 system was safe. In the 
same year, Lindstrom
40-42
 demonstrated the safety and efficacy of the Taunton Technologies model LV 2000 
excimer laser for myopic PRK. At that time, the Marshall
43, 44
 and Seiler
45
 groups published outcomes using the 
Summit Technology Eximed UV200 excimer laser. Also in 1991, Dausch and Schroeder
46
 presented results in 
high myopes with the Aesculap-Meditec excimer laser and later, in 1993, presented the first hyperopic 
ablation profiles. 
 
1.7 Laser In-situ Keratomileusis 
By the late 1980s, both the excimer laser and the microkeratome had been developed and were being used for 
PRK and keratomileusis respectively. Therefore, it was a natural progression for these to be combined to 
become laser in situ keratomileusis (LASIK). This concept of using an excimer laser to ablate tissue under a flap 
was being investigated independently in various parts of the world. In 1988, Razhev
47-49
 and co-workers in 
Novosibirsk, USSR began using a 5-mm trephine to produce a central 100 µm deep circular keratotomy and 
then a scalpel to create a lamellar hinged flap.
50
 They then used an excimer laser to ablate the stromal bed 
before replacing the lamellar flap in 4 myopic and 5 hyperopic eyes and presented their results with up to 2 
years’ follow-up in September 1990 at Columbia University, New York. 
 
At around the same time Buratto
51
 was performing classical keratomileusis but from October 1989 he began to 
use an excimer laser for ablation on the underside of the cap (instead of a lathe or microkeratome) and 
published his first 30 high myopic eyes with few complications and 1 year follow-up in 1992. In December 
Fig 11 
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1989, Buratto had a case where the cap was too thin for the required tissue removal, much like Ruiz previously 
with ALK, and so decided instead to perform the excimer laser ablation directly on the stromal bed before 
replacing the cap. 
 
Pallikaris also produced a hinged flap using a microkeratome he had designed for rabbit studies and performed 
the ablation with an excimer laser on the exposed bed followed by replacement of the flap without sutures. 
The term LASIK was first used to describe this procedure in his 1990 paper.
52, 53
 Pallikaris treated his first 
patients in October 1990 and published his results on 10 high myopic human eyes with one year-follow-up in 
1994.
54
  
 
1.8 Excimer Laser Ablation Profiles 
In the early years of excimer laser treatments, a small optical zone of about 4-4.5 mm was used for treatments 
as there was concern about the stability of the cornea if too much tissue was removed. However, it was found 
that this resulted in significant night vision disturbances and quality of vision side effects, due to the induction 
of higher order aberrations.
55
 It was also found that there was a refractive undercorrection compared to the 
theoretical ablation profile calculations by Munnerlyn et al.
27
 This was demonstrated to be largely due to 
epithelial remodelling with central epithelial thickening partially compensating for the ablated stromal tissue.
56
 
 
Both of these factors were found to be alleviated by using a larger optical zone. O’Brart et al
57
 showed in a 
series of papers how increasing optical zone diameter decreased the impact of night vision disturbances. 
Within a few years, it became clear that the optical zone diameter should be at least 6 mm in order to achieve 
acceptable results.
58
 Refractive stability and induction of higher order aberrations were also improved by the 
addition of a transition zone,
59
 further extending the ablated zone and creating a more gradual curvature 
change between the treated and untreated zones.   
 
The next improvement in ablation profile design was to use an aspheric shape, rather than being spherical as 
in the Munnerlyn formula. Aspheric profiles were first tested by Seiler et al
60
 who demonstrated significantly 
less induction of spherical aberration and consequently less glare compared to standard Munnerlyn profiles. 
All modern lasers have now incorporated a degree of asphericity in their ‘base’ ablation profiles to reduce the 
induction of spherical aberration. 
 
However, there were further factors contributing to the induction of spherical aberration; there was a 
degradation of the ablation profile caused by biomechanical tissue responses
61
 and physical laser fluence 
degradation.
62
 When a laser spot is projected onto the curved corneal front surface, the spot will be projected 
onto a larger area for peripheral locations compared to centrally where the cornea is perpendicular to the 
laser beam. Therefore, there is less fluence for peripheral ablation, which results in less ablation than intended 
peripherally. In addition, the fluence loss due to reflection is increased when the beam is oblique to the 
surface compared to when it is perpendicular. These phenomena result in effectively smaller fully corrected 
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ablation zones and optical distortion of the intended sphero-cylindrical profile, leading to increases in higher-
order aberrations, particularly spherical aberration. 
 
Biomechanically, it has been reported that the peripheral stroma actually thickens after LASIK.
61
 This 
biomechanical change seems to be an important cause for a significant proportion of spherical aberration 
induction. These findings also agreed with the results reported by Dupps and Roberts
63
 of peripheral stromal 
thickening outside the treatment zone after phototherapeutic keratectomy (PTK) in ex vivo human donor 
globes, which correlated with induced central flattening. 
 
1.9 Advances in Excimer Laser Design 
Corneal laser refractive surgery has also been advanced by the continued development and understanding of 
the excimer laser systems themselves.
64
 The introduction of flying spot lasers enabled the thermal load on the 
cornea to be reduced compared to broad beam laser systems, which reduced the risk of corneal haze. Safety 
was also increased as the ablation could be performed in layers, meaning that aborting an ablation mid-way 
through would not induce a corneal irregularity, there would just be an undercorrection. The laser beam was 
changed to a Gaussian profile, which reduced the cross-over between laser spots resulting in a smoother final 
stromal surface. Laser frequency has also been increasing over the years, which has greatly reduced the 
ablation time. This acted to reduce the impact of corneal dehydration on the ablation rate. 
 
The other area of significant improvement in excimer laser technology was the addition of eye tracking
65
 and 
cyclotorsion control by iris recognition software.
66
 Eye tracking improved ablation centration, which had 
previously been done manually by the surgeon – decentration being the other major source of quality of vision 
symptoms after corneal laser refractive surgery aside from spherical aberration induction. Dynamic eye 
tracking during the ablation improved the consistency and predictability of the treatment as eye movements 
would previously have led to an irregular ablation. An important additional feature was the use of passive eye 
tracking, which interrupts the laser ablation if the eye moves outside of a small central zone.
67
 While active eye 
tracking can continue to track the eye outside of this zone, there is increased degradation of the fluence due to 
projection and reflection errors when firing obliquely onto the surface. Therefore, the best option is simply to 
prevent ablation from occurring while the eye is not perpendicular, and use the laser algorithms to account for 
the peripheral ablation.  
 
The final aspect of eye tracking is cyclotorsion control as an error can be introduced for astigmatic treatments 
if there is a change in the axis of astigmatism between the sitting position (where the manifest refraction is 
measured) and the supine position (where the ablation is performed). This is also important for custom 
ablation profiles that are asymmetric. Cyclotorsion control is achieved by obtaining an image of the iris in the 
sitting position, usually as part of a topography or wavefront measurement. This image is imported into the 
treatment planning software and used to confirm and adjust for the rotation of the eye during the procedure. 
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1.10 Wavefront-guided Custom Ablation 
Another advance in corneal laser refractive surgery was the introduction of aberrometers. Firstly, this enabled 
a more in-depth analysis and understanding of the changes being made to the cornea and provided an 
objective measurement and explanation of the quality of vision symptoms being reported by patients. But 
more enticing was the potential of using these measurements to treat a patient’s naturally occurring higher 
order aberrations. Closed-loop experiments in PMMA proved that excimer lasers were capable of ablating such 
custom profiles – an irregularity was induced into the plastic, measured by an aberrometer, and then reversed 
by the ablation planned based on the wavefront measurement.
64
 
 
However, the promise of wavefront-guided treatments was not quite realised for two reasons. Firstly, the 
aberrations induced by tissue removal outweighed the nascent aberrations in virtually every case, particularly 
for higher corrections. In a sense, a wavefront-guided treatment was replacing one set of aberrations with 
another, at the expense of increasing the ablation depth. Secondly, the effective correction of existing higher 
order aberrations was found to be only about 30%, in studies of wavefront-guided ablations in highly 
aberrated eyes.
68
 The reasons for the undercorrection of the higher order aberrations could be due to a 
number of factors: (1) the aberrometers may not have high enough accuracy and repeatability; (2) there may 
be diurnal changes in wavefront; (3) the wavefront changes as the pupil diameter changes; and (4) the 
biomechanical response of the cornea serves partially to reverse some of the intended change (it is possible 
that a nomogram is required for each Zernike value). Therefore, the trend has been to move away from true 
wavefront-guided custom ablation and to focus more on controlling the induction of aberrations – referred to 
as wavefront-optimised ablation. 
 
The other factor is that it was realised that the ideal outcome is not actually to flatten the wavefront. In the 
studies of highly aberrated eyes, a subjective improvement was reported in every instance, despite only 30% 
reduction in spherical aberration.
68-80
 This indicated that there is a tolerable level of aberrations below which 
the brain can filter out the aberrations. In our study using the MEL80 wavefront-guided system, a 27% 
reduction in spherical aberration was enough to subjectively improve vision and restore contrast sensitivity to 
normal levels. In this study, with comparison to a post-LASIK control group with no visual quality symptoms, 
we found the tolerable level of spherical aberration to be about 0.56 µm (OSA notation, 6-mm analysis zone).
68
 
 
1.11 Topography-guided Custom Ablation 
Customized ablation profiles can also be generated using front surface topography data and some laser 
systems offer a topography-guided ablation profile. Topography-guided ablation algorithms are designed to 
calculate an ablation profile that would alter an irregular topography to become a smooth, regular, aspheric 
surface. An irregular front surface topography will cause significantly higher order aberrations; therefore, the 
consequence of regularizing the front surface corneal topography will be to reduce higher order aberrations. 
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Until recently, topography-guided systems have mainly been used for therapeutic treatment for treating 
irregular astigmatism. Topography-guided ablations have been found to be more effective in reducing 
aberrations, particularly spherical aberration, than wavefront-guided ablations. In our study using the MEL 80 
topography-guided system for postrefractive surgery complications, the spherical aberration was reduced by 
41% on average.
81
 Topography-guided ablations were found to be particularly successful for the correction of 
decentrations and for optical zone enlargement. One of the major advantages of topography-guided ablation 
over wavefront-guided ablation is the centration. By definition, topographic data are centered about the 
corneal vertex, which approximates the visual axis. On the other hand, wavefront data are currently calculated 
centered on the entrance pupil centre, since wavefront data can only be obtained within the pupil. There is 
increasing evidence that corneal vertex centration provides better safety and efficacy than the conventionally 
accepted entrance pupil centration.
82-86
 
 
1.12 Keratoconus Screening 
As highlighted by Barraquer from his initial experience with keratomileusis,
6
 the most significant risk of tissue 
subtractive corneal surgery is ectasia. The first cases were described after corneal laser refractive surgery by 
Seiler et al
87, 88
 in 1998 and many research groups have focused on determining the main risk factors and 
strategies for identifying patients most at risk. In ectasia, the corneal stroma undergoes a two-step process of 
delamination and interfibril fracture, which is clinically characterized by thinning and bulging of the cornea. 
This causes mild-to-severe irregular astigmatism, a myopic shift, and typically reduces uncorrected and 
corrected distance visual acuity, as well as affecting the quality of vision through increasing higher order 
aberrations, mostly coma.
89
  
 
The precise causes for ectasia after laser refractive surgery have not been fully defined, however, high myopia, 
lower preoperative corneal thickness, higher percentage of cornea removed, low residual stromal thickness 
(RST), and multiple retreatments have all been cited as independent risk factors.
90-99
 However, the majority of 
published cases of ectasia (certainly until the last few years) were in patients with unrecognised preoperative 
keratoconus.
87, 90, 92-94, 96, 97, 100-103
 This hastened the development of improved methods of screening for 
keratoconus, including indices based on corneal tomography notably the Belin-Ambrosio BAD-D enhanced 
ectasia screening display using the Pentacam tomographer,
104-106
 the SCORE algorithm by Gatinel and Saad
107-
109
 using the Orbscan tomographer, and the cone location and magnitude index (CLMI) by Mahmoud et al,
110
 
which is available using the Galilei tomographer. Other measurements including evaluation of epithelial 
thickness
111-115
 and attempts to directly measure corneal biomechanics
116-119
 have also been studied.  
 
The development of these detection systems and increased awareness of the importance of keratoconus 
screening has served to reduce the incidence of ectasia. The prognosis of ectasia has also been tempered by 
the introduction of corneal collagen cross-linking,
120, 121
 which has provided a therapeutic treatment for halting 
or at least slowing the progression and therefore preventing or at least delaying the need for a corneal 
transplant in cases of ectasia. 
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1.13 Femtosecond Lasers for Flap Creation 
The safety of LASIK was further improved by the introduction of femtosecond lasers for flap creation.
122
 
Femtosecond lasers greatly reduced the risk of some of the more significant flap complications, such as 
buttonhole, free cap, and irregular flaps, and also reduced the rate of epithelial ingrowth.
123, 124
 However, 
probably the main benefit of femtosecond lasers was to improve the reproducibility of flap thickness and 
enable the use of thinner flaps, both of which improved the safety with resepect to the risk of excessive 
keratectomy. Flap thickness reproducibility is the most important factor for residual stromal thickness (RST) 
safety planning as a thicker than intended flap can lead to a lower than predicted RST and possibly to ectasia. 
 
Figure 1-1 shows the results of a literature review of papers reporting central flap thickness reproducibility, 
grouped into mechanical microkeratomes and femtosecond lasers. Figure 1-2 shows the same review, but with 
the data averaged by year for each group. 
 
Central flap thickness standard deviation of certain older mechanical microkeratomes was reported to be in 
the range of 20 to 40 μm.
125-127
 With a flap thickness standard deviation of 30 µm, an RST error of over 90 µm 
is likely to occur in 0.15% of eyes. More recent mechanical microkeratomes have improved flap thickness 
standard deviation to between 10 and 20 µm,
128-130
 with some studies reporting 7 to 10 µm.
131, 132
 However, 
even with a reproducibility of 10 µm, the flap thickness can still be 30 µm thicker than intended. 
 
When femtosecond lasers were first introduced in 2004, the flap thickness reproducibility was reported to be 
between 10-15 µm,
133
 which was about 5% lower than the reproducibility for microkeratomes at that time. 
Since then, there has been a similar trend for improving flap thickness reproducibility such that most published 
reports find this to be less than 5 µm for the current femtosecond laser systems.
131, 134, 135
  
 
Therefore, femtosecond lasers enabled an improvement in flap thickness reproducibility since their 
introduction, which has continued to improve over time, keeping ahead of the improvement in 
microkeratomes. In addition, femtosecond lasers have also been shown to create flaps that are more regular in 
thickness, which has consequently reduced the induced higher order aberrations.
136
 Finally, femtosecond 
lasers are associated with a faster learning curve, so provide a safer option for less experienced or lower 
volume surgeons.
137
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Figure 1-1: Graph showing the central flap thickness reproducibility for all studies published between 1998 and 
2014, grouped by mechanical microkeratome (blue) and femtosecond laser (red). 
 
 
Figure 1-2: This graph includes the same data as from Figure 7, but with the data points representing the mean 
central flap thickness reproducibility averaging studies published within each year. 
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1.14 Small Incision Lenticule Extraction 
Ever since femtosecond lasers were first introduced into refractive surgery, the ultimate goal has been to 
create an intrastromal lenticule that can then be removed manually in one piece, thereby circumventing the 
need for incremental photoablation by an excimer laser. A precursor to modern refractive lenticule extraction 
(ReLEx) was first described in 1996 using a picosecond laser to generate an intrastromal lenticule that was 
removed manually after lifting the flap;
138, 139
 however significant manual separation was required leading to 
an irregular surface. The switch to using a femtosecond laser improved the precision
140
 and studies were 
performed in rabbit eyes in 1998
141
 and in partially sighted eyes in 2003,
142
 however these initial studies were 
not followed up with further clinical trials. 
 
Following the introduction of the VisuMax femtosecond laser (Carl Zeiss Meditec, Jena, Germany),
143
 the 
intrastromal lenticule method was reintroduced in a procedure called Femtosecond Lenticule Extraction 
(FLEx). The 6 month results of the first 10 fully seeing eyes treated were first presented in 2006 and published 
in 2008
144
 and results of larger populations followed.
145, 146
 The refractive results were similar to those 
observed in LASIK, but visual recovery time was longer due to the lack of optimization of energy parameters 
and scan modes. 
 
Following the successful implementation of FLEx, a new procedure called small incision lenticule extraction 
(SMILE) was developed; an all femtosecond laser, keyhole, flapless procedure that has realized Barraquer’s 
original concept of keratomileusis.
5
 This procedure involves passing a dissector through a small 2-3 mm 
incision to separate the lenticular interfaces and allow the lenticule to be removed, thus eliminating the need 
to create a flap. The SMILE procedure is gaining popularity following the results of the first prospective trials
147-
149
 and more recent reports which have demonstrated that the visual and refractive outcomes are similar to 
LASIK.
150-158
 The United States Food and Drug Administration (FDA) trial for spherical myopia was also 
completed and approved in October 2016.
159
  
 
From a scientific perspective, SMILE brings two main advantages over LASIK: faster dry eye recovery and an 
extended range of treatment due to better spherical aberration control as a result of better biomechanics. 
Both of these advantages stem from the nature of the opening through which the procedure is performed – a 
minimally invasive pocket incision – as this results in maximal retention of anterior corneal innervation as well 
as structural integrity. 
 
Dry eye is a well-documented temporary side effect of laser corneal refractive surgery that occurs in the early 
postoperative period but is known to recover over time. With SMILE, the hypothesis was that by better 
preservation of the anterior corneal anatomy the anterior stromal nerve plexus will be disrupted less in SMILE 
than by LASIK or PRK. Although the trunk nerves that ascend into the epithelial layer within the diameter of 
the cap will still be severed in SMILE, those that ascend outside the cap diameter or that are anterior to the 
cap interface will be spared. This should therefore result in fewer dry eye symptoms and a faster recovery 
Page | 12 
after SMILE. The evidence so far supports this both in terms of corneal nerve regeneration
160 
 and recovery of 
corneal sensitivity.
161
 For example, we have previously compared the average change in corneal sensitivity of 
all SMILE and LASIK published studies, demonstrating that corneal sensitivity recovered by 3-6 months after 
SMILE compared to 6-12 months after LASIK.
161
 
 
Biomechanically, SMILE offers an advantage over LASIK by preservation of the stronger anterior stromal 
lamellae. Randleman et al
162
 demonstrated that the cohesive tensile strength (i.e. how strongly the stromal 
lamellae are held together) of the stroma decreases from anterior to posterior within the central corneal 
region. In an experiment in which the cohesive tensile strength was measured for strips of stromal lamellae cut 
from different depths within donor corneoscleral buttons, a strong negative correlation was found between 
stromal depth and cohesive tensile strength. The anterior 40% of the central corneal stroma was found to be 
the strongest region of the cornea, whereas the posterior 60% of the stroma was at least 50% weaker. 
 
In addition to cohesive tensile strength, tangential tensile strength (i.e. stiffness along the stromal lamellae) 
and shear strength (i.e. resistance to torsional forces) have both been found to vary with depth in the stroma. 
Kohlhaas et al
163
 and Scarcelli et al
164
 found that the tangential tensile strength was greater for anterior stroma 
than posterior stroma, each using different methodology. Petsche et al
165
 found a similar result for transverse 
shear strength to decrease with stromal depth. The same group have used nonlinear optical high-resolution 
macroscopy to image the three-dimensional distribution of transverse collagen fibers and have shown that the 
non-linearity of tensile strength through the stroma is caused by the greater interconnectivity of the collagen 
fibers in the anterior stroma compared to the posterior stroma where the collagen fibers lie in parallel to each 
other.
166
 
 
Applying this knowledge to SMILE, since the anterior stroma remains uncut, the strongest part of the stroma 
continues to contribute to the strength of the cornea postoperatively, in contrast to both PRK and LASIK where 
the strongest anterior stroma is affected. This has been evaluated by a theoretical model by Reinstein et al.
167
 
The biomechanical advantage of SMILE has also been demonstrated by finite element modelling
168, 169
 and 
laboratory experiments.
170
 
 
1.15 Summary and Aims 
By the mid-to-late 2000s, corneal laser refractive surgery was established as a safe and effective treatment for 
myopia up to -10.00 D and hyperopia up to +3.00 D. Outside of this range, the results were more variable and 
many surgeons preferred intraocular surgery options such as phakic IOL implantation or refractive lens 
exchange (RLE) in these patients. However, intraocular surgery involves inherently greater risks than corneal 
surgery. Therefore, if the risks and side effects associated with the correction of high ametropia by corneal 
laser refractive surgery could be reduced, then this may offer a safer alternative than intraocular surgery. 
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The aim of this thesis is to investigate the potential for extending the conventional limits of corneal laser 
refractive surgery using the latest technological advances. Chapter 2 will describe the method for and results 
of treatment by LASIK of myopia up to -14.00 D.
171
 Chapter 3 will describe the method for and results of 
treatment by LASIK of hyperopia up to +7.00 D.
172
 Astigmatism correction is another area where results might 
be improved, particularly with respect to understanding the role of ocular residual astigmatism (the mis-match 
between manifest cylinder and corneal astigmatism), which will be covered in Chapter 4.
173
 For all of these 
treatments, it is also important that there are therapeutic treatment options to address potential 
complications. Chapter 5 will evaluate the use of topography-guided custom ablation for the treatment of 
irregular astigmatism due to small optical zone or decentration after LASIK.
174
  
 
Finally, the SMILE procedure has introduced the potential for treating higher prescriptions than LASIK due to 
the biomechanical advantages of leaving the anterior stroma intact. Chapter 6 is taken from our recent 
textbook on SMILE,
175
 which describes all aspects of the procedure, supported by analyses of our SMILE 
population and literature reviews. In this chapter, the optimal settings are evaluated for each treatment 
parameter. 
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Chapter 2 Long-term Visual and Refractive Outcomes After LASIK 
for High Myopia and Astigmatism From -8.00 to -14.25 D 
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2.1 Abstract  
 
Purpose: To evaluate outcomes of high myopic LASIK using the MEL 80 excimer laser. 
Methods: Retrospective analysis of 479 consecutive high myopic LASIK procedures (318 patients) using the 
MEL 80 excimer laser (Carl Zeiss Meditec) and VisuMax femtosecond laser (Carl Zeiss Meditec) in 77% of cases 
or zero compression Hansatome (Bausch & Lomb) microkeratome in 23% of cases. Inclusion criteria were 
preoperative spherical equivalent refraction (SEQ) of between -8.00 D to -14.25 D, and CDVA of 20/20 or 
better. Patients were followed for a minimum of 1 year. Flap thickness was between 80-160 µm and optical 
zone was between 5.75-6.50 mm. Standard outcomes analysis was performed. 
Results: Mean attempted SEQ was -9.39±1.22 D (-8.00 D to -14.18 D) and mean cylinder was -1.03±0.84 D 
(0.00 D to -4.50 D). Mean age was 37±9 (21 to 60) with 54% female patients. Of this population 69% were 
treated by DZR and 31% by GIC. Postoperative SEQ was ±0.50 D in 55% and ±1.00 D in 83% of eyes, after 
primary treatment. After retreatment, 69% of eyes were ±0.50 D and 95% were within ±1.00 D. UDVA was 
20/20 or better in 89% of eyes after final treatment. One line of CDVA was lost in 3% of eyes and no eyes lost 
two or more lines. Statistically significant increases (p<0.001) were measured in contrast sensitivity (CSV-1000) 
at 12 and 18 CPD. 
Conclusions: The MEL 80 excimer laser was found to achieve high efficacy and safety for treatment of high 
myopia between -8.00 D and -14.25 D and up to -4.50 D of cylinder. 
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2.2 Introduction 
In the 1990s many studies were published reporting PRK and LASIK correction of very high myopia (up to -
32.00 D in some cases),
176-181
 however, these treatments were associated with low predictability, significant 
regression, and induced night vision disturbances.
44, 182, 183
 During this period, it was found that these issues 
were in large part due to the use of small optical zones,
57, 184
 and the non-aspheric Munnerlyn ablation profiles 
leading to significant induction of spherical aberration.
60
 By 1998, authors concluded that LASIK was not an 
appropriate treatment for very high myopia above -15.00 D
181
 and were suggesting that phakic intraocular lens 
(IOL) implantation was more appropriate. Over the next 10 years, consensus shifted towards using phakic IOLs 
for high myopia and published LASIK studies rarely included myopia above -10.00 D. For example, the German 
Commission for Refractive Surgery’s guidelines state that laser correction should only be considered up 
to -8.00 D.
185
   
 
This thinking was further reinforced when a Cochrane review was published in 2010
186
 (and updated in 
2014
187
), which compared laser refractive surgery and phakic IOLs for the treatment of high myopia. This 
review concluded that “at one year post surgery, phakic IOLs are safer than excimer laser surgical correction 
for moderate to high myopia in the range of -6.00 to -20.00 D and phakic IOLs are preferred by patients”. 
However, by applying the rigorous Cochrane method, only three studies met the inclusion condition of being a 
randomized control trial (RCT), so the conclusion was based on a total of 114 eyes each for LASIK and phakic 
IOL. Furthermore, the LASIK studies were for first and second generation excimer lasers, two published in 2002 
and one in 2007, in which smaller optical zones and/or non-aspheric ablation profiles had been used.
188-190
 
Therefore, this review had not considered modern flying spot excimer lasers, advances in eye-tracking, and 
ablation profile design including the use of larger optical zones, wavefront-optimized aspheric profiles,
191, 192
 
modern algorithms for compensation for fluence projection and reflection errors,
62
 biomechanical factors
193
 
and the availability of topography-guided ablation profiles.
81
 Advances in femtosecond laser technology also 
allow ultra-thin flaps,
135
 thereby preserving stromal tissue and reducing the risk of ectasia. 
 
The comparison should also have been considered in the context of safety. The main risks for high myopic 
LASIK are inducing night vision disturbances or keratectasia.
89, 90, 100, 194
 However, phakic IOLs can also cause 
night vision disturbances,
195
 and also introduce less common but potentially serious complications associated 
with intraocular surgery such as malignant glaucoma, sub-capsular cataract, damage to zonules, macular 
edema, suprachoroidal hemorrhage, retinal detachment and endophthalmitis.
195-197
 Each type of lens also has 
specific complications that may require intraocular surgical intervention (over/undersized lens requiring 
exchange, explantation, cataract, rotation). Anterior chamber lenses can cause chronic endothelial cell loss
197-
199
 with an incidence of 0.8% in one study,
199
 although another study showed no change in endothelial cell 
count over 10 years, but concluded this might be related to surgeon expertise.
200
 Cataract formation in 
posterior chamber lenses has been reported to occur in 8.48% of myopic eyes, requiring lens explantation in 
3.4% of all eyes.
196
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The aim of our study was to report outcomes for a large high myopic LASIK population using the MEL 80 
excimer laser (Carl Zeiss Meditec, Jena, Germany). We also set out to compare our results to other methods 
for high myopia correction with respect to safety and efficacy. 
 
 
2.3 Methods 
2.3.1 Patients 
This was a retrospective case series of consecutive high myopic LASIK procedures by two experienced surgeons 
(DZR & GIC) using the MEL 80 excimer laser and VisuMax femtosecond laser (both Carl Zeiss Meditec) or zero 
compression Hansatome microkeratome (Bausch & Lomb) at the London Vision Clinic, London, UK. Inclusion 
criteria were attempted spherical equivalent refraction correction of -8.00 D or higher for the primary 
procedure, medically suitable for LASIK, no signs of keratoconus, no previous ocular, eyelid or orbital surgery, 
no visually significant cataract, and corrected distance visual acuity (CDVA) 20/20 or better. A minimum follow-
up of 1 year was applied. Informed consent and permission to use their data for analysis and publication was 
obtained from each patient prior to surgery as part of our routine preoperative protocol. 
 
A full ophthalmologic examination was performed before surgery by an in-house optometrist, as has been 
described previously.
191
 Manifest refraction was performed using a standardized and validated protocol.
201
 The 
manifest refraction was repeated on or before the day of surgery by the surgeon, which was used for 
treatment planning. Laser data entry was calculated using a multivariate regression derived nomogram 
including sphere, spherical aberration precompensation level (see below), cylinder, age, and flap thickness. 
 
2.3.2 Planning 
In our protocol for treating high myopia, the predicted residual stromal thickness (RST) must be greater than 
250 µm. For some eyes, this meant planning the treatment to be performed in two stages, so that the RST 
available for further correction could be accurately assessed before planning the second procedure. RST was 
calculated including safety biases for corneal thickness, flap thickness and ablation depth.
202
 The minimum of 
10 central handheld ultrasound pachymetry measurements was used, less a further 15 µm to allow for the 
mean overestimation based on our comparison to Artemis very high-frequency digital (VHF) ultrasound 
(Personal communication, Dan Z Reinstein, 01/09/2006). For flaps created with the zero compression 
Hansatome using the 160 µm head, we had previously measured our mean central flap thickness to be 119±13 
µm.
203
  By using a 160 µm flap thickness in the safety calculation, this incorporated a safety bias of 41 µm, 
meaning that the achieved central flap thickness would be thicker than 160 µm in only 0.8% of eyes. Similarly, 
a bias of 18 µm was added to the programmed VisuMax flap thickness, based on our previous study that found 
the mean central flap thickness to be 2 µm thicker than programmed with a standard deviation of 7.9 µm.
143
 
Finally, ablation depth was adjusted according to our previous study which found the MEL 80 ablation depth 
readout overestimated achieved ablation depth by approximately 20%,
204
 plus an additional 5 µm bias. 
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Postoperative keratometry was not included as part of the suitability assessment; this parameter was formerly 
used because it acts as a surrogate for induced spherical aberration, but we can now measure the spherical 
aberration directly. 
 
Patients in whom full correction could not be achieved using the above RST calculations, a two-stage protocol 
was used where the primary procedure was an intentional undercorrection, followed by a retreatment 
according to the criteria set out below. 
 
All patients were given extra consent forms that described the greater risks associated with treating high 
myopia by LASIK relative to lower corrections, including discussion of night vision disturbances, and refractive 
accuracy and stability. If a full correction was not possible or the RST indicated that further treatment would 
be unlikely, another extra consent form was used to clarify that only one treatment might be possible. The 
alternative of phakic IOL surgery was explained to all patients and that this would enable a full correction. 
Patients then decided which option to take after weighing up the relative risks and benefits. 
 
2.3.3 Surgical Protocol 
All treatments were performed as bilateral simultaneous LASIK. The Hansatome was used between 
08/08/2003 and 23/07/2010 in 23% and the VisuMax between 13/04/2007 and 29/12/2011 in 77% of eyes. 
The procedure was performed by surgeon DZR in 69% and by surgeon GIC in 31% of eyes. The CRS-Master 
software platform (Carl Zeiss Meditec, Jena, Germany) was used to generate the ablation profiles (version 1.1 
until 08/11/2004, version 1.3 until 01/03/2007, version 2.1.6 until 01/11/2009, version 2.3.0 thereafter).  
 
The standardized surgical technique has been described previously.
205, 206
 Both the flap and corneal ablation 
were centered on the coaxially sighted corneal light reflex (CSCLR),
83
 used as the best approximation of the 
intersection of the visual axis with the cornea.
207
 
 
The ablation profile used the Tissue Saving Ablation (TSA) profile for the correction of sphere and cylinder, but 
also included a predetermined level of spherical aberration pre-compensation with a Z4
0
 value ranging up to 
1.21 µm (6 mm zone equivalent). Optical treatment zone diameter for first (TSA) profiles was 5.75 mm in 7%, 
6.00 mm in 87%, 6.25 mm in 3%, and 6.50 mm in 3% of eyes. The spherical aberration component was treated 
at the same diameter as the base ablation in 30% and at a 7.00 mm diameter in 70% of eyes. In patients with 
thinner corneas, the optical zone was reduced to less than 6.00 mm in order to maximize the correction, with 
the patient counselled for greater risk of night vision disturbances. In patients with very large dark pupil 
diameter, the optical zone was increased if possible according to corneal thickness. 
 
Intended flap thickness was 160 µm in 23% with the Hansatome, and 80-85 µm in 47%, 90-100 µm in 29%, and 
110 µm in 2% of eyes using the VisuMax. Flap diameter ring used was 8.5 mm in 14% and 9.5 mm in 9% of eyes 
using the Hansatome, while flap diameters with the VisuMax were 8.0 mm in 70%, 8.5 mm in 1%, and 8.8 mm 
Page | 19 
in 5% of eyes. For VisuMax flaps, a small (S) contact glass was used for a 8.0 mm flap diameter otherwise a 
medium (M) contact glass was used. A 5 mm superior hinge was used in all VisuMax cases. 
 
Where a full correction was performed, we included an age dependent target hyperopic spherical refraction 
for all patients younger than 42 years according to a linear function whereby the target sphere was +0.66 D for 
a 21 year old decreasing to plano for a 42 year old. Our micro-monovision protocol
191
 was used for all patients 
older than 42 years, where the target sphere is plano for the dominant eye and -1.50 D for the non-dominant 
eye for the majority of patients. 
 
2.3.4 Postoperative Course and Evaluation 
Patients were instructed to instill tobramycin & dexamethasone (Tobradex: Alcon, Fort Worth, TX, USA) and 
ofloxacin (Exocin: Allergan Ltd, Marlow, UK) four times daily and wear plastic shields for sleeping during the 
first week. The surgeon reviewed the patient at day one and measured spherical refraction and uncorrected 
distance visual acuity (UDVA); if necessary, flap adjustments were performed at the slit-lamp using a surgical 
spear under topical anesthetic and antibiotic cover. An optometrist examined the patient at one, three, and 
twelve months and then yearly thereafter. All visits included measurements of monocular and binocular 
UDVA, manifest refraction, and corrected distance visual acuity (CDVA). Best-spectacle-corrected mesopic 
contrast sensitivity was performed at the 3 month visit to compare to baseline. ATLAS corneal topography 
(Carl Zeiss Meditec, Jena, Germany) and WASCA aberrometry (Carl Zeiss Meditec, Jena, Germany) were 
performed at 3 months, 1 year and 2 years.  
 
2.3.5 Retreatments 
Retreatments followed the same protocol for full correction and two-stage patients. Retreatments were 
performed once stability was demonstrated after at least 6 months, defined as no change in sphere and 
cylinder within ±0.25 D over an interval of at least two months. A topography-guided ablation
81
 was used if the 
patient reported significant night vision disturbances and it was demonstrated that full spectacle correction 
alone did not improve night vision disturbances whereas spectacles plus one drop of brimonidine 0.5% did 
improve night vision disturbances. 
 
In the majority of cases (66%), where the predicted RST was less than 275 µm, a VHF digital ultrasound scan 
was performed to obtain layered pachymetric maps of corneal, epithelial and residual stromal thickness.
208
 
The RST map was used to identify the thinnest point and applied in the RST safety calculation. The retreatment 
was planned such that the predicted RST after the retreatment was at least 250 µm at the location of the 
maximum ablation as well as the location of the minimum RST. Therefore, in some cases, the retreatment was 
not necessarily a full correction. 
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2.3.6 Statistical Analysis 
Outcome analysis was performed according to the Standard Graphs for Reporting Refractive Surgery.
209
 
Outcomes were analyzed separately for primary treatment data only, and after the final treatment. Data from 
the 2 year visit were used for analysis if available, otherwise 1 year data was used. Stability of keratometry was 
evaluated by calculating the mean simulated keratometry at 3 months, 1 year and 2 years. The change in 
higher order aberrations was assessed by the change in coma, spherical aberration and higher order RMS, 
using a 6 mm analysis zone. Student’s t-tests were used to calculate the statistical significance of changes in 
log contrast sensitivity. Microsoft Excel 2010 (Microsoft Corporation, Seattle, WA, USA) was used for data 
entry and statistical analysis. A p-value <0.05 was defined as statistically significant. 
 
 
2.4 Results 
2.4.1 Patient Population 
During the study period, 527 eyes were treated and one year data were available for 479 (91% follow-up), for 
which the last timepoint after the primary procedure was 2 years in 48% (n=230), 1 year in 46% (n=221), and 6 
months in 6% (n=27) of eyes. All eyes where the last timepoint after the primary procedure was earlier than 1 
year had undergone retreatment at that time. For these eyes, 1 year follow-up after the retreatment were 
used to analyze the final outcome. Table 2-1 shows the demographic data for the study population. 
 
2.4.2 Retreatments 
The primary procedure was performed as a partial correction (two-stage protocol) in 16% (79/479) of eyes, of 
which 71% (56/79) have undergone a retreatment. Of the 400 full correction eyes, 16% (64/400) have 
undergone a retreatment. Including all eyes, 25% (120/479) of eyes have undergone a retreatment, of which 
95% (114/120) were performed as a flap lift, 2.5% (3/120) as a PRK procedure, 1.7% (2/120) as a VisuMax 
LASIK procedure, and 0.8% (1/120) using the VisuMax sidecut only option (to create a flap within the original 
flap to avoid a zone of epithelial ingrowth scarring). A topography-guided custom ablation profile was used for 
8 eyes, which constitutes 1.7% of all 479 eyes treated (6.7% of the 120 retreatments performed), and was used 
to correct for a decentration in 5 eyes, and to enlarge the optical zone in 3 eyes. The scotopic pupil diameter 
(mean 6.04 mm, range: 5.34 to 7.10 mm) of this sub-group was not different to that of the population 
(p=0.282). 
 
2.4.3 Standard Outcomes 
Figure 2-1 shows the outcomes for primary treatments only. Figure 2-2 shows the final outcomes, including 
retreatments. 
 
Table 2-2 shows the normalized contrast sensitivity data preoperatively and after the final treatment. There 
was no change at 3 and 6 cpd, and small but statistically significant increase at 12 and 18 cpd (p<0.001). Table 
2-3 summarizes the ocular aberrations preoperatively and after the primary treatment. Coma and higher order 
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RMS were increased, as well as spherical aberration which increased by an average of 0.49 µm. ATLAS 
keratometry data showed that the mean keratometry was 38.09±1.65 D (range: 32.85 to 42.75 D, n=374) at 3 
months, 38.27±1.46 D (range: 34.57 to 42.51 D, n=297) at 1 year, and 38.36±1.47 D (range: 34.06 to 41.98 D, 
n=168) at 2 years. For 238 eyes with keratometry data at both 3 and 12 months, the mean change was 
0.22±0.43 D (range: -1.72 to 1.67 D, p<0.01). For 116 eyes with keratometry data at both 1 and 2 years, the 
mean change was 0.11±0.33 D (range: -0.88 to 1.43 D, p<0.01). 
 
2.4.4 Intraoperative Complications 
Table 2-4 provides the incidence of intraoperative complications. In the 109 eyes with flaps created using the 
Hansatome there were no intraoperative complications other than small epithelial defects requiring bandage 
contact lenses in 3 eyes (2.8%). There was no impact on CDVA in any of these cases. 
 
Of the 371 eyes treated using the VisuMax femtosecond laser, a peripheral epithelial defect requiring a 
bandage contact lens occurred in 8 eyes (2.2%). Suction loss occurred in 7 eyes (1.9%), 5 eyes in which the 
contact glass was immediately reapplied and flap creation completed with the same flap parameters; of these, 
a perfect flap was created in 4 eyes with the stromal bed appearing smooth prior to ablation. In the remaining 
eye some thin thread-like mid-peripheral stromal slivers were noted on the stromal bed with the central bed 
of good quality for ablation; the peripheral stromal slivers were repositioned before the excimer laser ablation 
was performed and the flap was repositioned perfectly with no subsequent loss of best spectacle corrected 
vision or contrast sensitivity. The remaining 2 eyes with repeated suction loss belonged to the same patient, 
where after four attempts on the first eye and one attempt on the second eye it was deemed not possible to 
adequately create flaps using the VisuMax. After discussion with the patient, the procedures were performed 
instead using the zero compression Hansatome microkeratome without further complication. In all 8 eyes that 
experienced a suction loss, there was no loss of CDVA nor contrast sensitivity, and 7 eyes actually experienced 
a gain of one line of CDVA. 
 
Further recorded complications in VisuMax treated eyes included one eye (0.3%) with a small tear to the hinge 
of the flap in an eye that subsequently gained two lines of CDVA; a small peripheral flap tear approximately 1 
mm within the flap boundary inferiorly in one eye (0.3%) where the flap lifting instrument perforated the flap 
while manually dissecting through a peripheral zone of dense opaque bubble layer (OBL) due to the presence 
of a small cryptic buttonhole in an 80 (programmed 98) µm flap – after ablation the flap was repositioned 
perfectly, a bandage contact lens was applied and after healing there was no change in CDVA. There were 3 
eyes (0.8%) in which there was inadequate or no femtosecond cutting within a small area of flap interface 
(centrally in 1 eye, peripherally in 2 eyes); in each case these areas could be dissected manually and there was 
no impact on CDVA or contrast sensitivity. 
 
Finally, there were 4 eyes (1.1%) in which a small buttonhole was discovered on lifting the flap (centrally in 1 
eye, peripherally in 3 eyes) probably secondary to previous focal contact lens related infections (with epithelial 
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plugs). In all cases, after carefully lifting the flap, the residual epithelium overlying Bowman’s layer was 
brushed off to reveal the stromal surface and the ablation was performed and flap replaced carefully followed 
by an overnight bandage contact lens. The eye with a central buttonhole lost one line of CDVA. 
 
2.4.5 Postoperative Complications Requiring Flap Lift 
Table 2-5 summarizes the incidence of postoperative complications that required a flap lift. A flap lift 
procedure was required at the 1 day visit to reposition the flap in 1 eye (0.3%) following a flap slip due to 
trauma to the eye overnight. This eye then also required a second flap lift procedure 1 week later for epithelial 
ingrowth removal which healed with no ingrowth. One other eye (0.3%) required a flap lift procedure for 
epithelial ingrowth following a retreatment procedure. A flap lift procedure was performed for 1 eye (0.3%) to 
treat microfolds at the 1 month timepoint. A flap lift procedure was performed for 1 eye (0.3%) to remove 
inorganic deposits from the flap interface. There was no impact on CDVA in any of these cases. 
 
Overall, across the 31 eyes that had intraoperative and/or postoperative complications, 1 eye lost 1 line of 
CDVA and none lost more than 1 line. 
 
 
2.5 Discussion 
The present study found the treatment of myopia between -8.00 D and -14.25 D using the MEL 80 excimer 
laser and either the VisuMax femtosecond laser or zero compression Hansatome microkeratome to be safe 
and effective. While there was an increase in higher order aberrations, as expected for a high myopic 
correction, this increase was not excessive as demonstrated by no reduction in contrast sensitivity. Safety in 
terms of change in CDVA was also excellent with no eyes losing 2 lines, 3% losing one line, and 50% gaining one 
line. While night vision disturbances were not objectively measured, a topography-guided retreatment was 
available for any patients reporting significant symptoms, but was only used in 8 eyes (1.7%) demonstrating 
that few patients experienced visually significant night vision disturbances. 
  
In order to compare the current study to published LASIK and phakic IOL studies, we performed a literature 
review for studies published within the last five years reporting results of myopia above -8.00 D. The main 
outcome parameters are shown in Table 2-6,
188-190, 198, 210-216
 as well as the studies included in the Cochrane 
review. The results of the present study were similar in terms of accuracy, efficacy and safety to those 
reported in the last five years for both LASIK and phakic IOLs, although the range treated was much higher for 
phakic IOLs (e.g. up to -23.00 D
214
). Nevertheless, as discussed earlier, intraocular surgery introduces potential, 
albeit unusual, serious visual complications. While ectasia can occur many years after surgery,
217
 with modern 
keratoconus screening techniques,
104, 218
 inclusion of biases for calculating predicted RST, direct measurement 
of RST before retreatment surgery, and the availability of corneal cross-linking,
120
 the risk of ectasia is 
significantly lower than 10 years ago. 
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It is important to note that the present study and other recent LASIK studies
210-212
 appear to contradict the 
conclusion from the Cochrane review;
186, 187
 these results are significantly better than those of both LASIK and 
phakic IOLs reported for studies included in the Cochrane review. The predictability ranged from 29% to 57% 
within ±0.50 D for the LASIK/PRK groups and from 24% to 76% for the phakic IOL groups in the Cochrane 
review, whereas the range was from 69% to 100% for recent LASIK studies. Similarly, postoperative UDVA was 
20/20 or better in 12% to 84% in the LASIK/PRK groups and 20% to 97% in the phakic IOL groups in the 
Cochrane review, whereas the range was 77% to 92% for recent LASIK studies. Finally, safety was much worse 
for the LASIK groups in the Cochrane review with a loss of 2 or more lines of CDVA between 4%
190
 and 12% of 
eyes,
188
 whereas no eyes lost even 2 lines in the recent LASIK studies. Therefore, it appears that the Cochrane 
review
186, 187
 only included studies that would be considered out-of-date, and the conclusions while applicable 
to earlier technology and protocols do not apply to modern LASIK. This demonstrates the limitation of the 
Cochrane review methodology to refractive surgery, as very few studies meet the strict criteria of being 
randomized control trials. This is further emphasized by the fact that the 2014
187
 update found no new studies 
meeting the inclusion criteria. While the Cochrane review methodology clearly represents a robust method 
scientifically, it suffers when applied to refractive surgery as the majority of studies reporting surgical 
outcomes are retrospective for obvious reasons. This however highlights the paucity of randomized controlled 
trials, outside of United States Food and Drug Administration trials,
219
 as a weakness of the refractive surgery 
field.  
 
In summary, LASIK for high myopia up to -14.25 D using modern technology was found to have similar 
outcomes to phakic IOLs, while avoiding the potentially serious complications associated with intraocular 
surgery.  
Page | 24 
2.6 Figures and Tables 
 
 
Figure 2-1: Nine standard graphs for reporting refractive surgery showing the visual and refractive outcomes 
for 479 high myopic eyes after initial treatment with the MEL 80 excimer laser and the VisuMax femtosecond 
laser (both Carl Zeiss Meditec) or the zero compression Hansatome microkeratome (Bausch & Lomb). UDVA = 
uncorrected distance visual acuity; CDVA= corrected distance visual acuity; D = diopters; Postop = 
postoperative; Preop = preoperative; SEQ = spherical equivalent refraction; TIA = target induced astigmatism; 
SIA = surgically induced astigmatism. 
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Figure 2-2: Nine standard graphs for reporting refractive surgery showing the visual and refractive outcomes 
for 479 high myopic eyes after final treatment with the MEL 80 excimer laser and the VisuMax femtosecond 
laser (both Carl Zeiss Meditec) or the zero compression Hansatome microkeratome (Bausch & Lomb). UDVA = 
uncorrected distance visual acuity; CDVA= corrected distance visual acuity; D = diopters; Postop = 
postoperative; Preop = preoperative; SEQ = spherical equivalent refraction; TIA = target induced astigmatism; 
SIA = surgically induced astigmatism. 
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Table 2-1: Study demographics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-2: Normalized mesopic contrast sensitivity (CSV-1000) 
 
 
 
 
 
 
 
CPD: Cycles Per Degree 
 
 
Table 2-3: Ocular aberrations (µm) 
 
HORMS: High Order Root Mean Square 
 
  
Number of Eyes (patients) 479 (318) 
Age (years) 
37±9 
(21 to 60) 
Gender Ratio (M/F %) 46 / 54 
Attempted Spherical 
Equivalent Refraction (D) 
-9.39±1.22 
(-8.00 to -14.18) 
Attempted Cylinder (D) 
-1.03±0.84 
(0.00 to -4.50) 
Scotopic pupil (mm) 
5.80±1.04 
(3.36 to 8.40) 
 3 CPD 6 CPD 12 CPD 18 CPD 
Pre 0.99±0.11 0.94±0.09 0.91±0.13 0.84±0.19 
Post 0.98±0.11 0.94±0.09 0.93±0.13 0.87±0.20 
p-value 0.127 0.249 <0.001 <0.001 
 Pre Post Change t-test 
Coma 0.169±0.103 0.266±0.201 0.100±0.221 p<0.001 
Spherical Aberration 0.135±0.148 0.626±0.222 0.491±0.074 p<0.001 
HORMS 0.324±0.109 0.737±0.198 0.426±0.196 p<0.001 
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Table 2-4: Intraoperative complications 
 
Occurrences 
Percentage 
of Total 
Epithelial Defect 8 2.2% 
Suction Loss 7 1.9% 
Incomplete Flap (Edge) 2 0.5% 
Incomplete Flap (Ablation Zone) 1 0.3% 
Buttonhole 4 1.1% 
Free Cap 0 0% 
Irregular Bed 0 0% 
Flap Tear 1 0.3% 
 
 
Table 2-5: Postoperative complications requiring flap lift 
 
Occurrences 
Percentage 
of Total 
Flap Lift for Trauma 1 0.3% 
Flap Lift for Epithelial Ingrowth 2 0.5% 
Flap Lift for Microfolds 1 0.3% 
Flap Lift for Interface Deposits 1 0.3% 
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 Table 2-6: Literature review of high myopic studies within last 5 years and included in Cochrane review  Accuracy UDVA Safety 
First Author N (eyes) Technique Preop SEQ (D) Age (years) FU 
Mean±SD (D) 
(range) 
±0.50 ±1.00 
Pre 
CDVA 
≤20/20 
≤20/20 ≤20/40 1 line ≥2 lines 
Reinstein 
2016
171
 
483 
LASIK 
VisuMax/Hansatome 
CZM MEL80 
-9.57±1.29 
(-7.50 to -14.18) 
36.8±9.4 
(21 to 60) 
1-2 years 
-0.26±0.47 
(-2.25 to +1.13) 
69% 95% 100% 89% 99% 3% 0% 
Kanellopoulos 
2013
210
 
116 
LASIK 
Wavelight FS200 
Wavelight EX500 
-7.67±1.55 
(-6.00 to -13.00) 
28.7 ± 7.5 
(17 to 51) 
3 months -0.37±0.08 89% 95% 73% 90.5% 97.4% 1.7% 0% 
Vega-Estrada 
2012
212
 
29 
LASIK 
IntraLase 
Schwind AMARIS 
-8.39±0.93 
(-6.75 to -11.25) 
36.7 ±10.8 
(24 to 61) 
6 months 
-0.42±0.82 
(-3.50 to +0.63) 
- 89.6% - - - - - 
Stonecipher 
2010
211
 
65 
LASIK 
IntraLase 
Allegretto Wave 400Hz 
-7.07±0.89 
(-6.86 to -12.63) 
33.8 
(20 to 60) 
6 months - 100% 100% - 92% 100% - 0% 
Stonecipher 
2010
211
 
141 
LASIK 
IntraLase 
Allegretto Wave 200Hz 
-6.76±1.01 
(-6.08 to -11.05) 
33.8 
(20 to 60) 
6 months - 86% 100% - 77% 100% - 0% 
Alió 
2015
215
 
40 
LASIK 
VISX 20/20 
(-6.00 to -18.00) 
51.1±6.7 
(35 to 60) 
15 years -1.37±2.21 - 46.2% - 43.6% 64.1% 10.3% 0% 
Oruçoğlu 
2012
216
 
143 
39 FU 
LASIK 
Technolas 
-21.70±5.80 
(-38.00 to -14.13) 
- 10 years 
-6.09±3.35 
(-14.38 to -0.50) 
- 
14% 
1 year 
- - 2.6% 10.3% - 
Hashemi 
2014
213
 
23 
PRK-MMC 
VISX STAR S4 
-8.82±1.25 
(≤ -8.00) 
28.7±5.3 1 year -0.25±0.41 85.7% - 76.2% 57.1% - 9.5% 0% 
Hashemi 
2014
213
 
23 
Phakic IOL 
Artiflex 
-9.49±1.94 
(≤ -8.00) 
27.7±5.3 1 year -0.17±1.17 95.7% - 95.7% 73.9% - 0% 0% 
Ju 
2013
214
 
82 
Phakic IOL 
STAAR ICL 
-15.56±4.35 
(-9.00 to -23.00) 
28.6 ± 7.6 
(19 to 45) 
3 months -1.85±0.72 72.5% 88% 45% 58.5% 92.7% 3.7% - 
Knorz 
2011
198
 
104 
Phakic IOL 
AcrySof Cachet 
-10.41±2.31 
(-6.00 to -16.50) 
36.6 ± 8.1 
(18 to 53) 
3 years 
-0.24±0.55 
(-2.00 to +1.63) 
78.8% 91.3% 100% 71.2% 98.1% 1% 1% 
El Danasoury 
2002
188
 
45 
LASIK 
NIDEK EC-5000 
-13.24±2.30 
(-9.13 to -17.50) 
33.7±7.1 
(21 to 47) 
1 year 
-0.87±0.8 
(-3.00 to -1.00) 
29% 56% - 12.2% 58.5% - 12.2% 
El Danasoury 
2002
188
 
45 
Phakic IOL 
Artisan 
-13.93±2.90 
(-9.50 to -19.38) 
33.7±7.1 
(21 to 47) 
1 year -0.64±0.8 42% 65% - 20.9% 88.4% - 0% 
Malecaze 
2002
190
 
25 
LASIK 
Hansatome 
Technolas 
-9.39±1.47 
(-8.00 to -12.00) 
38.4±7.6 
(31 to 52) 
1 year -0.74±0.67 44% 64% - 24% 80% 20% 4% 
Malecaze 
2002
190
 
25 
Phakic IOL 
Artisan 
-10.19±1.56 
(-8.00 to -12.00) 
38.4±7.6 
(31 to 52) 
1 year -0.95±0.45 24% 60% - 20% 60% 12% 0% 
Schallhorn 
2007
189
 
45 
PRK 
VISX S3 
-8.30±1.25 32.6±7.0 1 year +0.60±0.75 57% 80% 89% 82% - 7% 0% 
Schallhorn 
2007
189
 
43 
Phakic IOL 
TICL 
-8.04±1.28 30.8±6.0 1 year +0.27±0.36 76% 100% 93% 97% - 0% 0% 
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Chapter 3 LASIK for the Correction of High Hyperopic Astigmatism 
With Epithelial Thickness Monitoring 
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3.1 Abstract 
 
Purpose: To evaluate outcomes of high hyperopic LASIK using the MEL 80 excimer laser. 
Methods: Retrospective analysis of 785 consecutive high hyperopic LASIK procedures using the MEL 80 
excimer laser (Carl Zeiss Meditec) and either the VisuMax femtosecond laser (Carl Zeiss Meditec) or zero 
compression Hansatome (Bausch & Lomb) microkeratome. Inclusion criteria were attempted maximum 
hyperopic meridian ≥+4.00D and CDVA 20/20 or better. Patients were followed for a minimum of 1 year. 
Epithelial thickness monitoring by Artemis VHF digital ultrasound (ArcScan Inc) was used to evaluate potential 
for further steepening as a retreatment. A full review of the peer-reviewed literature was carried out for 
comparative purposes. 
Results: Mean attempted SEQ was +4.52±0.84D (+2.00 to +6.96D) and mean cylinder was 1.05±0.86D 
(0.00 to 5.25D). Mean age was 50±12 (18 to 70) with 61% female patients. Postoperative SEQ was ±0.50 D in 
50% and ±1.00 D in 77% of eyes, after primary treatment. After retreatment, 67% of eyes were ±0.50 D and 
89% were within ±1.00 D. UDVA was 20/20 or better in 76% of eyes after final treatment. One line of CDVA 
was lost in 25% of eyes and two lines were lost in 0.4%. There was a clinically insignificant but statistically 
significant decrease (P<.05) in contrast sensitivity (CSV-1000) by less than 1 log unit at 3 and 6 cpd, and by 1 
log unit at 12 and 18 cpd. Diurnal fluctuation in refraction was identified in 2 eyes, proven by VHF digital 
ultrasound to be due to diurnal epithelial remodelling overnight and unrelated to maximum postoperative 
keratometry induced. 
Conclusions: LASIK for hyperopia by cumulative treatment of up to +9.00 D with the MEL80 excimer laser was 
found to satisfy accepted criteria for safety, efficacy and stability. 
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3.2 Introduction 
Excimer lasers have been used as a treatment for high hyperopia since Dausch et al
220
 first reported the results 
of PRK for hyperopia up to +7.50 D in 1993 using the MEL60 excimer laser (Carl Zeiss Meditec, Jena, Germany). 
Numerous reports followed with results of high hyperopia correction with first generation excimer lasers, but 
many of these were associated with significant regression,
220-232
 undercorrection,
233-235
 and loss of corrected 
distance visual acuity (CDVA)
220, 222, 225, 226, 228-230, 235, 236
 leading a number of clinicians to suggest that safe and 
effective excimer laser correction of hyperopia might be limited to treatments below +4.00 D or +5.00 D.
224-226, 
231, 235, 237, 238
 However, there are more recent reports of safe, effective and stable outcomes
239
 for hyperopia 
above +5.00 D using these first generation excimer lasers.
227, 240-245
 
 
The first major improvement in hyperopic corneal ablation surgery came relatively early on as different groups 
found improved results, in particular improved stability, by increasing the optical zone and transition zone 
size.
226, 227, 240, 242, 246, 247
 The second major improvement was observed with the introduction of flying spot 
lasers to replace the broad beam scanning slit lasers, with an improvement in outcomes noted with the 
MEL70
248-250
 and MEL80
251, 252
 (Carl Zeiss Meditec, Jena, Germany), the LADARVision
245, 246, 253
 (Alcon, Fort 
Worth, TX), the EC-5000
254
 and NAVEX
255
 (NIDEK Co Ltd, Gamagori, Japan), the ESIRIS
256-259
 and Amaris
260-265
 
(Schwind GmbH, Kleinostheim, Germany), and the Allegretto,
266, 267
  Eye-Q
268
 and EX500
269
 (Alcon, Fort Worth, 
TX). Thirdly, alongside the development of excimer laser technology, significant progress has been made with 
ablation profile design. Finally, results have been improved by changing the protocol for ablation centration 
from the entrance pupil centre to the corneal vertex
260-262, 270, 271
 or coaxially sighted corneal light reflex.
82-84, 268, 
272
 
 
The purpose of the present study was to report the refractive outcomes of LASIK with the MEL80 excimer laser 
(Carl Zeiss Meditec, Jena, Germany) in a large number of eyes with high hyperopic refractive error of +4.00 D 
or more.  
 
 
3.3 Methods 
3.3.1 Patients 
This was a retrospective non-comparative consecutive case series including 835 eyes of 681 hyperopic primary 
LASIK procedures between 14/05/2003 to 20/12/2011 at London Vision Clinic.  
 
Inclusion criteria were: attempted maximum hyperopic correction of ≥+4.00 D (i.e. at least +4.00 D in one 
meridian), medically suitable for LASIK, no previous ocular, eyelid or orbital surgery, no visually significant 
cataract, CDVA 20/20 or better, age ≤70 years old, and a minimum follow-up of 1 year. Informed consent and 
permission to use their data for general analysis and publication was obtained from each patient prior to 
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surgery as part of our routine protocol. Because this was a retrospective study, institutional review board 
approval was not required. One patient did not provide permission, so was excluded from the analysis. 
 
A full ophthalmologic examination was performed by an in-house optometrist as described previously.
252
 This 
included a manifest refraction and a cycloplegic refraction according to a standardized protocol.
201
 The 
manifest refraction was repeated on a later date by the surgeon, which was used to plan the treatment. 
 
3.3.2 Planning 
In our protocol for high hyperopia, the following criteria must be met before the primary procedure. Firstly, 
the predicted post-operative residual stromal thickness must be greater than 250 µm. Secondly, the attempted 
correction was limited such that the predicted postoperative keratometry was less than 51.00 D. Finally, an 
arbitrary maximum laser data entry of +7.00 D was applied. Therefore, some patients were treated using a 
planned two-stage protocol where the primary procedure was an intentional undercorrection, followed by 
retreatment at a later date. 
 
3.3.3 Surgical Protocol 
All treatments were performed as bilateral simultaneous LASIK using the MEL80 excimer laser. The zero 
compression Hansatome microkeratome was used between 14/05/2003 and 10/07/2009 in 38% of eyes and 
the VisuMax femtosecond laser was used between 05/10/2007 and 20/12/2011 in the other 62% of eyes. The 
procedure was performed by author DZR in 71% of eyes and by author GIC in 29% of eyes. The CRS-Master 
software platform was used to generate the ablation profiles. 
 
The standardized surgical technique followed has been described previously.
205
 Both the flap and corneal 
ablation were centered on the coaxially sighted corneal light reflex (CSCLR).
83
 During surgery, the CSCLR was 
determined before the flap was lifted as the first Purkinje reflex, seen as the patient fixated coaxially with the 
aiming beam and the view of the surgeon’s contralateral eye through the operating microscope. The CSCLR 
was used as the best approximation of the intersection of the visual axis with the cornea. 
 
Optical treatment zone diameters were 6.50-mm (in 18%) and 7.00-mm (in 82%). Intended flap thickness was 
160 µm in 35% and 180 µm in 2% of eyes (using the Hansatome), and 90-95 µm in 24%, 100 µm in 28%, 110 
µm in 8%, and 120 µm in 2% of eyes (using the VisuMax). Flap diameter was 8.5 mm in 0.4% and 9.5 mm in 
37% of eyes (using the Hansatome), and 8.0 mm in 16%, 8.5 mm in 0.5%, and 8.8 mm in 45% of eyes (using the 
VisuMax). For VisuMax flaps, a small contact glass was used for an 8.0-mm flap diameter, otherwise a medium 
contact glass was used. A 4.5-mm superior hinge was used in all VisuMax cases. 
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3.3.4 Postoperative Course and Evaluation 
Patients were instructed to instill tobramycin with dexamethasone (Tobradex; Alcon Laboratories, Inc., Fort 
Worth, TX) and ofloxacin (Exocin; Allergan Ltd, Marlow, UK) four times daily and wear plastic shields for 
sleeping during the first week. The surgeon reviewed the patient at day 1 and flap adjustments were 
performed if necessary at the slit-lamp using a surgical spear under topical anesthetic and antibiotic cover. An 
in-house optometrist examined the patient at 1, 3, and 12 months and yearly thereafter with surgeon review 
for all outliers. All visits included monocular and binocular UDVA, manifest refraction, and CDVA. Best 
spectacle-corrected mesopic contrast sensitivity, ATLAS corneal topography and dilated WASCA aberrometry 
(both Carl Zeiss Meditec) were performed at 3 months, 1 year, and 2 years. 
 
Postoperative complications and dry eye symptoms were assessed at each visit. A 6-grade classification system 
was used for each parameter: trace, GD I-II (not visually significant), and GD III-V. In this scale, trace refers to 
any small amount inconsistent with an untreated cornea, even if not visually significant. 
 
3.3.5 Retreatments 
Retreatments followed the same protocol in those who had planned retreatments and in those who required 
retreatment following a full correction. Retreatments were performed once stability was demonstrated over 
an interval of at least two months, defined as no change in sphere within ±0.25 D and cylinder within ±0.25 D. 
 
In the majority of cases, an Artemis very high-frequency (VHF) digital ultrasound (ArcScan Inc, Morrison, Colo) 
scan was performed to obtain layered pachymetric maps of corneal, epithelial and residual stromal 
thickness.
273
 When planning a retreatment, the safety was assessed by checking that the predicted residual 
stromal thickness after the retreatment was greater than 250 µm at the location of the maximum ablation as 
well as the location of the (peripheral) minimum residual stromal thickness.  
 
Suitability was assessed using an epithelial thickness map to confirm that the minimum epithelium was 
sufficient to avoid apical syndrome if further steepening was induced. We have previously shown that the 
central epithelium thins by approximately 2 µm for every diopter of hyperopic correction using the MEL80.
273
 
This can be used to predict the central minimum epithelial thickness after the retreatment and ensure that this 
remains greater than 28 µm. This is sufficient given that epithelial breakdown tends to occur for epithelial 
thicknesses of about 21 µm (personal communication, Dan Z. Reinstein). This method enables us to safely 
perform further steepening in cases that would otherwise have been excluded based on standard keratometry 
limits. According to these two safety factors, in some cases the retreatment performed was not a full 
correction. 
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3.3.6 Statistical analysis 
Outcome analysis was performed according to the Standard Graphs for Reporting Refractive Surgery for both 
the primary treatment, and after the final treatment. Data from the 2-year visit were used for analysis if 
available, otherwise 1-year data were used. Stability of keratometry was evaluated as the mean simulated 
keratometry at 3 months, 1 year, and 2 years. The change in whole eye higher order aberrations was assessed 
using a 6-mm analysis zone. The incidence of postoperative complications and dry eye symptoms were 
assessed for the 1 year visit. Microsoft Excel 2010 (Microsoft Corporation, Redmond, WA) was used for data 
entry and statistical analysis. A P value less than .05 was defined as statistically significant. 
 
 
3.4 Results 
3.4.1 Patient Population 
During the study period, 835 eyes were treated and a minimum of 1-year timepoint examination data were 
available for 790 eyes (95% follow-up), for which the last time point after the primary procedure was the 2 
year visit in 57% (n = 448), the 1 year visit in 38% (n = 303), and the 6 month visit in 5% (n = 39) of eyes. All 
eyes where the last timepoint after the primary procedure was earlier than 1 year had undergone retreatment 
at that time. For these eyes, 1-year follow-up data after the retreatment were used to analyse the final 
outcome. Table 3-1 shows demographic data for the study population.  
 
3.4.2 Retreatments 
The primary procedure was performed as a partial correction in 20% (n = 158) of eyes, of which 51% (81/158) 
had undergone a retreatment to date. Of the 632 eyes intended for full correction, 35% (220/632) have 
undergone a retreatment. In total, including two stage protocol cases, 38% (301/790) of eyes have undergone 
a retreatment. Of these 301 eyes, a second retreatment was performed in 6 eyes (2%) within the two year 
follow-up period. Retreatments were performed at the 6 month visit in 13% (n = 39), at the 1 year visit in 55% 
(n = 164), at the 2 year visit in 28% (n = 83), and after the 2 year visit in 4% (n = 12) of eyes. The mean 
attempted spherical equivalent of the retreatments was +1.08±0.96 D (-1.88 to +3.88 D), of which 6% (n = 18) 
were myopic, 82% (n = 243) were hyperopic, and 12% (n = 37) were mixed cylinder. 
 
3.4.3 Standard Outcomes 
Figure 3-1 presents the standard graphs for reporting refractive surgery after the primary treatment. Figure 3-
2 presents the standard graphs for reporting refractive surgery after all treatments. Table 3-2 shows the 
normalized mesopic contrast sensitivity data. There was a clinically insignificant but statistically significant 
decrease in contrast sensitivity (P < .001) representing less than half a patch at 3 and 6 cpd, and almost one 
patch at 12 and 18 cpd. Table 3-3 summarizes the ocular aberrations preoperatively and after the primary 
treatment. Table 3-4 summarizes the change in keratometry over time.  
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3.4.4 Complications 
In the 298 eyes treated using the zero compression Hansatome microkeratome, there were two flap 
complications. In the 492 eyes treated using the VisuMax femtosecond laser, there was 1 suction loss (0.2%), 1 
peripheral buttonhole (0.2%), 1 peripheral cryptic buttonhole (0.2%), and 1 case of incomplete sidecut 
creation (0.2%). None of these complications resulted in abortion of the procedure or a loss of more than one 
line CDVA.  
 
Table 3-5 provides the incidence of postoperative complications that required either a flap lift or Nd:Yag 
treatment (for epithelial ingrowth). There were also two cases of diurnal refractive fluctuations, with a myopic 
shift from morning to evening. These cases have been described in detail in a previous publication for an 
estimated overall incidence for this complication of 0.3%.
274
 Table 3-6 summarizes the incidence of 
postoperative complications as measured at the 1-year postoperative appointment. There were no visually 
significant complications (GD III-V). Table 3-7 summarizes the dry eye symptom parameters both before and 1-
year after surgery. All instances where a patient presented preoperatively with a form of dry eye of GD II or 
higher were actively managed prior to any surgery. 
 
 
3.5 Discussion 
The current study found the treatment of high hyperopia for an attempted correction between +4.00 and 
+9.25 D in the maximum meridian using the MEL 80 excimer laser to be safe and effective by using a two stage 
treatment protocol employing epithelial thickness mapping and monitoring. Although there was an increase in 
higher order aberrations, as expected for a high hyperopic correction, this increase was not visually harmful as 
demonstrated by only a very small decrease in contrast sensitivity, and only a 0.4% loss of 2 lines in CDVA. The 
two stage treatment protocol enabled a safer and more accurate final correction for high hyperopia in cases of 
undercorrection by regression but also enabling us to capitalise on cases that overcorrected after the primary 
procedure. These results show that LASIK is a safe and effective option for high hyperopia as an alternative to 
intraocular surgery, although the balance of risks and benefits must be carefully considered between these 
options. 
 
To compare the current study to published LASIK and intraocular lens studies, a literature review was 
conducted to identify published LASIK
222, 223, 225-227, 229-233, 235, 239, 241-246, 248, 250-258, 260-269, 275-277
 
 (PRK studies were not included) and intraocular lens studies (clear lens exchange, phakic IOLs)
199, 278-293
 
reporting results of hyperopic greater than +4.00 D. The main outcome parameters are shown in Table 3-8 for 
LASIK and Table 3-9 for intraocular lens procedures. Chronological examination of the LASIK studies shows a 
clear trend in improvement over time with modern excimer laser platforms showing a loss of 2 lines CDVA rate 
of between 0 and 6%. Further, some loss of CDVA would be expected as a matter of course due to the 
minification effect produced by corneal correction compared to spectacle correction. These rates are similar to 
the safety reported for refractive lens exchange where the loss of 2 or more lines ranged from 0 to 6.7%
279
 and 
Page | 36 
in one study 11%.
278
 Such CDVA comparisons must also be considered in context of the more unusual but 
potentially catastrophic visual complications of intraocular surgery, which cannot be adequately assessed by 
studies with small populations. For example, refractive lens exchange has been associated with 
endophthalmitis,
294
 posterior capsule opacification,
295
 cystoid macular edema,
296
 retinal detachment,
297
 and 
suprachoroidal haemorrhage.
298
 Equally, phakic intraocular lens implantation is associated with cataract 
formation,
299
 pupil ovalization,
300
 pigment dispersion,
301
 endothelial cell loss,
302
 and retinal complications.
303
 
Long term safety of intraocular procedures should also be taken into account given that many of these 
patients are 50 or younger. Complications such as long term IOL dislocation,
304
 capsular fibrosis, and posterior 
capsule opacification are often underreported. 
 
Postoperative dry eye exacerbation is another factor that should be considered when comparing corneal and 
intraocular interventions, given that LASIK involves disturbing the corneal nerve plexus. However, intraocular 
surgery also leads to exacerbation of meibomian gland dysfunction, dry eye and ocular discomfort albeit less 
so.
305
 In the present study, the only dry eye symptom that was greater at 1 year than before surgery was SPK. 
 
Corneal and intraocular approaches to treating high hyperopia are also differentiated in terms of possible 
achievable refractive correction, refractive stability over the medium and long term, and hence also refractive 
predictability. It is possible to achieve a larger degree of correction with intraocular surgery simply by changing 
the power of the lens, whereas hyperopic correction by LASIK has to abide by the limits of corneal steepening, 
epithelial thinning and potential regression. Therefore, the balance shifts toward intraocular surgery for very 
high hyperopia as reflected by the treatment range in the published studies compared to LASIK. However, 
some patients may opt for an undercorrection by LASIK as a compromise to completely avoid the more serious 
albeit unusual visually compromising complications of intraocular lens surgery. 
 
Intraocular lens procedures are inherently speaking more stable than corneal hyperopic procedures, but the 
refractive regression generally reported after hyperopic LASIK has been significantly reduced with the use of 
modern excimer laser systems and ablation profiles. In the present study, there is an initial over-correction 
which returned to target at 3 months, after which there was a hyperopic shift of about 0.10 D every 6 months. 
However, it is worth noting that hyperopic refractions progress with time regardless of whether refractive 
surgery has been performed; progression of 0.42 D across five years (0.08 D per year) has been reported in 
patients of 50 or older.
306
  
 
Refractive changes that may occur over many years after LASIK are often identified as a reason to opt for an 
intraocular procedure in high hyperopia given the perception that this would translate to better refractive 
predictability. However, a review of refractive predictability data between LASIK and IOL surgery shows that 
the percentage of eyes within ±0.50 D of the intended target was similar between modern LASIK and the 
intraocular procedures in the short to medium term. Whereas it might be expected for further hyperopic shift 
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in the long term after LASIK, longer term studies on the stability of clear lens exchange surgery in younger non-
cataract patients are lacking. 
 
In this series, two cases of a rare, idiosyncratic diurnal refractive fluctuation syndrome we have previously 
described were identified by VHF digital ultrasound layered anatomical imaging and shown to be due to 
epithelial remodelling from morning to evening following compression by the eyelid overnight.
274
 This 
phenomenon was found also to occur in eyes with hyperopia as low as +3.25 D and in postoperative 
keratometry as low as 41.20 D, with a total incidence of 0.3%. In cases where persistent fluctuation remains, it 
may be necessary to reverse some of the steepening achieved in order to stabilise the corneal epithelial layer 
and hence address the root cause for the induced diurnal refractive fluctuations. 
 
Analysis of ocular higher order aberrations showed a significant increase in coma, spherical aberration and 
higher order RMS. However, the increase in coma can be largely attributed to the difference in where the 
treatment was centered and where the aberrations were measured, meaning that coma will be measured 
postoperatively when measured on the entrance pupil centre. Spherical aberration induction on average was -
0.52 µm, however this was offset by the spherical aberration being positive in the majority of eyes before 
surgery, meaning that the postoperative level of spherical aberration was not visually compromising. Induction 
of negative spherical aberration also carries the benefit of increasing the depth of field,
252, 307, 308
 something 
that can be taken advantage of if cataract surgery is required in the future enabling high quality monofocal 
lenses to be used in conjunction with micro-monovision rather than employing light transmission reducing 
multifocal IOLs. In the present study, there was a small decrease in contrast sensitivity, however this was no 
greater than the drop associated with multifocal intraocular lenses that are currently and commonly used 
world-wide for patients with this degree of high hyperopia. 
 
In summary, the treatment of high hyperopia within +4.00 to +7.50 D by LASIK with the MEL80 employing 
epithelial thickness mapping and monitoring represents an equivalent and less-invasive alternative to an 
intraocular procedure in patients without visually significant cataract. Characterisation and comparison of 
long-term stability differences between LASIK and intraocular surgery needs further study in order to balance 
stability benefits against quality of life costs of the rare but more severe visual complications that may occur 
with intraocular procedures. 
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3.6 Figures and Tables 
 
 
Figure 3-1: Nine standard graphs for reporting refractive surgery showing the visual and refractive outcomes 
for 792 high hyperopic eyes after initial treatment with the MEL 80 excimer laser and the VisuMax 
femtosecond laser (both Carl Zeiss Meditec) or the zero compression Hansatome microkeratome (Bausch & 
Lomb). UDVA = uncorrected distance visual acuity; CDVA= corrected distance visual acuity; D = diopters; 
Postop = postoperative; Preop = preoperative; SEQ = spherical equivalent refraction; TIA = target induced 
astigmatism; SIA = surgically induced astigmatism. 
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Figure 3-2: Nine standard graphs for reporting refractive surgery showing the visual and refractive outcomes 
for 792 high hyperopic eyes after final treatment with the MEL 80 excimer laser and the VisuMax femtosecond 
laser (both Carl Zeiss Meditec) or the zero compression Hansatome microkeratome (Bausch & Lomb). UDVA = 
uncorrected distance visual acuity; CDVA= corrected distance visual acuity; D = diopters; Postop = 
postoperative; Preop = preoperative; SEQ = spherical equivalent refraction; TIA = target induced astigmatism; 
SIA = surgically induced astigmatism. 
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Table 3-1 – demographic and refractive data 
 
Number of eyes 785 
Number of patients 644 
Gender (% male / female) 39 / 61 
Age (years) 
50.4±12 
(18 to 70) 
Preoperative spherical equivalent refraction (D) 
+3.84±1.35 
(+0.63 to +8.38) 
Preoperative refractive astigmatism (D) 
1.05±0.86 
(0.00 to 5.25) 
Intended postoperative spherical equivalent refraction 
after primary treatment (D) 
-0.68±0.89 
(-1.88 to +2.75) 
Attempted spherical equivalent refraction correction in 
primary treatment (D) 
+4.52±0.84 
(+2.00 to +6.96) 
Attempted maximum hyperopic meridian correction in 
primary treatment (D) 
+5.04±0.84 
(+4.00 to +7.00) 
Spherical equivalent refraction relative to intended 
target after primary treatment (D) 
+0.30±0.85 
(-3.63 to +4.25) 
Refractive astigmatism after primary treatment (D) 
0.77±0.58 
(0.00 to 3.50) 
Intended postoperative spherical equivalent refraction 
after all treatments (D) 
-0.82±0.82 
(-2.38 to +2.50) 
Attempted spherical equivalent refraction correction 
including all treatments (D) 
+4.65±0.98 
(+2.00 to +8.33) 
Attempted maximum hyperopic meridian correction 
including all treatments (D) 
+5.18±0.99 
(+4.00 to +9.00) 
Spherical equivalent refraction relative to intended 
target after all treatments (D) 
+0.09±0.67 
(-2.38 to +2.50) 
Refractive astigmatism after all treatments (D) 
0.61±0.47 
(0.00 to 3.25) 
Pre-operative corneal thickness (µm) 
547±33 
(467 to 662) 
Scotopic pupil size (mm) 
5.10±0.96 
(2.05 to 7.85) 
Preoperative average keratometry (D) 
43.25±1.49 
(38.70 to 47.81) 
Average keratometry after primary treatment (D) 
46.64±1.90 
(40.99 to 51.85) 
Average keratometry after all treatments (D) 
46.80±1.99 
(41.50 to 54.50) 
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Table 3-2 - Mean normalized mesopic contrast sensitivity ratio for before and after the primary treatment 
 
cpd Pre Post p-value 
3 0.97 0.95 ↓ <0.001 
6 0.94 0.90 ↓ <0.001 
12 0.92 0.85 ↓ <0.001 
18 0.83 0.72 ↓ <0.001 
 
cpd: cycles per degree, ↓: indicates a decrease in mesopic contrast sensitivity 
 
Table 3-3: Change in ocular aberrations  
 
 
 
Table 3-4: Change in mean simulated keratometry 
 
 
 
 
 
 
 
  
Higher Order Aberration 
Pre 
Mean ± SD 
Post 
Mean ± SD 
Change 
Mean ± SD 
t-test 
Coma (µm) 0.22±0.13 0.77±0.32 0.54±0.33 p<0.001 
Spherical Aberration (µm) 024±0.14 -0.28 ±0.21 -0.52±0.18 p<0.001 
High Order Root Mean Square  
(µm) 
0.43±0.13 0.90±0.26 0.48±0.27 p<0.001 
Time Point / Interval n 
Mean K (D) 
± SD (range) 
P-value 
3 months 635 
46.9 ± 1.9 
41.3 to 52.4 
 
1 year 451 
46.6 ± 2.0 
41.0 to 51.8 
 
2 years 313 
46.6 ± 1.8 
41.0 to 51.5 
 
3-12 months change 371 
-0.34 ± 0.51 
-3.32 to 1.22 
<.01 
1-2 years change 211 
-0.13 ± 0.47 
-1.60 to 1.97 
<.01 
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Table 3-5: Incidence of postoperative complications requiring surgical intervention 
Postoperative complications after primary treatment 
requiring intervention (out of n = 785) 
Occurrence Percentage of Total 
Flap lift for trauma 3 0.38% 
Flap lift for inflammation 2 0.25% 
Postoperative complications after retreatment 
requiring intervention (out of n = 298) 
  
Flap lift for epithelial ingrowth 4 1.34% 
Nd:Yag for epithelial ingrowth 8 2.68% 
 
 
Table 3-6: Incidence of postoperative complications at 1 year 
Grade: Nil Trace 1 2 3 4 5 
Microfolds 99.9% 0.1% - - - - - 
Epithelial ingrowth 95.9% 3.1% 1.0% - - - - 
Interface haze 97.1% 2.9% - - - - - 
Infection 100% - - - - - - 
Interface debris 99.5% 0.5% - - - - - 
Diffuse lamellar keratitis 100% - - - - - - 
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Table 3-7: Incidence of dry eye symptoms before and 1 year after surgery 
(Data indicated as percentages) 
 
 
  Nil Trace 1 2 3 
SPK (exposure, inferior SPK) Pre 91.7 6.2 (1.0) 1.9 (0.6) 0.1 (0.0) 0.0 
SPK (exposure, inferior SPK) 1 year 72.4 18.0 (5.7) 7.5 (2.8) 2.2 (0.3) 0.0 
MGD Pre 67.5 22.2 8.0 2.2 0.1 
MGD 1 year 70.1 20.0 7.1 2.8 0.0 
Anterior blepharitis Pre 93.4 4.5 2.0 0.1 0.0 
Anterior blepharitis 1 year 96.4 2.4 1.1 0.0 0.0 
Posterior blepharitis Pre 95.3 2.4 2.0 0.1 0.1 
Posterior blepharitis 1 year 95.7 2.9 1.3 0.1 0.0 
Mixed blepharitis Pre 94.6 4.5 0.8 0.1 0.0 
Mixed blepharitis 1 year 98.1 1.5 0.4 0.0 0.0 
ABMD Pre 96.6 2.9 0.5 0.0 0.0 
ABMD 1 year 97.1 2.9 0.0 0.0 0.0 
Lash deposits Pre 99.9 0.1 0.0 0.0 0.0 
Lash deposits 1 year 99.7 0.1 0.0 0.0 0.1 
Meibomitis Pre 99.7 0.3 0.0 0.0 0.0 
Meibomitis 1 year 100.0 0.0 0.0 0.0 0.0 
Scurf Pre 99.7 0.3 0.0 0.0 0.0 
Scurf 1 year 99.6 0.4 0.0 0.0 0.0 
    Nil Present 
   Entropion Pre 99.9 0.1 
   Entropion  1 year 100.0 0.0 
   Ectropion Pre 99.9 0.1 
   Ectropion 1 year 99.9 0.1 
   Chalazion Pre 100.0 0.0 
   Chalazion 1 year 99.9 0.1 
   Pitted lid margins Pre 100.0 0.0 
   Pitted lid margins 1 year 99.9 0.1 
   Lid thickening Pre 100.0 0.0 
   Lid thickening 1 year 99.9 0.1 
   Blocked meibomian glands Pre 99.9 0.1 
   Blocked meibomian glands 1 year 99.9 0.1 
   Band keratopathy Pre 99.9 0.1 
   Band keratopathy 1 year 100.0 0.0 
    
Page | 44 
Table 3-8: Literature review of published LASIK studies for hyperopia greater than +4.00 D 
 
       Accuracy UDVA Safety 
First Author Year 
N 
(eyes) 
Technique Preop SEQ Age (years) Timepoint 
Mean±SD 
(range) 
±0.50D ±1.00D ≤20/20 ≤20/40 1 line 
≥2 
lines 
de Ortueta
261
 2016 38 
LASIK 
Amaris 
Carriazo-Pendular 
+4.07±0.90 
+2.38 to +5.75 
40±10 
18 to 57 
6 months +0.28±0.58 61 96 18 84 8 8 
Arba Mosquera
262
 2016 46 
LASIK 
Amaris 
Carriazo-Pendular 
+3.64±1.42 
+1.27 to +6.18 
45±11 
18 to 62 
6 months +0.39±0.43 61 93 30 85 13 6.5 
Plaza-Puche
263
 2016 51 
LASIK 
Intralase & Amaris  
OZ 6.2-6.9mm 
+6.33±0.83 
+5.00 to +8.50 
33±9 
21 to 54 
6 months 
+0.50±1.06  
-0.50 to +3.38 
 71 53 98 11 6.5 
Amigo
267
 2015 
 
24 
 
Allegretto 400 Hz & 
Hansatome 
Wavefront Optimised 
+3.66±0.61 
+2.75 to +5.00 
39±9 
20 to 49 
6 months 
+0.08± 0.56 
-0.75 to +1.25 
57 96 67 92 21 4 
16 
Aspheric Customised 
Profile 
OZ 6.5 mm 
+4.05±0.59 
+2.75 to +5.13 
+0.21±0.44 
-0.50 to +1.00 
100 100 81 100 12 0.0 
Plaza-Puche
264
 2015 86 
LASIK 
Intralase & 
500kHz Amaris excimer 
OZ 6.3-7.0mm 
+2.66±1.68 
-1.38 to +5.75 
40±10 
23 to 64 
36 months 
+0.40±0.65 
-1.63 to +2.00 
70 85 76 99 6.2 1.2 
Antonios
265
 2015 
53 
LASIK 
Moria M2 & Amaris 
+2.25±1.06 
+0.75 to +5.00 
45±12 
19 to 61 
6 months 
+0.22±0.75 
-1.25 to +1.75 
43 72 85 92 0.0 0.0 
72 LDV femto & Amaris 
+2.24±0.95 
+0.50 to +4.75 
46±10 
18 to 66 
 
-0.32±0.76 
-2.13 to +1.50 
65 90 88 100 0.0 0.0 
Alio
260
 2013 27 
LASIK 
Intralase & 
500kHz Amaris excimer 
OZ 6.2-6.9mm 
+6.33±0.83 
+5.00 to +8.50 
 6 months 
+0.55±1.09 
-0.50 to +3.38 
70  44 92 8 0.0 
Kanellopoulos
269
 2012 
34 
LASIK Xtra 
IntraLase / FS200 
+3.40±1.78 
+0.25 to +8.00 
 
2 years 
+0.20±0.40       
34 
LASIK Xtra 
EX500 
+3.15±1.46 
+0.25 to +8.00 
 -0.20±0.56       
Kanellopoulos
268
 2012 202 
LASIK 
Eye-Q 
+3.04±1.75 
+0.75 to +7.25 
(sphere) 
40±12 
19 to 62 
2 years 
-0.39±0.30 
(sphere) 
76 94 59 96 2.9 2.4 
Kermani
255
 2009 52 
LASIK 
NAVEX 
OZ 6.5mm (TZ 9mm) 
(visual axis group) 
+2.57±1.26 
+0.13 to +5.63 
 3 months 
+0.29±0.70 
-1.00 to +1.75 
81 96 51 95 21 10 
de Ortueta
258
 2009 33 
LASIK 
Carriazo-Pendular 
ESIRIS 
OZ 6.25mm 
+2.61±1.39 
+0.75 to +6.00 
52 
34 to 65 
3 months 
+0.26±0.51 
-0.38 to +1.88 
88 94    0.0 
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Llovet
251
 2009 49 
LASIK 
Moria I 
MEL80 
OZ 6mm 
+3.30±1.30 
+3.60 to +6.25 
36.9 
20 to 56 
1 year +0.40±0.60 63 90   8 4 
Reinstein
252
 2009 258 
LASIK 
Hansatome 
MEL80 
+2.54±1.16 
+0.25 to +5.75 
56 
44 to 66 
1 year +0.09±0.48 79 95 86 100 17 0.0 
Young
275
 2009 
Sub-
group 
of 1659 
eyes 
LASIK 
IntraLase FS60 
S4 
+4.00 to +5.50  1 month    38   20 
Alio
257
 2008 51 
LASIK 
ESIRIS 
+4.45±1.08 
+2.50 to +7.25 
 6 months 
+0.88±1.10 
-0.50 to +3.50 
80 88 54 95 4 0.0 
Waring
254
 2008 279 
LASIK 
EC-5000 
OZ 6mm (TZ 9mm) 
+3.51±1.45 
+0.50 to +6.75 
50±9 
23 to 69 
1 year 
+0.35±0.54 
-1.63 to +2.00 
61 99 63 90 15 1.4 
Desai
235
 2008 12 
LASIK 
Hansatome 
Star S2 
OZ 5mm (TZ 9mm) 
+4.10±0.69 
+4.00 to +5.50 
54±14 ≥3 years +0.59±1.18 32 68 17 67 0 9 
Alio
276
 2006 41 
LASIK 
Incl. retreatments 
Keracor 217C 
OZ 6mm 
5.30±0.90 
+4.00 to +7.75 
31±11 1 year 
+0.30±1.30 
-2.50 to +3.50 
46 63     
Alio
256
 2006 55 
LASIK 
Carriazo Pendular 
ESIRIS 
≥6mm 
+5.10±0.90 
+4.00 to +7.00 
 6 months 
+0.40±0.50 
0.00 to +2.00 
86 91   5.5 1.8 
Spadea
250
 2006 100 
LASIK 
Hansatome 
MEL70 
OZ 6mm 
+4.49±1.20 
+2.25 to +7.25 
40±8 
22 to 55 
2 years +0.29±0.66 70 92 64 96 6 0 
Kanellopoulos
266
 2006 23 
LASIK 
Moria M2 
Allegretto Wave 
+2.24±1.18 
+0.25 to +6.50 
 1 year 
+0.69±0.92 
0.00 to +1.50 
71    8 0 
Jaycock
232
 2005 47 
LASIK 
Microkeratome (180um) 
Summit Apex Plus 
OZ 6.0mm 
+3.58±1.48 
+0.75 to +7.00 
51.5 
32 to 66 
5 years +0.89±0.94 32 60 43 87 2.1 0 
Oral
245
 2004 
39 
LASIK 
S2 
+2.98±1.60 
+0.87 to +6.50 
51±10 
6 months 
+0.51±0.51 63 88 67 100 2.5 0.0 
25 S3 
+2.71±1.36 
+1.00 to +5.37 
58±9 +0.35±0.58 68 88 48 100 12 0.0 
41 LADARVision 
+2.59±1.28 
+0.62 to +5.62 
53±10 +0.24±0.57 76 86 76 100 0.0 0.0 
Esquenazi
231
 2004 18 
LASIK 
ACS 
Keracor 117C 
OZ 5.5mm (8.5mm TZ) 
+5.48±1.23 
+4.25 to +7.25 
 5 years +2.24±1.00 22 33 10 42   
Zadok
230
 2003 26 
LASIK 
ACS 
Keracor 117CT 
OZ 5.0-8.5 
+4.29±0.89 
+3.00 to +5.90 
45 
19 to 65 
1 year +0.21±0.60  92 23 92 11 0.0 
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  22  
+7.52±1.36 
+6.00 to +10.00 
  +1.62±1.50  36 14 59 4 13 
El-Agha
244
 2003 40 
S2 
LASIK 
+2.86±1.28 
+1.38 to +6.50 
41±9 
35 to 63 
9 months +0.44±0.57 
 
 
86 68 100 22 0.0 
Carones
246
 2003 53 
LASIK 
SKBM 
LADARVision 
OZ 7mm 
+2.34±2.09 
+0.50 to +6.00 
40±10 
20 to 58 
 
-0.22±0.41 
-1.75 to +0.75 
79 98 53 100 4 0.0 
Lian
243
 2002 54 
LASIK 
ACS 
Keracor 117C 
PZ 5-5.5 (TZ 8.5-9.5) 
+3.12 
+1.00 to +5.75 
38±13 
18 to 55 
1 year +0.29±0.78 61 83 63 93 12 1.9 
Ditzen
248
 2002 
23 
LASIK 
Hansatome 
MEL70 
Spherical 
+4.88±2.13 
+2.13 to +9.63 
28 
20 to 42 
1 year 
+0.30±0.90 
-0.75 to +2.50 
78  39 83 6 0.0 
44 Astigmatic 
+4.33±2.15 
+0.50 to +9.50 
30 
25 to 43 
+0.29±1.27 
-3.25 to +3.25 
42  4 63 4 4 
Cobo-Soriano
229
 2002 
74 
LASIK 
Moria LSK-One 
Keracor 217CT 
+4.40±0.30 
+4.00 to +4.90 
35.5 
18 to 65 
8 months 
  82 - - - 2.8 
56 
+5.30±0.20 
+5.00 to +5.90 
  80    5.8 
47 
+6.50±0.50 
+6.00 to +7.90 
  80    16.6 
Salz
253
 2002 
39 
LASIK 
Hansatome 
LADARVision 
OZ 6mm (TA 9mm) 
Spherical 
+3.00 to +6.00  
6 months 
 41 69 29 79  2.6 
48 Astigmatic +3.00 to +5.75   46 79 32 84  8.5 
Choi
239
 2001 32 
LASIK 
Hansatome 
S2 
+4.00±4.50 
+1.50 to +8.75 
55 
35 to 71 
6 months 
+0.30±1.70 
-3.00 to +2.70 
34 53  66 25 9 
Tabbara
233
 2001 80 
LASIK 
ACS 
Keracor 117C 
+3.40±2.00 
+0.50 to +11.50 
42±13 
18 to 65 
6 months 
+0.26±0.80 
-2.00 to +3.50 
58 84 44 98  1.25 
Argento
227
 2000 
251 
LASIK 
Microkeratome (160um) 
Keracor 117CT 
4.5-5.5mm OZ 
+5.28±0.69 
+5.50 to +8.50 
30.9% <40 
69.1% >40 
1 year 
+0.88±0.96 52 81  78 5 0.0 
32 5.9mm OZ 
+5.13±0.61 
+5.00 to +8.50 
19.1% <40 
80.9% >40 
-0.48±0.45 52 93  77 5 0.0 
Esquenazi
226
 1999 58 
LASIK 
Chiron 
Keracor 117CT 
OZ 5-7mm 
+4.50±1.73 
+1.75 to +8.50 
47 
20 to 63 
1 year 
+0.88±1.87 
-1.25 to +2.50 
61 73 35 81 6 6 
Barraquer
242
 1999 
30 LASIK 
Chiron 
Schwind-Keratom II 
OZ 7mm 
+4.67 
+3.51 to +6.00 
 
6 months 
+0.82 
0.00 to +2.50 
 80    0.0 
18 
+7.44 
+6.01 to +10.00 
 
+1.10 
-0.50 to +3.00 
 77    0.0 
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Arbelaez
225
 1999 
20 
LASIK 
ACS 
Keracor 117C 
4.5-5.5mm (TZ 8mm) 
+3.10 to +5.00  
1 year 
 43 83 28 93 24 0.0 
16 +5.10 to +9.00   38 50 0 50 24 12 
14 +3.10 to +5.00   41 58 10 81 21 7 
13 +5.10 to +9.00   17 17 0 15 61 15 
Argento
223
 1998 95 
LASIK 
Chiron 
Keracor 117CT 
5.0-5.5mm OZ 
+5.28±0.69  6 months +0.88±0.96 10 71 45  6 0.0 
Goker
241
 1998 54 
LASIK 
ACS 
Keracor 116 
OZ 8.5mm 
+6.50±1.33 
+4.25 to +8.00 
24 
21 to 64 
18 months +0.44±1.95 39 76 15 67  6.8 
Ditzen
222
 1998 23 
LASIK 
ACS 
MEL60 
OZ 5mm 
+5.28±1.92 
+4.25 to +8.00 
33±12 1 year 
+1.91 
-0.08 to +3.71 
   13 4.3 7.3 
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Table 3-9: Literature review of published CLE and phakic IOL studies for hyperopia greater than +4.00 D 
       Accuracy UDVA Safety 
First Author Year 
N 
(eyes) 
Technique Preop SEQ Age (years) Timepoint 
Mean±SD 
(range) 
±0.50D ±1.00D ≤20/20 ≤20/40 1 line 
≥2 
lines 
Hua
278
 2013 19 CLE + piggyback IOL 
+9.81±2.62 
+6.00 to +14.50 
45±8 
32 to 55 
2 years -0.20±1.39 31.6 68.4  21 21 11 
Ferrer-Blasco
279
 2012 30 CLE (ReSTOR) 
+4.52±1.14 
+3.00 to +7.00 
52 
44 to 60 
6 months -0.04±0.46 33 97   0.0 6.67 
Alfonso
280
 2011 45 CLE (AcriLISA) 
+3.53±2.29 
+0.25 to +10.00 
55 
45 to 64 
6 months 
-0.15±0.40 
-0.50 to +1.25 
87 93   24 0.0 
Alfonso
281
 2009 41 LASIK + CLE (ReSTOR) 
+2.71±1.61 
+1.25 to +5.50 
51±6 
45 to 65 
6 months 
-0.06±0.51 
-1.25 to +1.25 
73    22 2.4 
Fernandez-
Vega
282
 
2007 158 CLE (ReSTOR) 
+3.86±2.52 
+0.75 to +8.50 
53±6 
45 to 70 
6 months +0.23±0.32 89 100   11 0.0 
Pop
283
 2004 19 CLE (Acrysof / PMMA) +2.75 to +7.50 26 to 46 2 month +0.18±0.71 55 91  82 0.0 0.0 
Preetha
284
 2003 20 CLE (Staar IOL / Rayner) 
+6.66±2.17 
+4.75 to +13.00 
36 
19 to 50 
16 months 
+0.68±0.67 
0.00 to +2.50 
70 90 10 50 10 0.0 
Dick
285
 2002 26 CLE (Array IOL) 
+3.04±1.04 
+1.63 to +5.75 
52 
44 to 62 
6 months 
+0.04±0.45 
-0.83 to +1.00 
88 100 31 100 0.0 0.0 
Fink
286
 2000 24 CLE (SurgiAA-4203V) 
+6.32±1.32 
+4.75 to +10.25 
54.7 10 months 
+1.02±0.16 
+0.67 to +1.25 
71 88 25 63 29 0.0 
Siganos
287
 1998 35 CLE (Coburn) 
+9.19±0.34 
+6.75 to +13.75 
40 
19 to 55 
5 years 
+0.02±0.82 
-2.50 to +3.00 
74 91 14 100 0.0 0.0 
Lyle
288
 1997 20 CLE (Chiron / Ioptex) 
+4.73±1.98 
+2.38 to +7.63 
49±6 
37 to 60 
2 years 
-0.21±0.95 
-2.25 to +1.88 
 75  85 15 0.0 
Guell
199
 2008 41 Artisan +4.92±1.70 32 4 years -0.11±0.74 35 64 0 43   
Munoz
289
 2005 39 Artisan + LASIK 
+7.39±1.30 
+5.25 to +9.75 
26 
23 to 31 
1 year 
+0.06±0.52 
-1.50 to +0.75 
80 95 17 90 23 0.0 
Pop
283
 2004 19 Artisan +2.75 to +9.25 20 to 41 2 month -0.03±0.75 50 78  89 0.0 0.0 
Saxena
290
 2003 26 Artisan 
+6.80±1.97 
+3.00 to +11.00 
44 
28 to 60 
6 months 
-0.08±0.74 
-1.50 to +1.38 
59 86 50 96 11 0.0 
Alio
291
 2002 29 Artisan 
+6.06±1.26 
+3.00 to +9.00 
34 
19 to 54 
1 year 
0.10±0.57 
-1.00 to +2.00 
79 97 7 66 3.4 0.0 
Pesando
292
 1999 15 ICL 
+7.77±2.08 
+4.75 to +11.75 
38 
22 to 56 
1 year 
+0.02±0.64 
1.00 to +1.50 
69 92 0 46 8 0.0 
Davidorf
293
 1998 24 ICL 
+6.51±2.08 
+3.75 to +10.50 
 8 months 
-0.39±1.29 
+1.25 to -3.88 
58 79 8 63  4 
ICL = implantable Collamer lens, CLE = clear lens exchange, IOL = intraocular lens
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4.1 Abstract 
 
Purpose: Compare manifest refractive cylinder (MRC) correction predictability by LASIK between eyes with low 
and high ocular residual astigmatism (ORA). 
Settings: London Vision Clinic, London, UK 
Design: Case-control study 
Methods: Retrospective analysis of myopic astigmatism LASIK. ORA was calculated as the vector difference 
between MRC and corneal astigmatism (CA). The outcome measure was the Index of Success (IOS); ratio of 
Difference Vector / MRC. Groups were selected for comparison. Stage-1: low-ORA (ORA/MRC<1), high-ORA 
(ORA/R≥1). Stage-2: low-ORA group reduced to only include eyes matched for MRC in the high-ORA group. 
Stage-3: grouped by ORA magnitude with low-ORA <0.50D, mid-ORA 0.50D-1.24D, and high-ORA ≥1.25D. 
Stage-4: high-ORA group subdivided into low (<0.75D) and high (≥0.75D) CA. 
Results: Stage-1: mean preoperative MRC was -1.32±0.65D (-0.55 to -3.77D) in the low-ORA group (n=3,130) 
and -0.79±0.20D (-0.56 to -2.05D) in the high-ORA group (n=798). Mean IOS was 0.27 in the low-ORA group 
and 0.37 in the high-ORA group (p<0.001). Stage-2: mean IOS increased to 0.32 in the low-ORA group after 
matching MRC (p<0.001). Stage-3: mean preoperative MRC was -1.44±0.76D (-0.59 to -3.77D) in each group 
(n=316). Mean IOS was 0.28, 0.29, and 0.31 in the low, mid, and high-ORA groups respectively (p>0.05). Stage-
4: mean IOS was 0.20 in the high-ORA/low-CA group, and 0.35 in the high-ORA/high-CA group (p<0.001). 
Conclusions: Refractive cylinder predictability was slightly worse in eyes with high ORA when grouped by 
ORA/MRC. Matching for MRC and grouping by ORA magnitude resulted in similar predictability between the 
low and high-ORA groups, however, eyes with high ORA and high CA were found to be less predictable. 
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4.2 Introduction 
Ocular residual astigmatism (ORA) is the vectorial difference between corneal and refractive astigmatism at 
the corneal plane.
309-311
 It is the result of the combination of crystalline lens and posterior corneal surface 
astigmatisms with perceptual physiology and has been shown to be between 0 and 1.25 D for the majority of 
eyes in the normal population, but can range up to 2.00 D and beyond in otherwise normal eyes.
310-314
 With-
the-rule astigmatism is more likely in eyes with low ORA, while oblique and against-the-rule astigmatism is 
related to high ORA.
314
 The magnitude of ORA has been found to be abnormally high in some pathological 
conditions, such as keratoconus
315-317 
or post-LASIK ectasia,
318
 as well as after keratorefractive surgery.
309
 
Indeed, it has been hypothesized to have potential diagnostic value for the detection of some corneal 
disorders.
312 
 
High amounts of ORA have also been shown to be a potentially limiting factor for the predictability of 
refractive correction with an excimer laser. Some authors have reported a relationship between the 
magnitude of ORA and the remaining astigmatism after keratorefractive procedures.
310, 319, 320
 In 1997, Alpins 
introduced the concept that the ORA was a relevant factor to be considered when planning corneal refractive 
surgery to treat astigmatism, proposing that the treatment should be planned to also minimize corneal 
astigmatism.
310, 321
 Kugler et al.
319
 found that conventional LASIK was twice as efficacious in terms of correction 
of refractive astigmatism in a low-ORA group (ORA/refractive astigmatism < 1.0) as in a high-ORA group 
(ORA/refractive astigmatism ≥ 1.0). Similarly, Qian and colleagues
320
 demonstrated in a retrospective study 
evaluating the outcomes of myopic LASIK that this procedure was less effective in correcting refractive 
astigmatism when the astigmatism was mainly located at the internal optics. These authors recommend the 
consideration of both topography and refractive astigmatism values in the surgical planning when a significant 
amount of ORA is detected preoperatively. 
 
The aim of the current study was to evaluate the impact of the preoperative magnitude of ORA on the 
predictability of LASIK surgery for the correction of myopic astigmatism, but considering also the influence of 
the magnitude of refractive and corneal astigmatism in order to provide a more comprehensive analysis of 
such potential impact. 
 
 
4.3 Methods 
This study was a retrospective analysis including consecutive myopic patients who had undergone LASIK 
between July 2003 to July 2013 at London Vision Clinic, London, UK. Inclusion criteria were: medically suitable 
for LASIK, no previous ocular, eyelid or orbital surgery, no visually significant cataract, myopic manifest sphere 
treated between -0.25 and -10.00 D, manifest refractive cylinder treated between -0.75 and -4.00 D, corrected 
distance visual acuity (CDVA) not worse than 20/25, age less than 55 years (to minimize the influence of early 
cataract) and a minimum follow-up of 3 months after LASIK with the MEL80 excimer laser and either the 
VisuMax femtosecond laser (both Carl Zeiss Meditec, Jena, Germany) or zero compression Hansatome 
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microkeratome (Bausch & Lomb, Salt Lake City, UT). Informed consent and permission to use their data for 
analysis and publication was obtained from each patient. 
 
4.3.1 Preoperative Assessment 
A full ophthalmologic examination was performed by one of our in-house optometrists as described 
previously.
191
  
 
4.3.2 Surgical Procedure 
All treatments were performed as bilateral simultaneous LASIK using the MEL80 excimer laser and VisuMax 
femtosecond laser by one of two surgeons; DZR or GIC. The CRS-Master software platform was used to 
generate the ablation profiles (version 2.1.6 until 01/11/2009, version 2.3.0 thereafter - the software version 
upgrade changed the graphical user interface, but did not affect the ablation profiles). Proprietary aspheric 
ablation profiles were used, which incorporated a small amount of spherical aberration; the profiles were 
intended to control the induction of spherical aberration to a level that would provide an increased depth of 
field, without affecting contrast sensitivity and quality of vision. Optical treatment zone diameter was between 
6.00 and 6.50 mm, with a larger optical zone used for patients with larger pupil diameter. Intended flap 
thickness was between 80 and 120 µm when using the VisuMax and 160 µm when using the Hansatome.  
 
4.3.3 Postoperative Evaluation 
Patients were instructed to wear plastic shields while sleeping for 7 nights. Topical tobramycin 
0.3%/dexamethasone 0.1% and ofloxacin 0.3% were applied four times daily for the first week, which is our 
standard protocol for broad spectrum prophylaxis. Patients were reviewed at one day, one, three, six and 
twelve months using our standard protocol as described previously.
191
 All postoperative examinations were 
conducted by one of seven in-house optometrists. Manifest refraction was performed based on a standardized 
protocol,
201, 322
 and all optometrists had undergone refraction training with this protocol. 
 
4.3.4 Statistical Analysis 
The study included 4 stages of analysis to investigate the different outcomes according to the method used for 
selecting the groups of high and low ocular residual astigmatism (ORA) and whether the groups were matched 
for manifest refractive cylinder treated (MRC). All groupings were based on preoperative ORA and the MRC 
that was treated. In each stage, the outcomes were then evaluated by comparing the mean index of success 
(IOS) as defined by Alpins
309
 as the ratio of the difference vector (DV) magnitude over the target induced 
astigmatism vector (TIA) magnitude. The efficacy index (mean postoperative UDVA/mean preoperative CDVA) 
and safety index (mean postoperative CDVA/mean preoperative CDVA) were also calculated for each group. 
Mesopic contrast sensitivity was converted into log values before calculating statistics. The mean normalized 
mesopic contrast sensitivity ratio was calculated.
323
 Student’s unpaired t-tests or Mann-Whitney U tests were 
used to compare between groups according to normality of the data. A p-value less than 0.05 was deemed 
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statistically significant. Microsoft Excel 2010 (Microsoft Corporation, Seattle, WA, USA) was used for data entry 
and statistical analysis. 
 
Stage 1: Grouped by Ratio ORA/MRC, not matched for MRC. The four stages of the study are set out as a tree 
diagram in Figure 4-1. The first stage of the study was to replicate the methods as used by Kugler et al
319
 and 
Qian et al
320
 where the high and low ORA groups were selected according to the following criteria. First the 
ratio of ocular residual astigmatism over manifest refractive cylinder treated (ORA/MRC) was calculated for all 
eyes. All eyes where the ORA/MRC ratio was ≥1 were included in the high ORA group and all eyes where the 
ORA/MRC ratio was <1 were included in the low ORA group. The mean IOS was compared between the two 
groups.  
 
Stage 2: Grouped by Ratio ORA/MRC, matched for MRC. The second stage of the study was to investigate the 
effect of matching for manifest refractive cylinder treated, as opposed to the method described in Stage 1. In 
both the Kugler et al
319
 and Qian et al
320
 studies, the method of defining low and high ORA using the ratio of 
ORA/MRC resulted in the groups not being matched for refractive astigmatism treated. The ratio of ORA/MRC 
is more likely to be greater than 1 for eyes with low refractive astigmatism, therefore the high ORA group was 
biased towards eyes with low refractive astigmatism and vice versa for the low ORA group. To account for this, 
the second stage of the study repeated the analysis after matching for manifest refractive cylinder treated. For 
each eye in the high ORA group from stage 1 (the group with fewer eyes), an eye was found in the low ORA 
group from stage 1 matched for manifest sphere within ±0.25 D and manifest refractive cylinder within ±0.25 
D. The mean IOS was then compared between the two groups. 
 
Stage 3: Grouped by ORA magnitude, matched for MRC. The other consequence of the method of defining 
low and high ORA using the ratio of ORA/MRC was that the low ORA group also included eyes with a high ORA 
magnitude if the manifest refractive cylinder was high and for the same reasons, the high ORA group included 
eyes with a low ORA magnitude. Therefore, the analysis was repeated after selecting the groups based on the 
ORA magnitude alone. Eyes with an ORA magnitude <0.50 D were included in the low ORA group and eyes 
with ORA magnitude ≥1.25 D were included in the high ORA group, while the remaining eyes with ORA 
magnitude ≥0.50 D and <1.25 D were included in a third group representing mid ORA values. As in Stage 2, the 
groups were then reduced in order to be matched for manifest sphere and astigmatism treated; for each eye 
in the high ORA group (the group with fewest eyes), an eye was found in both the low and mid ORA groups 
matched for manifest sphere within ±0.25 D and manifest refractive cylinder within ±0.25 D so that all groups 
included the same number of eyes. The mean IOS was then compared between the three groups. 
 
Stage 4: Grouped by ORA magnitude, matched for MRC, subdivided for corneal astigmatism magnitude. 
Finally, the high ORA group generated in stage 3 was further subdivided into two groups based on the 
magnitude of corneal astigmatism (CA). Eyes with corneal astigmatism of ≥0.75 D were included in the high 
ORA/high CA group (i.e. the astigmatism treated was not well aligned with the corneal astigmatism), and eyes 
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with corneal astigmatism of <0.75 D were included in the high ORA/low CA group (i.e. the treatment would 
induce astigmatism onto a relatively spherical cornea). The mean IOS was then compared between the two 
groups as well as the three groups from Stage 3. 
 
 
4.4 Results 
4.4.1 Stage 1: Grouped by Ratio ORA/MRC, not matched for MRC 
Table 4-1 shows demographic data for the low and high ORA groups selected according to the ORA/MRC ratio. 
This shows that there was a large difference in the ORA/MRC ratio due to the group selection method, 
however, this meant that there was also a 0.53 D difference in manifest refractive cylinder treated (p<0.001). 
IOS was 0.09 lower in the low ORA group than the high ORA group (p<0.001), although there was no 
statistically significant difference in efficacy or safety index. The ORA was greater than the corneal astigmatism 
in 16% of eyes in the low ORA group and 56% of eyes in the high ORA group. 
 
4.4.2 Stage 2: Grouped by Ratio ORA/MRC, matched for MRC 
Table 4-1 shows demographic data for the low ORA group selected according to the ORA/MRC ratio after 
matching for manifest refractive cylinder treated in the high ORA group. There was still a large difference in 
the ORA/MRC ratio due to the group selection method, however, the manifest sphere and refractive 
astigmatism treated were matched exactly between groups. After matching, the difference in IOS between 
groups was smaller (0.05 lower in the low ORA group than the high ORA group), but this was still a statistically 
significant difference (p<0.001). The efficacy and safety indices were similar between groups. 
 
4.4.3 Stage 3: Grouped by ORA magnitude, matched for MRC 
Table 4-2 shows demographic data for the low, mid and high ORA groups selected according to the ORA 
magnitude and matched for manifest refractive cylinder treated. This shows that there was a large difference 
in the ORA magnitude, but the manifest sphere and refractive astigmatism treated were exactly matched 
between all three groups due to the group selection method. IOS was highest in the high ORA group (0.31), 
then the mid ORA group (0.29) and lowest in the low ORA group (0.28), however these differences were not 
statistically significant (p>0.05) and the efficacy and safety indices were also similar. 
 
4.4.4 Stage 4: Grouped by ORA magnitude, matched for MRC, subdivided for corneal 
astigmatism magnitude 
Figure 4-2 shows polar plots of the MRC, corneal astigmatism, and ORA for the four stage 4 groups. Table 4-2 
shows demographic data for the high ORA magnitude group divided into high and low corneal astigmatism. 
Although the groups were not matched exactly for manifest refractive cylinder treated, the difference was not 
statistically significant. The groups were also found not to be matched according to the axis of astigmatism, 
with 97.5% of the high ORA/low CA group having against-the-rule manifest refractive cylinder. The IOS was 
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found to be 0.15 higher in the high corneal astigmatism group (p<0.001), while the IOS in the low corneal 
astigmatism group was even 0.08 lower than the low ORA magnitude group (p<0.001). There was also a 
statistically significant difference in the efficacy index between the high ORA/low CA group and the high 
ORA/high CA group. 
 
 
4.5 Discussion 
The present study found that the predictability of the correction of manifest refractive cylinder was better for 
eyes with a lower degree of ORA than eyes with a higher degree of ORA when grouped by ORA/MRC, however, 
this difference was reduced after matching for MRC. Defining the groups according to the magnitude of ORA 
further reduced the differences such that there were no statistically significant differences between the low 
and high ORA groups although there was a trend for better predictability in the low ORA group. After dividing 
the high ORA group further, it was found that eyes with high ORA and low corneal astigmatism demonstrated 
the best predictability of all groups, and the worst predictability was found in the group of eyes with high ORA 
and high corneal astigmatism. 
 
The first stage of the present study was to replicate the methods used in two previous studies where the low 
and high ORA was defined according to the ORA/MRC ratio.
319, 320
 The present study found a similar result in 
that the IOS was greater for the high ORA group than the low ORA group. However, the IOS difference was 
0.09 between the groups, which was significantly less than the 0.26 D difference reported by Kugler et al,
319
 
and the 1.16 D difference reported by Qian et al.
320
 One reason why the result was so much higher in the study 
by Qian et al was that eyes with refractive astigmatism of -0.25 D were included. These eyes would almost all 
have been included in the high ORA group as an eye would only need an ORA of more than 0.25 D to qualify as 
high ORA (since the ORA/MRC ratio would be >1). If these eyes had a -0.25 D astigmatism postoperatively 
(which would not be surprising given the accuracy of refraction and refractive fluctuations), then the IOS 
would be 1, which would greatly inflate the mean IOS for this group. 
 
The second stage of the present study was to investigate whether the results were influenced by the groups 
not being matched for manifest refractive cylinder treated. As shown in the example above, using the IOS ratio 
as the outcome measure penalizes a postoperative refractive astigmatism of -0.25 D much more for an eye 
with less manifest refractive cylinder treated. This therefore introduces a potential bias in the results towards 
the group with higher manifest refractive cylinder treated. As the method for selecting the groups uses the 
ORA/MRC ratio, the group labeled as low ORA will inevitably end up with more eyes with higher manifest 
refractive cylinder treated and therefore gain the benefit from the skew introduced by evaluating the IOS 
ratio. In the present study, we found that the IOS difference between the low and high ORA groups was 
reduced by 42% from 0.09 to 0.05 once the two groups had been matched for manifest refractive cylinder 
treated. This implies that you could expect the results in the previous studies
319, 320
 to become a difference of 
0.15 (down from 0.26) and 0.67 (down from 1.16). 
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Next, we investigated whether the same results would be achieved if the groups were selected based on the 
magnitude of ORA rather than on the ORA/MRC ratio. This was done in order to avoid classifying an eye with 
very high ORA in the low ORA group; for example, using the ORA/MRC ratio selection criteria, an eye with ORA 
of 1.75 D would be included in the low ORA group if the manifest refractive cylinder was 2.00 D or more. After 
repeating the analysis with groups based on the magnitude of ORA, the IOS difference between the low and 
high ORA groups was further reduced by another 37% from 0.05 to 0.03, while this difference was also no 
longer statistically significant. This implies that you could expect the results in the previous studies
319, 320
 to 
become 0.09 and 0.42 had the groups been selected based on ORA magnitude. 
 
The final stage of the study was to further investigate the high ORA group to see whether the predictability of 
manifest refractive cylinder correction was affected by preoperative corneal astigmatism. The high ORA group 
was therefore subdivided into eyes with low corneal astigmatism and high corneal astigmatism. After 
repeating the analysis for these groups, a large difference of 0.15 was found between them. The high ORA/low 
CA group were found to have the best outcomes out of all the groups analyzed, 0.08 better even than the low 
ORA group. This group of eyes represents those with an essentially spherical cornea where a refractive 
astigmatism treatment induces astigmatism onto the cornea to balance the existing ORA. The question 
therefore is why the highest predictability was achieved in these eyes? The first explanation is that 97.5% of 
these eyes happened to have against-the-rule refractive astigmatism preoperatively, which might be expected 
as lenticular astigmatism is most commonly against-the-rule.
312, 314, 324
 Therefore, in such cases, a with-the-rule 
corneal astigmatism was created compensating efficiently for the levels of ORA, which is known to be better 
tolerated than against-the-rule astigmatism.
325, 326
 It is known that a correlation exists between the toricity of 
anterior and posterior corneal surfaces in the healthy human eye, with a ratio of posterior to anterior 
astigmatism between 0.3 and 0.4 depending on the author.
327-329
 As the magnitude of anterior corneal 
astigmatism was low in this group, the magnitude of posterior corneal astigmatism is expected to be even 
lower, with a negligible contribution to the magnitude of ORA.  Therefore, the ORA was mainly due to the 
crystalline lens optics in this group, which was compensated for by the induced anterior corneal astigmatism 
postoperatively.
 
 
Conversely, the worst results were found in the high ORA/high CA group. In this group, the IOS was 
significantly higher than in the high ORA/low CA group, indicating that the astigmatism correction was not 
performed at the appropriate axis and/or magnitude for achieving a complete balance of the corneal 
astigmatism and the ORA. One explanation may be the influence of the posterior corneal astigmatism. As 
described earlier, there is a positive correlation between magnitudes of anterior and posterior corneal 
astigmatism in the healthy cornea.
327-329
 Therefore, the posterior corneal astigmatism would be expected to be 
high in this high ORA/high CA group due to the high anterior corneal astigmatism. Given the presence also of 
high ORA, the postoperative target was to leave anterior corneal astigmatism with the same magnitude as the 
ORA at an axis orthogonal to the ORA. Therefore, there would still be high anterior corneal astigmatism 
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postoperatively, but at a different axis to the preoperative anterior corneal astigmatism, and consequently the 
alignment of the anterior and posterior corneal astigmatism would also be different to before surgery. 
However, it has been shown that the compensation between anterior and posterior corneal astigmatism is 
different for with-the-rule and against-the-rule astigmatism. The posterior corneal surface of the normal 
healthy eye has been shown to compensate for approximately 53%, 23%, and 22% of the magnitude of the 
anterior surface power vector components J0, J45, and astigmatism, respectively.
330
 This partial compensation is 
not only due to differences in the magnitude of anterior and posterior corneal astigmatism, but also to 
differences in the orientation of both astigmatisms. Koch et al
331
 recently demonstrated in a normal population 
that the magnitudes of anterior and posterior corneal astigmatism were correlated when the steeper anterior 
meridian was aligned vertically but not when it was aligned horizontally. Such differences in compensation 
between anterior and posterior corneal astigmatism may be the cause of the reduced predictability in the high 
ORA/high CA group. Bragheeth and Dua
332
 demonstrated a similar result in a previous study which showed 
that the predictability of refractive astigmatism correction was lower in eyes with a larger disagreement 
between the axis of refractive and corneal astigmatism (i.e. eyes with higher ORA). 
 
Another possibility is that the change in axis of the anterior corneal astigmatism means that the brain has 
greater difficulty in adjusting to astigmatism at a different axis to the natural preoperative astigmatism, as has 
been described by Vinas et al.
326
 This phenomenon has been described with relation to higher order 
aberrations in studies using adaptive optics, such as the study by Artal et al
333
 who showed that vision was 
degraded simply by rotating the nascent higher order aberrations. Therefore, part of the reduced predictability 
in the high ORA/high CA group may be due to the reduced ability of the brain to adjust to a change in 
orientation of the anterior corneal astigmatism. 
 
Another factor that may be contributing to the worse results in the high ORA/high CA group is the fact that 
astigmatic ablation profiles and simulated keratometry values assume the astigmatism to be orthogonal. While 
it is true that corneal astigmatism is orthogonal in the majority of normal eyes, there are also cases where the 
corneal astigmatism is asymmetric (i.e. at a different axis in the superior and inferior hemidivisions) meaning 
that corneal astigmatism calculated using simulated keratometry values does not accurately represent the true 
corneal astigmatism. Alpins et al. have described a parameter called Topographic Disparity
309, 334
 to account for 
asymmetric corneal astigmatism and have recently introduced a new parameter called CorT
335
 derived from a 
vector combination of astigmatism calculated for each Placido ring, which they showed corresponded better to 
manifest refractive cylinder than other commonly used measures. In such cases of asymmetric corneal 
astigmatism, the simulated keratometry method will be more likely to be misaligned with the manifest 
refractive cylinder and hence be classified as having high ORA. Given also that the ablation profile is calculated 
to correct orthogonal astigmatism, it would be expected for the accuracy of the astigmatism correction to be 
less predictable in these cases of asymmetric corneal astigmatism. 
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There are also some eyes where the corneal topography is irregular. In these cases, it might be expected for 
the refractive predictability to be affected even more, and a topography-guided ablation may have provided a 
better option. For example, it may be that the higher order aberrations are contributing to the refractive 
astigmatism (e.g. secondary astigmatism), but these elements are not accounted for by a sphero-cylindrical 
ablation.  
 
Finally, one other possibility is that a high ORA measurement was due to an error in the manifest refraction in 
some eyes. In such cases, the outcome would be less accurate by definition, which means there is a bias in the 
high ORA group towards a less predictable outcome. The presence of a high ORA measurement should be 
taken as an indication to double check the manifest refraction and can therefore be used to improve refractive 
outcomes. 
 
In conclusion, the magnitude of the ORA should be considered prior to the correction of refractive astigmatism 
by corneal laser refractive surgery as it can be a factor limiting the predictability of the planned correction in 
some patients, however, the influence of this factor may not be as great as previously reported. Eyes with high 
levels of ORA and anterior corneal astigmatism appear to be at higher risk for a less predictable astigmatic 
correction, which might be due to the contribution of the posterior corneal astigmatism. Surgical planning in 
such cases might be defined according to a vector analysis calculation considering the ORA, the MRC and the 
planned treatment correction vector (TIA), in order to minimize the induction of anterior corneal astigmatism 
as has been previously suggested by Alpins.
2, 12
 Future studies evaluating in detail the exact contribution of 
posterior corneal astigmatism to the refractive astigmatism predictability of corneal laser refractive surgery 
should be performed in order to confirm the results of our study. 
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4.6 Figures and Tables 
 
 
Figure 4-1: The four stages of analysis are set out in this tree diagram. Stage 1 was to group by the ORA/MRC 
ratio, but without matching for MRC. Stage 2 was to group by the ORA/MRC ratio and also match for MRC. 
Stage 3 was to group by the ORA magnitude and match for MRC. Stage 4 was to further subdivide the high 
ORA magnitude group according to high and low corneal astigmatism.  
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Figure 4-2: Polar plots showing the manifest refractive cylinder (left column), corneal astigmatism (middle 
column), and ocular residual astigmatism (right column) for the four groups in stage 4 of the analysis. These 
plots demonstrate how the group selection process was performed to differentiate firstly between low, mid 
and high ORA and then between low and high corneal astigmatism within the high ORA group. 
Page | 61 
Table 4-1 – Results for stage 1: grouped according to the ORA / MRC ratio into low ORA (if ORA/MRC ratio <1) and high ORA (if ORA/MRC ratio ≥1), with no matching for 
refractive cylinder treated. Results for stage 2: grouped according to the ORA / MRC ratio into low ORA (if ORA/MRC ratio <1) and high ORA (if ORA/MRC ratio ≥1), after 
matching for refractive cylinder treated. 
  Stage 1 Stage 2 
Mean±SD (range) 
High ORA 
(ORA/MRC≥1) 
Low ORA 
(ORA/MRC<1) 
(not matched) 
Mean difference with 
high ORA 
(p-value) 
Low ORA 
(ORA/MRC<1) 
(matched) 
Mean difference with 
high ORA 
(p-value) 
# Eyes 798 (682) 2,952 (2,008) - 798 (703) - 
Gender (% female) 55% 51%  50%  
Age (years) 
40.1±9 
(19 to 55) 
38.6±9 
(18 to 55) 
1.5 
(<0.001) 
38.0±9 
(18 to 55) 
2.1 
(<0.001) 
Preoperative Manifest Sphere (D) 
(corneal plane) 
-3.94±2.02 
(0.00 to -8.81) 
-3.67±2.03 
(0.00 to -8.81) 
-0.27 
(<0.001) 
-3.94±2.01 
(0.00 to -8.81) 
0.00 
(0.981) 
Preoperative Manifest Refractive 
Cylinder Treated (D) (corneal plane) 
0.79±0.20 
(0.56 to 2.05) 
1.32±0.65 
(0.55 to 3.77) 
-0.53 
(<0.001) 
0.80±0.21 
(0.55 to 2.03) 
0.00 
(0.717) 
Preoperative Manifest Refractive 
Cylinder Orientation 
(% WTR/Oblique/ATR) 
36 / 18 / 46 66 / 11 / 23 - 69 / 12 / 19 - 
Preoperative Corneal Astigmatism 
(D) 
0.97±0.61 
(0.00 to 2.90) 
1.31±0.70 
(0.06 to 4.00) 
-0.34 
(<0.001) 
0.94±0.42 
(0.10 to 2.75) 
0.03 
(0.154) 
Preoperative Ocular Residual 
Astigmatism (D) 
1.08±0.31 
(0.61 to 2.74) 
0.58±0.32 
(0.00 to 2.62) 
0.50 
(<0.001) 
0.47±0.21 
(0.00 to 1.50) 
0.61 
(<0.001) 
ORA / MRC 
1.38±0.37 
(1.00 to 3.89) 
0.49±0.25 
(0.01 to 0.99) 
0.89 
(<0.001) 
0.59±0.25 
(0.01 to 0.99) 
0.79 
(<0.001) 
IOS 0.37 0.28 
0.09 
(<0.001) 
0.32 
0.05 
(<0.001) 
Efficacy Index 1.00 0.99 
0.01 
(0.156) 
1.01 
-0.01 
(0.589) 
Safety Index 1.10 1.10 
0.00 
(0.185) 
1.10 
0.00 
(0.431) 
MRC = manifest refractive cylinder, WTR = with-the-rule (60-120˚), ATR = against-the-rule (0-30˚ and 150-180˚), ORA = ocular residual astigmatism, IOS = index of success  
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Table 4-2 – Results for stage 3: grouped according to the ORA magnitude into low ORA (ORA<0.50 D), mid ORA (0.50≤ORA<1.25 D), and high ORA (ORA≥1.25 D), after 
matching for refractive cylinder treated. 
 Stage 3 Stage 4 
Mean±SD (range) 
High ORA 
(ORA≥1.25 D) 
(matched) 
Mid ORA 
(0.50≤ORA<1.25 D) 
(matched) 
Mean difference 
with high ORA 
(p-value) 
Low ORA 
(ORA<0.50 D) 
(matched) 
Mean difference 
with high ORA 
(p-value) 
High ORA 
(ORA≥1.25 D) 
High CA 
(CA≥0.75 D) 
High ORA 
(ORA≥1.25 D) 
Low CA 
(CA<0.75 D) 
Mean 
difference 
(p-value) 
# Eyes 316 (274) 316 (297) - 316 (297) - 230 (206) 86 (80) - 
Gender (% female) 53% 46%  47%  52% 56%  
Age (years) 
40.2±9 
(19 to 55) 
38.2±9 
(18 to 55) 
2.0 
(0.006) 
37.9±10 
(18 to 55) 
2.3 
(0.002) 
40.2±9 
(19 to 55) 
40.2±9 
(25 to 55) 
0.0 
(0.973) 
Preoperative Manifest Sphere (D) 
(corneal plane) 
-3.39±2.03 
(0.00 to -8.42) 
-3.40±2.03 
(-0.25 to -8.42) 
0.01 
(0.961) 
-3.45±2.00 
(-0.25 to -8.62) 
0.06 
(0.717) 
-3.55±1.98 
(0.00 to -8.22) 
-1.34±0.45 
(-0.69 to -2.53) 
-2.21 
(0.023) 
Preoperative Manifest Refractive 
Cylinder Treated (D) (corneal plane) 
1.44±0.76 
(0.59 to 3.77) 
1.44±0.76 
(0.60 to 3.75) 
0.00 
(0.961) 
1.45±0.75 
(0.61 to 3.75) 
0.00 
(0.945) 
1.48±0.85 
(0.59 to 3.77) 
1.34±0.45 
(0.69 to 2.53) 
-0.13 
(0.118) 
Preoperative Manifest Refractive 
Cylinder Orientation 
(% WTR/Oblique/ATR) 
24 / 15 / 59 55 / 12 / 33 - 81 / 7 / 12 - 33 / 20 / 47 0.0 / 3.5 / 97.5  
Preoperative Corneal Astigmatism (D) 
1.31±0.78 
(0.08 to 3.90) 
1.39±0.80 
(0.00 to 3.80) 
-0.08 
(0.234) 
1.44±0.74 
(0.20 to 3.90) 
0.13 
(0.031) 
1.63±0.68 
(0.77 to 3.90) 
0.47±0.19 
(0.08 to 0.75) 
1.16 
(<0.001) 
Preoperative Ocular Residual 
Astigmatism (D) 
1.50±0.24 
(1.25 to 2.74) 
0.80±0.21 
(0.50 to 1.24) 
0.70 
(<0.001) 
0.30±0.13 
(0.05 to 0.49) 
1.20 
(<0.001) 
1.51±0.25 
(1.25 to 2.74) 
1.46±0.21 
(1.25 to 2.19) 
0.05 
(0.088) 
ORA / MRC 
1.32±0.64 
(0.36 to 3.89) 
0.70±0.37 
(0.18 to 2.02) 
0.62 
(<0.001) 
0.27±0.18 
(0.01 to 0.76) 
1.05 
(<0.001) 
1.37±0.71 
(0.36 to 3.89) 
1.18±0.34 
(0.68 to 1.85) 
0.19 
(0.020) 
IOS 0.31 0.29 
0.02 
(0.545) 
0.28 
0.03 
(0.152) 
0.35 0.20 
0.15 
(<0.001) 
Efficacy Index 0.99 0.97 
-0.02 
(0.464) 
0.97 
-0.02 
(0.825) 
0.98 1.03 
-0.05 
(0.043) 
Safety Index 1.10 1.10 
0.00 
(0.825) 
1.10 
0.00 
(0.949) 
1.10 1.11 
-0.01 
(0.328) 
MRC = manifest refractive cylinder, WTR = with-the-rule (60-120˚), ATR = against-the-rule (0-30˚ and 150-180˚), ORA = ocular residual astigmatism, IOS = index of success 
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5.1 Abstract  
 
Purpose: To report the visual and refractive outcomes, optical zone enlargement and recentration using 
topography-guided CRS-Master TOSCA II software with the MEL 80 excimer laser (Carl Zeiss Meditec) after 
primary myopic laser refractive surgery. 
Methods: Retrospective analysis of 73 eyes (40 patients) with complaints of night vision disturbances due to 
either a decentration or small optical zone following a primary myopic laser refractive surgery procedure using 
the MEL 80. Multiple Atlas topography scans were imported into the CRS-Master software for topography-
guided ablation planning. The topography-guided retreatment procedure was performed either as a LASIK flap 
lift, a new LASIK flap, a sidecut only, or as PRK. Axial curvature maps were analyzed using a fixed grid and set of 
concentric circles superimposed to measure the topographic optical zone diameter and centration. Follow-up 
was 12 months.  
Results: The optical zone diameter was increased by 11% from a mean of 5.65 mm to 6.32 mm, with a 
maximum change of 2 mm in one case. Topographic decentration was reduced by 64% from a mean of 0.58 to 
0.21 mm. There was a 44% reduction in spherical aberration, 53% reduction in coma, and 39% reduction in 
total higher order aberrations. A subjective improvement in night vision symptoms was reported by 93%. 
Efficacy: 82% of eyes reached 20/20 and 100% reached 20/32 (preop CDVA was 20/20 or better in 90%). 
Safety: No eyes lost 2 lines of CDVA and 27% gained one line. Predictability: 71% of retreatments were within 
± 0.50 D.  
Conclusions: Topography-guided ablation was effective in enlarging the optical zone, re-centering the optical 
zone and reducing higher order aberrations. Topography-guided custom ablation appears to be an effective 
method for retreatment procedures of symptomatic patients after myopic LASIK. 
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5.2 Introduction 
Ablation-related complications following refractive surgery such as decentered ablations, small optical zones, 
or irregular ablations can produce irregular optics and compromise quality of vision.
81
 Over the last two 
decades, several excimer laser platforms have developed topography-guided treatments to treat corneal 
irregularities starting with the MEL 70 and the original Topography Supported Custom Ablation (TOSCA) 
software (Carl Zeiss Meditec, Jena, Germany),
336, 337
 This was followed by the Topographic Assist LASIK (Chiron 
Vision Corp, Claremont, CA),
338
 B&L Technolas Keracor 117C (Bausch & Lomb Surgical Technolas, Munich, 
Germany),
339
 Laserscan 2000 (LaserSight, Orlando, Fla),
340, 341
 NIDEK Advanced Excimer Laser System (NAVEX; 
NIDEK, Gamagori, Japan) with Customized Aspheric Treatment zone (CATz),
342
 ALLEGRETTO WAVE excimer 
laser (WaveLight Technologie AG, Erlangen, Germany) with Topolyzer software,
343-346
 the Visx S4 with the 
custom-contoured ablation pattern (C-CAP) software (Johnson & Johnson),
347
 the Technolas 217C with 
TOPOLINK software (Bausch & Lomb Surgical Technolas),
348
 and ESIRIS with the ORK-CAM system (Schwind 
eye-tech-solutions, Kleinostheim, Germany).
349, 350
 
 
Published reports to date have found topography-guided treatment in general to be effective, successfully 
increasing uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), reducing corneal 
aberrations, and improving the regularity of the corneal surface.
336-350
 However, unpredictability of refractive 
outcome was reported as relatively common with the first generation topography-guided systems, with many 
authors recommending topography-guided treatments be approached as a two-stage procedure.
338, 339, 343, 344, 
348
 The MEL 80 (and MEL 90) CRS-Master (Carl Zeiss Meditec) includes a TOSCA II module, which combines 
corneal elevation data with corneal wavefront data to improve the refractive predictability relative to the 
original TOSCA system with the MEL 70.
336, 337
 Other more recent topography-guided systems have also 
incorporated more advanced algorithms for better refractive control. 
 
Topography-guided treatments have been shown to be more effective at improving corneal surface regularity 
and reducing patient subjective symptoms when treating regularly irregular astigmatism (a regularly-shaped 
irregularity, such as decentered of small optical zone) compared with irregularly irregular astigmatism (a more 
random appearance), such as that due to flap complications, trauma, cataract surgery, or corneal transplant.
81, 
348
 We have shown that the reduced effectiveness of topography-guided treatments in irregularly irregular 
astigmatism is due to epithelial thickness remodeling, which masks the stromal surface irregularity from front 
surface topography.
351-353
 The magnitude of the epithelial masking effect is driven by the stromal surface 
curvature gradient, which is higher in irregularly irregular astigmatism where the irregularities are more 
localized, hence increasing the stromal curvature gradient.
354, 355
 Therefore, our protocol is to first use trans-
epithelial PTK in such cases and use topography-guided ablation for regularly irregular astigmatism where the 
majority of the irregularity can be proved to be on the topography by measuring the epithelial thickness 
profile. 
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The purpose of the present study was to evaluate the effectiveness of using topography-guided custom 
ablation with the MEL 80 and CRS-Master platform to treat regularly irregular astigmatism in the form of 
decentration or small optical zones after primary myopic laser refractive surgery. 
 
 
5.3 Methods 
This was a retrospective study of consecutive eyes for patients reporting quality of vision symptoms (including 
glare, halos, starbursts, ghosting) related to either a topographic decentration or small optical zone following a 
primary myopic laser refractive surgery performed at London Vision Clinic, London, UK, that subsequently 
underwent a topography-guided retreatment between November 2005 and August 2013. All primary 
procedures were performed by one of two experienced surgeons (DZR & GIC) using the MEL 80 excimer laser 
and VisuMax femtosecond laser (both Carl Zeiss Meditec, Jena, Germany) or zero compression Hansatome 
microkeratome (Bausch & Lomb, Salt Lake City, UT). During the primary procedure, both the flap and corneal 
ablation were centred on the coaxially sighted corneal light reflex (CSCLR),
83
 used as the best approximation of 
the intersection of the visual axis with the cornea.
207
 
 
A full ophthalmologic examination was performed before retreatment by an in-house optometrist, as has been 
described previously.
137
 Manifest refraction was performed using a standardized and validated protocol.
201
 The 
manifest refraction was repeated by the surgeon at least 1 day before the retreatment, which was used for 
treatment planning. Informed consent and permission to use their data for general analysis and publication 
was obtained from each patient prior to surgery as part of our routine protocol. Because this was a 
retrospective study, institutional review board approval was not required. 
 
5.3.1 Atlas Topography Acquisition  
The Atlas is a Placido-based topographer with well documented surface reconstruction accuracy.
356, 357
 
Multiple Atlas examinations were obtained for each eye, using artificial tears if the mire rings were irregular. 
The criteria for selecting the examination to use for treatment were for the exam to a) be in focus, b) have 
smooth, regular mires rings, c) have continuous data within sufficient diameter, and d) be repeatable across 
multiple exams. The Atlas topographic examination to be used for treatment was selected by the surgeon.  
 
5.3.2 CRS-MASTER TOSCA II Ablation Software  
The CRS-Master, as described previously,
81
 features an approach for the control of sphere and cylinder (lower 
order aberrations) while simultaneously correcting topographical irregularities (higher order aberrations). The 
algorithm uses the corneal elevation and wavefront data to derive the ablation profile. The user can choose to 
address only the corneal irregularity, leaving corneal sphere and cylinder unchanged (setting “Topography 
Smooth”), or to perform a treatment that addresses corneal irregularity and calculates the ideal final surface 
based on the differences between the residual corneal lower order aberrations and the aberration-free 
manifest refractive error. TOSCA II treatments with the CRS-Master also include radially based ablation depth 
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energy correction algorithms. In summary, the TOSCA II algorithm is designed to correct corneal irregularities, 
control refraction to a specified target, and reduce the induction of higher order aberrations while correcting 
residual refractive error.  
 
5.3.3 Ablation Profile Generation 
The CRS-Master software platform (version 2.1) was used to generate the ablation profiles. The Atlas 
topographic data were imported into the CRS-Master. The CRS-Master automatically selects the center of the 
pupil as found by the Atlas to use as the center for the ablation generation algorithms. The CRS-Master also 
allows the surgeon to shift this location, and the corneal vertex was chosen for all eyes in this study to match 
the intended centration to the CSCLR intraoperatively. The corneal vertex was determined as the center of the 
topography mires as calculated automatically by the Atlas. During surgery, the corneal vertex was determined 
as the first Purkinje reflex, seen as the patient fixated coaxially with the aiming beam and the view of the 
surgeon’s contralateral eye through the operating microscope, and a 200 µm adjustment for parallax error.
83
 
Artemis very high-frequency digital ultrasound (ArcScan Inc, Morrison, CO) three-dimensional layered corneal 
pachymetry
61, 358
 was used to determine whether the treatment could be performed as LASIK. Safety was 
assessed by checking that the predicted residual stromal thickness after the retreatment was greater than 250 
µm at the location of the maximum ablation (non-central due to the custom profile) and the location of the 
minimum residual stromal thickness by VHF digital ultrasound. 
 
The parameters that were adjusted to control the ablation depth included manifest refraction, optical zone 
size, and whether to treat under an existing flap or as a surface procedure. The optical zone size was set as 
large as possible according to residual stromal thickness safety limits. The transition zone provided a total 
ablation zone that was 2 mm larger in diameter than the fully corrected optical zone. In cases where manifest 
refraction was near emmetropia, the “Topography Smooth” algorithm was used, which is designed to 
regularize the corneal topography leaving a target residual toric surface without affecting refraction.  
 
5.3.4 Postoperative Course and Evaluation 
Patients were instructed to instill tobramycin & dexamethasone (Tobradex: Alcon, Fort Worth, TX, USA) and 
ofloxacin (Exocin: Allergan Ltd, Marlow, UK) four times daily (our standard protocol for broad spectrum 
prophylaxis) and wear plastic shields for sleeping during the first week. Patients were reviewed at one day by 
the surgeon at which point if any microfolds were identified, flap adjustments were performed at the slit-lamp 
using a surgical spear under topical anaesthetic and antibiotic cover; to ensure any epithelial defects were fully 
healed, surgeon follow-up continued by the treating surgeon over the early postoperative period. All other 
follow-up appointments were carried out by the assigned in-house optometrist at one, three, and twelve 
months. Uncorrected distance visual acuity (UDVA) and spherical refraction were obtained at the one day 
postoperative visit. All subsequent follow-up visits included measurements of monocular and binocular UDVA, 
manifest refraction, and corrected distance visual acuity (CDVA). Best-corrected mesopic contrast sensitivity 
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was performed at the 3 and 12 month visits. ATLAS corneal topography was performed at 3 and 12 months. 
Subjective night vision disturbances were discussed with the patient at each visit. 
 
5.3.5 Visual and Refractive Outcomes Analysis 
Outcome analysis was performed according to the Standard Graphs for Reporting Refractive Surgery.
209
 Eyes 
where the intended postoperative refraction was not emmetropia were excluded in the efficacy analysis. 
Vector analysis was performed as described by Alpins.
309
 Data from the 1 year visit were used for analysis if 
available, otherwise 3 month data were used. Subjective symptoms were evaluated based on the notes 
entered in the medical record using four categories: worse, no change, improved - mild remaining, resolved. 
 
5.3.6 Topographic Outcome Analysis 
Topographic analysis of optical zone centration and diameter was performed as described previously.
359, 360
 
The preoperative and 3-month postoperative Atlas axial curvature maps with automatic scaling using 
expanded colors were imported into Microsoft PowerPoint 2010 (Microsoft Corporation, Redmond, WA). A 
previously prepared grid and set of concentric circles was overlaid; the lines of the grid were distributed 
equally with 0.1-mm steps and the concentric circles had radii increasing in 0.2-mm steps, between 4- and 7-
mm radii. The map was enlarged on the screen so that the center of the optical zone could be confidently 
visualized within half a step. The concentric circles were used to visually align and superimpose the best-fitting 
circle to the optical zone, defined as the region of consistent power. The achieved optical zone diameter was 
measured to the nearest 0.2 mm using the concentric circles. A histogram of the optical zone diameter before 
and after retreatment was generated. 
 
The central grid was then used to determine the centration offset of the optical zone with reference to the 
corneal vertex, with the optical zone center represented by the (0,0) coordinate of the central grid and the 
corneal vertex represented by the center of the topography map. The x- and y-coordinates of the location of 
the optical zone center with reference to the corneal vertex was measured to the nearest 0.05 mm using the 
central grid. 
 
The x-coordinates obtained for left eyes were mirrored in the vertical axis so that nasal/temporal 
characteristics of right and left eyes could be combined. The location of the center of the optical zones, 
relative to the corneal vertex (plotted as the origin), were displayed by plotting the x- and y-coordinates on a 
360° polar plot for before and after the retreatment. The vectorial mean and standard deviation ellipse were 
calculated for each population using principal component analysis to find the orientation with the greatest 
standard deviation. 
 
5.3.7 Corneal Aberrations 
Corneal aberrations obtained by the ATLAS were analyzed in a 6-mm zone using Optical Society of 
America notation. The change in corneal aberrations was calculated as the difference from before to 
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3 months after surgery for each third and fourth order Zernike coefficient. The root mean square (RMS) was 
also calculated for coma and total third and fourth order higher order aberrations. The change in aberrations 
was evaluated as a histogram. 
 
5.3.8 Statistical Analysis 
Student’s t-tests were used to calculate the statistical significance of changes in each parameter measured. 
Microsoft Excel 2010 (Microsoft Corporation, Seattle, WA, USA) was used for data entry and statistical analysis. 
A p-value <0.05 was defined as statistically significant.  
 
 
5.4 Results 
5.4.1 Population 
A total of 75 eyes of 41 patients underwent a topography-guided retreatment during the study period; 12-
month data were available in 66 eyes (88%) with 3-month data in the remaining 9 eyes (12%). Table 5-1 
presents demographic data for before and after the primary myopic procedure and after the topography-
guided retreatment. Table 5-2 presents information related to the type of procedure performed for the 
primary treatment and retreatment. A new LASIK flap was created in 8% (n=6) of eyes to create a thinner flap 
to enable the procedure to be performed as LASIK. A sidecut only was created in 3% (n=2) to avoid an area of 
old epithelial ingrowth.
361
 
 
5.4.2 Visual and Refractive Outcomes 
Figure 5-1 presents the standard graphs for reporting refractive surgery after the topography-guided 
retreatment. There were 3 eyes where the refractive correction was more than 1.50 D from the intended 
target. The primary procedure in all 3 cases had been PRK for very high myopia of -12 to -13 D. No eyes lost 
more than one line CDVA. 
 
Figure 5-2 shows the vector analysis for refractive cylinder after the topography-guided retreatment. There 
was a tendency for an overcorrection of refractive cylinder correction as shown in the target induced 
astigmatism (TIA) vector vs surgically induced astigmatism (SIA) vector scatterplot and the correction index 
polar plot. The angle of error demonstrated an accurate alignment of the treatment; the one case where angle 
of error was -88˚ (indicating an increase in cylinder at the same axis) was for an eye with -0.25 DC before 
surgery increasing to -0.50 DC.  
 
Table 5-3 shows the normalized mesopic contrast sensitivity data for before and after the primary treatment, 
and after the topography-guided retreatment. There had only been a small drop in contrast sensitivity at 3 cpd 
after the primary treatment, with no change at 6, 12, or 18 cpd. There was a small but statistically significant 
increase in contrast sensitivity at 6 cpd, and no change at 3, 12, or 18 cpd following the topography-guided 
retreatment. Table 4 shows the change in patient subjective night vision disturbances. 
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5.4.3 Optical Zone Centration 
Figure 5-3 shows axial topography maps before and after the topography-guided retreatment for 5 randomly 
selected cases. Figures 5-4 and 5-5 show the 360° polar plot for the center of the optical zone for before and 
after the retreatment, which showed a significant improvement in centration (P<.001). Table 5-5 includes the 
data for the centration offset of the optical zone relative to the corneal vertex before and after the 
retreatment. 
 
5.4.4 Optical Zone Diameter 
Table 5-6 includes the data and Figure 5-6 shows box plots for the optical zone diameter before and after the 
topography-guided retreatment, which showed a significant increase in optical zone diameter (P<.001). 
 
5.4.5 Corneal Aberrations 
Table 5-7 reports the change for coma, spherical aberration and total higher order RMS (HORMS) before and 
after the topography-guided retreatment. There was a significant reduction in each of coma, spherical 
aberration and HORMS (P<.001). 
 
 
5.5 Discussion 
The current study found the CRS-Master topography-guided custom ablation profile to be effective for optical 
zone enlargement and recentration following previous myopic corneal laser refractive surgery; optical zone 
centration was improved by 63% and optical zone diameter was increased by 11% on average. This 
improvement in topographic optical zone consequently achieved a significant reduction in higher order 
aberrations, with a 53% reduction in coma and 44% reduction in spherical aberration.  
 
These improvements were associated with a significant improvement in subjective night vision disturbances 
with 93% of patients reporting an improvement and 55% reporting complete resolution of symptoms. There 
was no change in subjective symptoms for 5 eyes (7%) of 3 patients, although there was an obvious 
topographic improvement in 4 of these eyes, both in terms of centration and optical zone diameter. Such cases 
of objective improvement, but no subjective improvement have also been reported in other studies.
343
 A 
weakness of this study is that this symptom analysis was based on patient discussion rather than a formal 
structured questionnaire. There was also no other objective measure of night vision disturbances, except for 
contrast sensitivity, which showed a slight improvement only at 6 cpd. However, this small change in contrast 
sensitivity was explained by the fact that there had been no drop in contrast sensitivity after the primary 
procedure other than a small decrease at 3 cpd. Therefore, an increase in contrast sensitivity might not be 
expected and patient symptoms were rather related to night vision, such as glare, halo, starburst, and 
ghosting.  
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At the same time as addressing the quality of vision symptoms, the uncorrected vision and refractive outcomes 
also demonstrated a significant improvement with UDVA 20/20 or better improving from 60% to 80% of eyes. 
All eyes achieved 20/32 or better after topography-guided retreatment compared with 82% before. Safety was 
also excellent with no eyes losing 2 lines of CDVA, and 27% gaining a line. Aside from the 3 eyes with previous 
high myopic PRK, refractive predictability was good, given that most treatments were for less than ±1.00 D 
with the main aim of treatment being topographic regularisation. There was a tendency for both myopic and 
hyperopic treatments to end up slightly myopic; mean postoperative SEQ was -0.20 D. 
 
To consider these results in the context of other topography-guided systems, a literature search was 
performed to identify published studies reporting outcomes of topography-guided retreatment for 
decentration and/or optical zone enlargement. Studies that reported only treatment of irregularly irregular 
astigmatism (e.g. after previous corneal transplant) and treatment of keratoconus were excluded. For studies 
that included both regularly and irregularly irregular astigmatism, only the cases with regularly irregular 
astigmatism were considered where possible (either by having been analysed as a separate group, or by 
extracting data for those cases if all patient data was available). A total of 16 studies were identified and 
included for analysis.
81, 337, 339-350, 362, 363
 All studies reported improvement or resolution of quality of vision 
symptoms in the majority of patients, demonstrating the effectiveness of topography-guided treatment of 
regularly irregular astigmatism. 
 
Table 5-8 provides a summary of the visual and refractive outcomes for these studies. Refractive predictability 
has improved over time with the modern systems achieving significantly better refractive control than the first 
generation systems. Safety was consistently with good with a loss of 2 lines CDVA in only 4 eyes across all 
studies (0.73%).  
 
Table 5-9 provides a summary of corneal aberration change for those studies where this data was reported. All 
studies showed a significant reduction in corneal aberrations. Topographic decentration was measured in only 
three studies, as summarized in Table 5-10, and topographic optical zone diameter was reported in only one 
study, as summarized in Table 5-11. In both cases, a significant improvement was achieved by topography-
guided retreatment. 
 
As described earlier, epithelial remodelling has been identified as a limiting factor for conventional 
topography-guided treatment based on front surface corneal topography data. Chen et al
364
 have pioneered 
the technique of combining trans-epithelial PTK with topography-guided treatment into a single treatment, 
such that the trans-epithelial PTK corrects the irregularities masked by the epithelium and the topography-
guided treatment corrects the irregularity visible on the front corneal surface. Vinciguerra et al
365
 have 
developed another approach to this problem by planning the treatment based on topography data obtained 
intraoperatively having first removed the epithelium. Finally, we have previously described the first case in 
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which the epithelial thickness profile was incorporated into the ablation generation algorithm to derive a 
stromal topography-guided ablation.
366
 It is likely that the ideal future of therapeutic refractive surgery will be 
based on stromal surface shape itself in order to account for the masking effect of the epithelium.  
 
Wavefront-guided custom ablation is an alternative option for treating highly aberrated eyes, however, the 
reduction in aberrations reported for wavefront-guided treatments has been lower than for topography-
guided treatments.
68
 Another disadvantage of wavefront-guided treatments is that these are forced to be 
centered on the entrance pupil, since this is where the data is captured. These treatments are therefore less 
effective for recentration of the optical zone to the corneal vertex, and can actually increase the decentration 
in eyes with a large angle kappa.
367
  
 
In conclusion, MEL 80, CRS-Master, TOSCA II retreatments appear effective for correcting topographic 
decentrations, optical zone enlargement, and reduction of higher order aberrations following unsatisfactory 
outcomes of previous refractive surgery with good simultaneous control of refractive error. 
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5.6 Figures and Tables 
 
 
Figure 5-1: Nine standard graphs for reporting refractive surgery showing the visual and refractive outcomes 
for 73 eyes after a topography-guided retreatment to correct a decentration or small optical zone. UDVA = 
uncorrected distance visual acuity; CDVA = corrected distance visual acuity; D = diopters; Postop = 
postoperative; Preop = preoperative; SEQ = spherical equivalent refraction; TIA = target induced astigmatism 
vector; SIA = surgically induced astigmatism vector 
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Figure 5-2: Vector analysis of refractive cylinder displayed as polar plots for target induced astigmatism vector 
(TIA), surgically induced astigmatism vector (SIA), difference vector (DV), and correction index (CI). 
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Figure 5-3: Four example cases showing the axial curvature map before and after a topography-guided 
retreatment. The difference map is shown in the third column, next to the ablation profile that was used; the 
region of flattening on the difference map corresponded with the area of maximum ablation. 
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Figure 5-4: Plot showing the optical zone center relative to the corneal vertex after the primary myopic 
treatment. The red data point indicates the vector mean and the red oval indicates the standard deviation (SD) 
ellipse. 
 
 
Figure 5-5: Plot showing the optical zone center relative to the corneal vertex after the topography-guided 
treatment. The red data point indicates the vector mean and the red oval indicates the standard deviation (SD) 
ellipse. 
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Figure 5-6: Box plots for the topographic optical zone diameter after the primary myopic treatment and after 
the topography-guided retreatment. The median is indicated by the horizontal line, the mean is indicated by 
the diamond, the interquartile (IQR) range is indicated by the grey box, and the minimum and maximum are 
indicated by the error bars. 
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Table 5-1: Demographic data for before and after the primary myopic procedure and topography-guided 
retreatment 
 
Eyes (patients) 73 (40) 
Gender (% M/F) 63 / 37 
Age (years) 
35±8 
(22 to 57) 
Scotopic pupil (mm) 
6.44±0.79 
(4.52 to 8.02) 
Primary myopic procedure 
SEQ treated (D) 
-7.37±2.17 
(-3.49 to -12.47) 
Cyl treated (D) 
-0.97±0.89 
(0.00 to -4.25) 
Postop SEQ relative to intended target 
(D) 
-0.20±1.02 
(-2.88 to +2.42) 
Postop cylinder (D) 
-0.52±0.37 
(0.00 to -1.50) 
Postop UDVA 20/20 or better 60% 
Postop UDVA 20/40 or better 91% 
Loss 1 line CDVA 5.5% 
Loss 2 lines CDVA 1.4%* 
Topography-guided retreatment 
Time after primary procedure (months) 
20±15 
(5 to 72) 
SEQ treated (D) 
-0.54±0.99 
(-3.75 to +1.00) 
Cyl treated (D) 
-0.48±0.45 
(0.00 to -2.00) 
Postop SEQ relative to intended target 
(D) 
-0.20±0.63 
(-1.88 to +2.25) 
Postop cylinder relative to intended 
target (D) 
-0.43±0.39 
(0.00 to -2.00) 
 
*One eye lost 2 lines CDVA due to haze following PRK. 
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Table 5-2: Information related to the primary myopic procedure and topography-guided retreatment 
 
Primary myopic procedure 
VisuMax LASIK (80-130 μm flaps) 49% 
Hansatome microkeratome (160 μm flaps) 33% 
PRK 18% 
Programmed optical zone diameter (mm) 
6.05±0.20 
(5.75 to 6.50) 
Topography-guided retreatment 
LASIK flap lift 75% 
New VisuMax LASIK flap 8% 
Sidecut only 3% 
PRK 14% 
Programmed optical zone diameter (mm) 
6.77±0.38 
(5.70 to 7.00) 
 
 
Table 5-3: Mean normalized mesopic contrast sensitivity ratio for before and after the topography-guided 
retreatment 
 
cpd 3 6 12 18 
Preoperative 1.01 0.90 0.87 0.81 
After primary procedure 0.96 0.90 0.87 0.82 
p-value ↓ <0.01 0.942 0.856 0.703 
After topography-guided retreatment 0.97 0.90 0.90 0.80 
p-value 0.118 0.802  0.036 0.812 
 
cpd: cycles per degree; ↓: indicates a decrease in mesopic contrast sensitivity; : indicates an increase in 
mesopic contrast sensitivity 
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Table 5-4: Change in patient subjective night vision disturbances after topography-guided retreatment 
 
Category Percentage 
Worse 0% 
No change 7% 
Improved - mild 
remaining 
38% 
Resolved 55% 
 
 
Table 5-5: Optical zone centration before and after topography-guided retreatment 
 
Optical zone offset from corneal vertex 
(mm) 
Mean±SD 
(range) 
After primary treatment 
0.58±0.26 
(0.05 to 1.28) 
After topography-guided retreatment 
0.21±0.14 
(0.00 to 0.54) 
Change 
-0.37±0.27 
(-1.10 to 0.27) 
Change (%) ↓ 64% 
p-value <0.001 
Closer to the corneal vertex 89% 
Further from the corneal vertex 11% 
 
↓: indicates a decrease in optical zone offset from the corneal vertex 
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Table 5-6: Optical zone diameter before and after topography-guided retreatment 
 
Optical zone diameter (mm) 
Mean±SD 
(range) 
After primary treatment 
5.65±0.52 
(4.80 to 7.00) 
After topography-guided retreatment 
6.32±0.52 
(5.00 to 7.60) 
Change 
0.67±0.52 
(-0.40 to 2.00) 
Change (%)  11% 
p-value <0.001 
Increase in diameter 97% 
Decrease in diameter 3% 
 
: indicates an increase in optical zone diameter 
 
 
Table 5-7: Corneal aberrations in a 6-mm analysis zone before and after topography-guided retreatment 
 
Corneal aberrations (µm) Coma Spherical Aberration HORMS 
After primary treatment 
0.60±0.35 
(0.01 to 1.73) 
0.69±0.21 
(0.33 to 1.33) 
0.97±0.34 
(0.50 to 1.95) 
After topography-guided 
retreatment 
0.28±0.17 
(0.02 to 0.79) 
0.38±0.24 
(-0.01 to 1.12) 
0.59±0.23 
(0.24 to 1.39) 
Change 
-0.32±0.35 
(-1.29 to 0.29) 
-0.30±0.23 
(-0.88 to 0.39) 
-0.39±0.32 
(-1.16 to 0.15) 
Change (%) ↓ 53% ↓ 44% ↓ 39% 
p-value <0.001 <0.001 <0.001 
Increase in aberrations 21% 10% 11% 
Decrease in aberrations 79% 90% 89% 
 
HORMS: higher order root mean square; ↓: indicates a decrease in aberrations 
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Table 5-8: Visual and refractive outcomes for published studies of topography-guided retreatment for decentration and/or small optical zone 
 
    SEQ (D) LogMAR UDVA LogMAR CDVA Efficacy Safety 
Study Eyes Patient Type Software / Laser Pre Post ±0.50 ±1.00 Pre  Post Pre Post 
Pre 
CDVA 
20/20 
Post 
UDVA 
20/20 
Post 
UDVA 
2040 
Loss 2 
lines 
CDVA 
Knorz 2000339 11 
Decentration, small 
zone 
CAS / 117C 
-1.00±2.24 
-3.63 to +3.50 
+0.20±2.41 
-4.00 to +3.70 
NR NR 0.48 0.40 0.40 0.24 NR NR NR 9% 
Alessio 2001340 32 Decentration 
CIPTA / LaserScan 
2000 
-2.62±1.50 
-6.75 to -0.75 
-0.05±0.70 
-1.50 to +1.00 
69% 88% 0.83 0.13 0.13 0.04 NR 59% 91% 0% 
Alio 2003348 26 
Regularly irregular 
astigmatism 
TOPOLINK / 217C 
-1.10±2.00 
-6.00 to +2.00 
-0.30±0.84 
-3.00 to +1.00 
65% 89% NR 0.20 0.16 0.09 NR 0% 96% 0% 
Kymionis 2004337 11 Decentration TOSCA / MEL 70 
-0.14±1.58 
-1.75 to +3.00 
+0.46±1.02 
-1.00 to +1.75 NR NR 0.35 0.12 0.13 0.02 NR NR NR 0% 
Lin 2004347 8* Decentration C-CAP / S4 
0.20±1.78 
-1.75 to +4.13 
+0.77±1.27 
-0.50 to +3.63 50% 75% 0.32 0.29 0.14 0.10 38% 25% 75% 0% 
Kanellopoulos 
2005343 
27 
Decentration, small 
zone, and other 
Topolyzer / 
ALLEGRETTO 
WAVE 
-1.12±1.59 
-3.88 to +0.25 
-0.88±0.94 
-2.38 to +0.75 NR NR 0.39 0.10 0.20 0.02 NR NR NR 0% 
Jankov 2006344 16 
Decentration, small 
zone, and other 
Topolyzer / 
ALLEGRETTO 
WAVE 
-2.16±3.07 
-7.88 to +2.25 
-0.97±0.94 
-2.25 to +0.50 NR NR 0.81 0.29 0.07 0.05 NR NR NR 0% 
Toda 2007342 32 
Decentration, small 
zone, asymmetric 
astigmatism 
NAVEX / EC-5000 NR NR NR NR NR NR NR NR 59% 33% 70% 6% 
Wu 2008341 18 Decentration 
AstraPro2.2z / 
LaserScan LSX 
-1.87±1.38 
NR -0.13±0.57 67% 89% 0.43 0.03 0.08 0.01 NR NR NR 0% 
Lin 2008345 67 Decentration 
Topolyzer / 
ALLEGRETTO 
WAVE 
NR NR 76% 94% 0.41 0.08 0.11 0.00 NR 76% 94% 0% 
Lin 2008345 48 Small zone 
Topolyzer / 
ALLEGRETTO 
WAVE 
NR NR 81% 94% 0.37 0.04 0.02 0.00 NR 63% 94% 0% 
Alio 2008349 34 Decentration CAM / ESIRIS 
+0.47±1.16 
-1.75 to +3.00 
-0.06±0.57 
-1.50 to +1.25 74% 97% 0.20 0.12 0.07 0.07 NR NR NR 3% 
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Alio 2008350 28 Small zone CAM / ESIRIS 
-0.22±1.14 
-2.13 to +2.50 
+0.33±0.54 
-1.13 to +1.25 NR NR 0.33 0.17 0.11 0.08 43% 18% 89% 0% 
Reinstein 200981 33* 
Decentration, small 
zone 
TOSCA II / MEL 80 
-0.83±1.25 
-3.25 to 1.13 
+0.02±0.75 
-1.63 to +2.38 70% 82% 0.15 0.05 -0.03 -0.05 88% 68% 88% 0% 
Lin 2012346 37 Decentration 
Topolyzer / 
ALLEGRETTO 
WAVE 
NR NR 76% 94% NR NR NR NR NR 74% 92% 0% 
Lin 2012346 25 Small zone 
Topolyzer / 
ALLEGRETTO 
WAVE 
NR NR 81% 92% NR NR NR NR NR 62% 88% 0% 
Aslanides 2012362 18 Symptomatic CAM / ESIRIS 
-0.38±1.85 
-2.75 to +3.75 
-0.09±0.22 
-0.50 to +0.25 90% 100% 0.32 0.03 0.05 0.00 55% 73% 100% 0% 
Allan 2013363 5* 
Irregular 
astigmatism 
ZCAD / Pulsar Z1 
-0.15±1.10 
-2.00 to +0.75 
+0.83±0.92 
-0.13 to +1.88 40% 60% 0.46 0.11 0.05 -0.07 60% 40% 80% 0% 
Reinstein 2018174 73 
Decentration, small 
zone 
TOSCA II / MEL 80 
-0.20±1.02 
-2.88 to +2.42 
-0.20±0.63 
-1.88 to +2.25 71% 90% -0.05 -0.07 -0.02 0.05 90% 82% 100% 0% 
 
 
CAS = Corneal Analysis System (EyeSys Premier, Irvine, CA); TOPOLINK, 117C, 217C (Bausch & Lomb, Salt Lake City, UT); CIPTA = Corneal Interactive Programmed 
Topographic Ablation (LIGI, Taranto, Italy); LaserScan 2000, LaserScan LSX (Lasersight, Orlando, FL); TOSCA = topography supported custom ablation, MEL 80 (Carl Zeiss 
Meditec, Jena, Germany); C-CAP = custom-contoured ablation pattern, S4 (Johnson & Johnson, New Brunswich, NJ); Topolyzer, ALLEGRETTO WAVE (Alcon, Fort Worth, TX); 
CAM = Custom Ablation Manager, ESIRS (Schwind eye-tech solutions,  Kleinostheim, Germany); ZCAD, Pulsar Z1 platform Nd:YAG ablative laser (CV Laser Pty Ltd., Osborne 
Park, Australia)
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Table 5-9: Change in corneal aberrations for published studies of topography-guided retreatment for 
decentration and/or small optical zone 
 
   Coma Spherical Aberration HO RMS 
Study Eyes Software / Laser Pre Post Pre Post Pre Post 
Kymionis 2004337 11 TOSCA / MEL 70 NR NR NR NR 0.61 0.37 
Lin 2004347 8* C-CAP / S4 NR NR NR NR 0.66 0.36 
Toda 2007342 32 NAVEX / EC-5000 NR NR NR NR 1.38 1.01 
Wu 2008341 18 
AstraPro2.2z / 
LaserScan LSX 
1.33 0.99 1.36 1.02 1.89 1.50 
Alio 2008350 34 CAM / ESIRIS 0.88 0.61 0.02 -0.19 NR NR 
Alio 2008350 28 CAM / ESIRIS 0.61 0.43 0.75 0.43 NR NR 
Reinstein 200981 33* TOSCA II / MEL 80 0.25 0.30 0.56 0.24 0.68 0.54 
Aslanides 2012362 18 CAM / ESIRIS 0.45 0.25 0.22 0.10 0.75 0.45 
Reinstein 2018174 73 TOSCA II / MEL 80 0.60 0.28 0.69 0.38 0.97 0.59 
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Table 5-10: Change in optical zone diameter for published studies of topography-guided retreatment for 
optical zone enlargement 
 
   Optical Zone Diameter (mm) 
Study Eyes Software / Laser Pre Post Change 
Lin 2012346 25 
Topolyzer / 
ALLEGRETTO 
WAVE 
3.50 5.20 1.70 (49%) 
Reinstein 2018174 73 TOSCA II / MEL 80 
5.65±0.52 
4.80 to 7.00 
6.32±0.52 
5.00 to 7.60 
0.67 (11%) 
 
 
Table 5-11: Change in centration offset for published studies of topography-guided retreatment for 
decentration 
 
   Optical Zone Centration (mm) 
Study Eyes Software / Laser Pre Post Change 
Wu 2008341 18 
AstraPro2.2z / 
LaserScan LSX 
1.32±0.28 
0.82 to 1.90 
0.61±0.23 
0.25 to 1.06 
-0.71 (54%) 
Lin 2008345 67 
Topolyzer / 
ALLEGRETTO 
WAVE 
0.92 0.30 -0.62 (67%) 
Lin 2012346 37 
Topolyzer / 
ALLEGRETTO 
WAVE 
1.10 0.40 -0.70 (64%) 
Reinstein 2018174 73 TOSCA II / MEL 80 
0.58±0.26 
0.05 to 1.28 
0.21±0.14 
0.00 to 0.54 
-0.37 (64%) 
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Chapter 6 SMILE surgery planning and VisuMax software 
This chapter is an extract from: The surgeon’s guide to SMILE: Small incision lenticule extraction 
Dan Z. Reinstein, Timothy J. Archer, Glenn I. Carp, Editor. Thorofare, NJ: SLACK Incorporated, 2018. 
https://www.amazon.co.uk/Surgeons-Guide-SMILE-Lenticule-Extraction/dp/1630912654/ 
 
Mr. Archer’s contributions included: study concept and design, data collection (implementation of the medical 
record database), data quality processing, data analysis (using custom built outcomes analysis software), 
preparation of the manuscript, literature review. 
 
Reprinted with permission from SLACK Inc. 
 
This Chapter describes how to use the VisuMax treatment planning software for programming a SMILE 
procedure. There is currently no offline version for this software, so the treatment planning can only be done 
on the VisuMax itself. Therefore, treatment planning is best done in advance of the day of surgery in order to 
have uninterrupted access to the VisuMax. This also enables the planning to be done in a stress-free 
environment without the time pressure of keeping to the schedule of patients, and provides an opportunity to 
confirm any queries before starting the surgery list. In many clinics, the treatment planning is performed by a 
laser technician according to the treatment parameters defined by the surgeon. 
 
6.1 Using the VisuMax software 
This section of the chapter describes how to use the VisuMax software. This section has not been reproduced 
as part of this thesis as it does not include any original work and acts purely as a user manual. Figure citations 
start from 6-18 as the first 17 figures are included in section 6.1. 
 
6.2 SMILE geometry 
Before moving onto the treatment planning parameters, it is useful to review the geometry of a SMILE 
procedure to better understand the different values. During SMILE, four interfaces are created that delineate 
the lenticule, cap and small incision(s) as shown in Figure 6-18. These interfaces are created from posterior to 
anterior as once an interface has been created, this will obstruct the focus of the femtosecond laser. 
 
1) Lenticule interface; this interface defines the refractive power of the lenticule; performed from out-
to-in so that the patient’s vision and perception of the bubbles changes more gradually; also to 
avoid coalescence of bubbles centrally that may distort the cap interface. 
2) Lenticule side cut; this interface is created at the border of the lenticule to provide a clearly defined 
edge, otherwise the lenticule may be easily torn if it tapers to nothing like an excimer laser ablation 
profile. This is also known, and programmed, as the minimum lenticule thickness. 
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3) Cap interface; this interface is created parallel to the corneal surface to delineate the upper surface 
of the lenticule, and extend further peripherally to provide access for the surgeon; performed from 
in-to-out so that the femtosecond laser motors can move smoothly onto the small incisions. 
4) Small incision(s); this interface creates a tunnel to link the cap interface to the corneal surface, 
created at the outside edge of the cap; up to three small incisions can be created. 
 
 
Figure 6-18: Series of diagrams showing the femtosecond cutting sequence for a SMILE procedure; 1) lenticule interface from out-to-in, 2) 
lenticule side cut, 3) cap interface from in-to-out, and 4) the small incision(s). 
 
6.3 Refraction (lenticule interface) 
On the Lenticule tab, the first section relates to the refractive correction (Figure 6-19). Firstly, ensure that the 
vertex distance is set correctly according to the manifest refraction that was performed for the patient. This is 
displayed in the title of the refractions box, and can be changed in the settings menu if required. 
Unfortunately, there is no quick way to change this value directly within the planning window. 
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Figure 6-19: VisuMax software screenshot of the fields to enter the manifest and target refraction. 
 
The next fields allow entry of the preoperative manifest refraction (Manifest) and the target refraction 
(Target), from which the planned refractive correction (Correction) is calculated and displayed. The sphere and 
cylinder can be manually typed in to the nearest 0.01 D, or changed using the up/down buttons that adjust the 
value in 0.25 D increments. The axis can be manually typed or changed using the up/down buttons in 1° 
increments. Sphere can be set between -0.50 and -10.00 D, and cylinder up to -5.00 D can be entered, with a 
maximum spherical equivalent refraction of -12.50 D. 
 
To maximize efficiency, it is recommended to use the keyboard to type in the refractions, using the tab key to 
jump between fields (and shift+tab to jump in reverse order). Using the up/down buttons is particularly 
inefficient if the axis is larger. It should also be noted that the permissible range for axis is 0˚ to 179˚, so 0˚ 
must be used instead of 180˚.  
 
The manifest refraction is obviously the most important aspect of the treatment plan, so extra care and 
consideration should be given to checking these values. The manifest refraction should have been performed 
on at least two separate days, together with the patient’s spectacle prescription, an aberrometric refraction 
(or autorefraction), and a cycloplegic refraction. The technician planning the treatment should take the time to 
cross-check the sphere, cylinder, and axis amongst the set of refractions and notify the surgeon if there is any 
unexplained significant discrepancy, in which case a further manifest refraction might be indicated. It is also 
useful to calculate the ocular residual astigmatism (ORA) to compare the refractive cylinder with the corneal 
astigmatism, as a large ORA may uncover a possible error in the manifest refraction. Finally, if the patient is 
presbyopic, the micro-monovision target should be confirmed as being in the non-dominant eye, unless 
reversal was explicitly indicated by the surgeon. 
 
If a personal nomogram is being used,
368-371
  then the values entered into the VisuMax would be different to 
the manifest refraction in the patient’s chart, so it is important that the double check process includes both 
transferring the manifest refraction from the medical record to the nomogram, as well as from the nomogram 
to the laser. When using a nomogram, the laser data entry values are unlikely to be a multiple of 0.25 D, so the 
values must be entered using the keyboard rather than the up/down buttons next to the fields. Also, as the 
target refraction should have been considered as part of the nomogram calculation, the target should always 
be set to zero in the software to avoid repeating this part of the treatment plan. If the target refraction is used 
only within the software, then this part of the correction will not have been nomogrammed.  
Page | 89 
Page | 89 
 
 
In our experience with SMILE, using a manifest refraction protocol that pushes maximum plus and cylinder,
201
 
there is an undercorrection for both sphere and cylinder that requires a nomogram adjustment. An 
undercorrection has been identified in many of the published papers,
149, 154, 372, 373
 such as by Hjortdal et al
149
 
who reported a mean spherical equivalent refraction undercorrection of -0.25 D for a moderate to high myopic 
population (mean spherical equivalent refraction treated -7.05 D). This study also demonstrated a similar 
undercorrection for cylinder, as has been found in other studies that analyzed cylinder outcomes.
373-378
 Many 
other users have anecdotally confirmed an undercorrection for higher myopia. Therefore, we recommend a 
new user to initially use a nomogram of adding 10% to both sphere and cylinder treated, before developing a 
personal nomogram. 
 
In a recent study, we have also identified a difference between with-the-rule and against-the-rule cylinder 
treatments. Vector analysis (Figure 6-20) of a population of 313 eyes 3 months after SMILE for myopic cylinder 
of at least 0.75 D revealed an overcorrection in terms of cylinder magnitude from the plot of target induced 
astigmatism (TIA) against surgically induced astigmatism (SIA) – having used a personal nomogram to account 
for the previously reported undercorrection, as described above. The histogram of angle of error (AE) showed 
a symmetrical distribution, demonstrating no evidence of any systematic torque effect. However, inspection of 
the correction index (CI = TIA/SIA) polar plot showed that the data points were clustered around a CI of 1 (i.e. 
on target) for with-the-rule treatments, whereas the CI was greater than 1 for most against-the-rule 
treatments. To investigate this further we sub-divided the analysis according to the cylinder axis and plotted 
the TIA vs SIA scatter plot for with-the-rule, oblique, and against-the-rule groups. This quantified the difference 
in the form of the regression line slope, which increased from 1.07 for the with-the-rule group, to 1.15 for the 
oblique group and 1.32 for the against-the-rule group. Following this, we now use a dynamic nomogram for 
cylinder where the nomogram regression line slope is calculated according to the cylinder axis. 
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Figure 6-20: Vector analysis of a population of 313 eyes treated by SMILE for myopia with cylinder of at least 0.75 D. A) The TIA vs SIA 
scatter plot showed an overcorrection in terms of cylinder magnitude. B) The angle of error histogram showed a symmetrical distribution 
and therefore no evidence of any systematic torque effect. C) The correction index polar plot showed an overcorrection was more 
common for against-the-rule treatments than with-the-rule. D-F) This was quantified by grouping the analysis according to cylinder axis 
with the regression line slope increasing from the with-the-rule group, to the oblique and against-the-rule groups. 
 
The initial thought to explain this result is that there is a systematic induction of cylinder due to the small 
incisions. However, we have found no evidence of an astigmatic change from the incisions when analyzing 
eyes with spherical myopia. 
 
In addition to a personal nomogram (to maximize the refractive outcome), we also apply an age factor for non-
presbyopic patients to maximize the visual outcome. Even with the most sophisticated nomogram there will 
still be some scatter in the results, meaning that some eyes will be undercorrected and some overcorrected. 
Any patient, of any age, will be dissatisfied if left myopic after surgery, but a non-presbyopic patient will be 
happy if left slightly hyperopic. Therefore, we can take advantage of the existing accommodation in younger 
patients to maximize patient satisfaction by targeting slight hyperopia. In this group, overcorrected patients 
are still happy because they can accommodate, and undercorrected patients are also still happy because their 
refraction is plano or maybe -0.25 D – very few patients will be more myopic than this. The other advantages 
of this protocol is that it provides room for some regression, or more likely, progression, in the long term. All in 
all, it is likely that their refraction will have shifted back towards emmetropia for one reason or another by the 
time they become presbyopic. 
 
Our protocol uses a linear sliding scale such that the target refraction becomes less hyperopic for older 
patients (Figure 6-21). The linear function we routinely use starts with a target of +0.65 D for a 20 year old 
patient, and reaches emmetropia for a 42 year old. For example, the target for a 35 year old patient would be 
+0.20 D. For presbyopic patients, we will either perform PRESBYOND Laser Blended Vision LASIK,
191, 252, 379
 or 
use micro-monovision with SMILE, which we have found works very well as there is still some spherical 
aberration induction. 
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Figure 6-21: Line graph used to calculate the target postoperative refraction. A hyperopic age-factor is used for patients younger than 42 
to maximize the visual outcome and guard against regression or natural progression of the refraction. For presbyopic patients, a micro-
monovision protocol is used targeting the distance eye (usually the dominant eye) for emmetropia and the near eye for -1.50 D. 
 
6.4 Optical zone diameter  
The next section in the planning software to complete relates to the Lenticule parameters, the first of which is 
the optical zone (Figure 6-22). The optical zone will initially be set according to the treatment parameters that 
have been saved as the default using the Save as default checkbox. The optical zone can be selected within the 
range 5.00 to 7.90 mm. The optical zone can be manually typed to the nearest 0.01 mm, or changed using the 
up/down buttons to adjust the zone in 0.10 mm increments.  
 
 
Figure 6-22: VisuMax software screenshot of the fields to enter the lenticule parameters. 
 
As is well-established from the decades of experience with LASIK and PRK, the optical zone should be at least 
6.00 mm in order to reduce the risk of night vision disturbances and increase the refractive stability.
184, 380
 For 
SMILE, another reason for increasing the optical zone is to increase the lenticule thickness in low myopia.
156
 
Initially, SMILE was used for moderate and high myopia because of several prejudicial factors due to the 
concern that a thin lenticule for a low myopic treatment would be difficult to handle, or at greater risk of 
interaction between the interfaces distorting the lenticule regularity. However, simply increasing the optical 
zone to 7.00 mm, or even larger, increases the lenticule thickness and eliminates these concerns. At the same 
time, this protocol provides the patient with excellent quality of vision due to the large zone. In our published 
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series of SMILE for myopia between -1.00 and -3.50 D (Figure 6-23), the results were equivalent to LASIK for 
low myopia.
156
 
 
 
Figure 6-23: Visual and refractive outcomes for a population of 110 eyes treated by SMILE for low myopia between -1.00 and -3.50 D. 
Reproduced with permission from Reinstein DZ, Carp GI, Archer TJ, Gobbe M. Outcomes of small incision lenticule extraction (SMILE) in low 
myopia. J Refract Surg. 2014;30:812-818. 
 
However, the main reason for adjusting the optical zone in SMILE is to control the induction of spherical 
aberration; increasing the optical zone will reduce the induction of spherical aberration. Figure 6-24 shows the 
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induction of corneal spherical aberration (6 mm analysis zone, OSA notation) comparing groups from our 
SMILE population treated with optical zones of a 6.00 mm (n=72), 6.50 mm (n=118), and 7.00 mm (n=218). The 
induced spherical aberration decreased as expected for larger optical zones; the regression line slope was 
0.081 for 6.00 mm, 0.051 for 6.50 mm, and 0.027 for 7.00 mm zones.
381
  
 
 
Figure 6-24: Scatter plot showing the change in corneal spherical aberration (OSA notation) plotted against the spherical equivalent 
refraction treated by SMILE in a 6, 6.5, and 7 mm optical zone (blue lines), and compared to LASIK using the PRESBYOND Laser Blended 
Vision ablation profile (red).  
 
A further analysis was conducted to compare these results of SMILE, where the refractive lenticule is only 
minimally aspheric, to LASIK using the MEL 80 with the PRESBYOND Laser Blended Vision module,
191
 which 
uses a non-linear aspherically optimized ablation profile. As shown in Figure 6-24, the induction of spherical 
aberration for 6.00 mm LBV treatments was equivalent to a 6.00 mm SMILE treatment. Therefore, SMILE 
though minimally aspheric, produced similar spherical aberration induction to the highly aspherically 
optimized myopic LBV profile.  
 
Another factor to be considered is the lenticule thickness / ablation depth. Due to the aspheric optimization of 
the LBV ablation profiles, the ablation depth is greater than the SMILE lenticule thickness for the same optical 
zone; a 6.00 mm LBV ablation is equivalent to a 6.25 mm SMILE lenticule in terms of stromal tissue removal. 
Therefore, since we know that spherical aberration induction decreases for larger optical zones, spherical 
aberration induction after SMILE is significantly less than LASIK for an equivalent stromal tissue removal. 
 
Finally, the biomechanical difference between the two procedures can also be considered, for which purpose 
we developed a mathematical model to compare the postoperative total tensile strength (PTTS) between 
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SMILE and LASIK.
167
 If the optical zone is increased further beyond 6.25 mm, although this would require 
greater tissue removal, the tensile strength still favors SMILE even for an optical zone of 7.00 mm according to 
our mathematical model. Therefore, the biomechanical advantage of SMILE can be used to increase the optical 
zone and provide better optical quality (less spherical aberration induction) while still leaving the cornea 
stronger than after LASIK. 
 
To demonstrate this, the model was retrospectively applied to a SMILE case series (n=96) and the PTTS was 
compared to a control group of LASIK eyes matched for refraction (±0.25 D) and pachymetry (±20 μm).
382
 
Optical zone was not part of the matching criteria, so that the populations represented routine clinical use of 
the two procedures. Mean optical zone was 6.70±0.39 mm (range: 5.90 to 7.00 mm) for the SMILE group and 
6.08±0.22 mm (range: 5.75 to 7.00 mm) for the LASIK group. Mean lenticule thickness was 107±19 μm (range: 
72 to 149 μm) for the SMILE group, and mean ablation depth 87±25 μm was (range: 25 to 134 μm) for the 
LASIK group. Mean SMILE cap thickness was 130 μm (range: 120 to 140 μm). Mean LASIK flap thickness was 96 
μm (range: 80 to 120 μm). Mean spherical equivalent refraction was -4.83±1.59 D (range: up to -8.00 D) for 
both groups. Mean central corneal pachymetry was 539±30 μm (range: 468 to 591 μm) for the SMILE group 
and 545±36 μm (range: 469 to 626 μm) for the LASIK group. 
 
Figure 6-25 shows the PTTS calculated for all eyes using our model. Mean PTTS was 73% (range: 65 to 82%) for 
the SMILE group and 57% (range: 45 to 72%) for the LASIK group. Figure 6-26 shows the corneal spherical 
aberration induction (Atlas) for a 6 mm analysis zone for both groups. Mean change in spherical aberration 
(OSA notation) was 0.11±0.16 μm (range: -0.19 to 0.51 μm) for the SMILE group and 0.31±0.12 μm (range: -
0.11 to 0.66 μm) for the LASIK group. 
 
 
Figure 6-25: Postoperative total tensile strength (as calculated by a previously published model167) plotted against maximum myopic 
meridian treated for a routine clinical population of SMILE cases and a population of LASIK cases matched for sphere, cylinder and 
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pachymetry. Despite a larger optical zone used in the SMILE group, the postoperative total tensile strength was still 16% greater on 
average than in the LASIK group. 
 
 
Figure 6-26: Change in spherical aberration (OSA notation) plotted against maximum myopic meridian treated for a routine clinical 
population of SMILE cases and a population of LASIK cases matched for sphere, cylinder and pachymetry. The greater postoperative total 
tensile strength after SMILE enabled the use of a larger optical zone in the SMILE group and consequently a lower induction of spherical 
aberration and therefore better optical quality than in the LASIK group. 
 
Therefore, SMILE enables the use of larger optical zones than are generally used in LASIK. However, increasing 
the optical zone must also be balanced against the desired refractive correction and the corneal pachymetry. 
Tissue constraints may limit the optical zone that can be safely used meaning that a 6.00 mm optical zone 
might be the largest possible zone. In patients with low tissue availability for the desired correction, a smaller 
zone of 5.75 mm might be considered, in the context of appropriate informed consent of the increased risks of 
regression and reduction in quality of vision. Scotopic and dark pupil diameter can also be considered in these 
patients, with patients with smaller pupils likely to be at lower risk of night vision disturbances. 
 
In a retrospective analysis of our first 4,000 SMILE procedures, we have used the optical zone diameters as set 
out in Table 6-1. As can be seen, an optical zone of 6.50 mm or more was used in 89% of eyes, whereas these 
would most likely have been treated with a 6.00 mm optical zone with LASIK. As an aside, there was one eye 
where an 8.25 mm optical zone was used in order to increase the lenticule thickness for a low myopic 
correction of -0.75 -0.50 x 32. This was the near eye of a monovision patient targeting -1.25 DS for a 
preoperative manifest refraction of -2.00 -0.50 x 32 (20/12.5
-2
). At 3 months, UDVA was 20/63
-1
 with manifest 
refraction of -1.50 -0.50 x 5 (20/12.5), and the topography difference map showed the large optical zone 
(Figure 6-27). 
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Figure 6-27: Topography difference map following a SMILE treatment for -0.75 -0.50 x 32 using a 8.25 mm optical zone. 
 
Table 6-1: Distribution of optical zone diameter used for SMILE in 4,000 procedures 
Optical zone (mm) Count Percentage 
5.70 to 5.99 21 0.5% 
6.00 to 6.24 209 5.2% 
6.25 to 6.49 215 5.4% 
6.50 to 6.74 947 23.7% 
6.75 to 6.99 348 8.7% 
7.00 to 7.24 2,054 51.4% 
7.25 to 7.49 143 3.6% 
7.50 62 1.6% 
8.25 1 0.03% 
 
Induction of aberrations after SMILE has been reported in a number of published studies,
154, 376, 383-387
 which 
support the findings described above relating to control of spherical aberration. Table 6-2 summarizes the 
induction of spherical aberration for SMILE for these studies, analyzed for a 6 mm zone, using OSA notation. 
Simulated night visual acuity and contrast sensitivity have also been reported to be unaffected by SMILE.
388
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Table 6-2: Literature review of spherical aberration induction after SMILE. Data presented for 6 mm analysis 
zone in OSA notation. 
Study 
Spherical Aberration (µm) Spherical 
Aberration per D Pre-op Post-op Change 
Yildirim 2016
383
 0.20 0.56 0.36 0.05 
Liu 2016
384
 0.23 0.35 0.12 0.02 
Xu 2015
385
 0.20 0.46 0.26 0.05 
Pedersen 2017
376
 0.18 0.25 0.07 0.01 
Agca 2014
154
 0.21 0.28 0.07 0.02 
Wu 2016
386
 0.22 0.48 0.26 0.04 
Yu 2015
387
 0.24 0.26 0.02 0.00 
 Average 0.21 0.38 0.17 0.03 
 
6.5 Transition zone 
The next parameter to set is the transition zone (Figure 6-22). The transition zone will initially be set according 
to the treatment parameters that have been saved as the default using the Save as default checkbox. Our 
protocol is to include a transition zone of 0.10 mm for all myopic treatments as this introduces a slight bevel to 
the lenticule edge, which helps the instrument to engage the lenticule interface compared to a vertical 
lenticule edge. The transition zone can be selected within the range 0.00 to 2.60 mm. This can be manually 
typed to the nearest 0.01 mm, or changed using the up/down buttons to adjust the zone in 0.10 mm 
increments.  
 
In the current software, the transition zone will be disabled for a spherical treatment. As it is beneficial to 
include a transition zone for all cases, the transition zone field can be activated by setting the cylinder to +0.01 
D. This is enough to activate the transition zone box, but will not affect the treatment outcome. 
 
The total lenticule diameter is defined by the optical zone plus the transition zone. The total lenticule diameter 
is limited by the requirement for leaving sufficient clearance between the lenticule diameter and the cap 
diameter. If the lenticule diameter is too close to the cap, it will be difficult to find the two interfaces through 
the small incision. As myopic SMILE treatments are virtually always performed using a small ‘S’ size contact 
glass, the maximum cap diameter is 8.00 mm. Considering an example treatment using a 7.00 mm optical zone 
and 0.10 mm transition zone, the total lenticule diameter would be 7.10 mm, leaving a difference of 0.90 mm 
between the lenticule and cap diameters. In this instance, the clearance would therefore be 0.45 mm. 
 
If using a 7.50 mm optical zone and 0.10 mm transition zone, the total lenticule diameter is 7.60 mm, meaning 
that the clearance is 0.20 mm (Figure 6-28). As shown in Table 6-1, we have used a 7.50 mm optical zone for 
1.5% (n=60) of our SMILE procedures, and have had no issue in identifying the two interfaces. Similarly, given 
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that the optical zone and transition zone are crucial for optimizing outcomes of hyperopic corrections, these 
were maximized in our hyperopic SMILE study,
359, 360, 389
 leaving a clearance of 0.20 mm. Therefore, we have 
found that 0.20 mm is sufficient clearance for an experienced SMILE surgeon. For a novice SMILE surgeon, we 
would recommend a clearance of 0.50 mm.  
 
 
Figure 6-28: In this eye, the treatment parameters were 7.93 mm cap diameter, 7.50 mm optical zone diameter, and 0.10 mm transition 
zone. Therefore, the clearance of the lenticule border from the small incision was only 0.17 mm. 
 
6.6 Minimum lenticule thickness and lenticule side cut 
The final aspect of the lenticule that needs to be defined is the minimum lenticule thickness and lenticule side 
cut (Figure 6-22). In SMILE, there must be a small lamellar addition to the lenticule profile in order to provide 
definition between the lenticule and cap interfaces. This is referred to as the minimum lenticule thickness. 
Without this, a myopic lenticule profile would taper to nothing and would be likely to tear during interface 
edge delineation and separation.  
 
The minimum lenticule thickness will initially be set according to the treatment parameters that have been 
saved as the default using the Save as default checkbox. A 10-15 µm minimum lenticule thickness is used by 
the majority of SMILE surgeons, with our preference being 10 µm. The minimum lenticule thickness can be 
selected within the range 10 to 30 µm. This can be manually typed or changed using the up/down buttons in 1 
µm increments. It is important that extra care is taken when entering the minimum lenticule thickness as it is 
not currently shown on the treatment review page that is used to double check the data entry immediately 
before surgery. In cases where this has been changed, our protocol is for the technician to initial the 
nomogram printout beside each value so that the surgeon will be aware of the non-default value. 
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Increasing the minimum lenticule thickness can be useful for low myopic corrections as an alternative method, 
or in addition, to increasing the optical zone diameter to make the lenticule easier to handle. Sri Ganesh has 
anecdotally found that using a minimum lenticule thickness of 20-30 µm in low myopia helps to improve visual 
recovery in low myopia. In a recent study published by Liu et al
390
, a greater inflammatory response was found 
for low myopic eyes (-2.00 D) compared to moderate (-4.00 D) and high myopia (-8.00 D), using a 6.50 mm 
optical zone and 15 µm minimum lenticule thickness in all cases. This difference was correlated to more 
difficult interface separation for low myopia due to the thin lenticule, and the authors postulated that 
increasing the minimum lenticule thickness would improve the ease of separation and consequently improve 
visual recovery. However, we have not found a significant difference between 10 and 30 µm in this patient 
group. The other scenario where the thickness should be increased is for hyperopia; a hyperopic lenticule 
profile requires a minimum thickness of 25 µm to avoid creating a central buttonhole in the lenticule.
359, 360, 389
 
 
Another group where the minimum lenticule thickness might be changed is high myopia. In these patients, 
every micron is useful for optimizing the refractive correction and maximizing the optical zone diameter. We 
have been fortunate to have access to the VisuMax study software, which allows minimum lenticule thickness 
down to 3 µm,
134, 157, 391
 and have used this in 766 eyes without any issues, except for some slight fraying at the 
lenticule edges. Hopefully, this option will become widely available in the future. 
 
The other aspect of the lenticule side cut is the angle. The default value is 90° with a permitted range from 90° 
to 179° – a lenticule side cut less than 90° is not allowed as this would encroach on the lenticule profile. The 
lenticule side cut can be manually typed to the nearest 1°, or changed using the up/down buttons in 5° 
increments. There is no real need to use a lenticule side cut greater than 90° as this would make the edge of 
the lenticule tapered and therefore more likely to tear or fray. 
 
The minimum lenticule thickness is sometimes cited as being a weakness of SMILE given that it might be 
expected to induce an abrupt ‘cliff’ discontinuity on the corneal surface, and that this might induce excess 
spherical aberration. However, this is not an issue thanks to the natural epithelial remodeling mechanism that 
compensates for the discontinuity on the stromal surface by thickening over the trough and thinning over the 
relative peak.
354, 392, 393
 The lenticule edge is a highly localized discontinuity, so the epithelium is able to mask 
the majority of the irregularity, as epithelial compensation is driven by the curvature gradient. This has some 
interesting consequences on the epithelial thickness profile after SMILE. This is most apparent in low myopic 
SMILE. Increasing the minimum lenticule thickness increases the curvature gradient at the lenticule edge. At 
the same time, a low myopic correction using a large optical zone minimizes the curvature gradient within the 
optical zone. Therefore, the amount of epithelial remodeling is increased at the lenticule edge and decreased 
centrally. The result is an epithelial thickness profile that looks like that after a hyperopic correction,
273
 being 
thinner centrally with an annulus of thicker epithelium at the edge of the optical zone, as opposed to being 
thicker centrally and thinner paracentrally as expected after a myopic correction.
61, 392, 394
 For example, Figure 
6-29 shows the epithelial thickness profile for an eye treated for -2.50 -0.50 x 91 using a 7 mm optical zone 
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(plus 0.1 mm transition zone) and a 20 µm minimum lenticule thickness, compared to an eye treated for -9.25 -
1.00 x 13 using a 6 mm optical zone and a 3 µm minimum lenticule thickness.  
 
 
Figure 6-29: Examples of Artemis VHF digital ultrasound epithelial thickness profiles after SMILE for low myopia (left), SMILE for high 
myopia (middle), and LASIK for moderate hyperopia (right). The epithelial thickness profile is thicker centrally and thinner paracentrally 
after high myopia, as expected, but thinner centrally and thicker paracentrally after low myopia. The relative dominance of the minimum 
lenticule thickness in low myopic SMILE (20 µm in this example) means that that the epithelial thickness profile appears more similar to a 
hyperopic than myopic treatment. 
 
6.7 Keratometry 
The first section on the Cap tab is for Anatomical parameters (Figure 6-30), including the Corneal radius and 
Pachymetry. The Corneal radius label refers to the average simulated keratometry value and can be entered 
within a range from 6.50 to 8.50 mm (39.7 to 51.9 D). This average keratometry is used to calculate the 
peripheral femtosecond laser focal depth to account for the accurvation of the cornea to the curved contact 
glass according to the curvature of each individual eye. The corneal curvature also impacts the maximum cap 
diameter that is allowed; the cap diameter can be larger for flatter corneas. 
 
 
Figure 6-30: VisuMax software screenshot of the fields to enter the keratometry and pachymetry. 
 
The Corneal radius field itself can only be entered in mm. In order to enter values in Diopters, or if the average 
value is not available on the topography printout, the K-readings button provides access to a pop-up window 
that allows the minimum and maximum K values to be entered in either mm or Diopters (Figure 6-31). The mm 
and Diopters fields are linked so that entering a value into one will auto-calculate the other corresponding field 
to match. Clicking OK on this window saves these values and the average K will be calculated and shown in the 
Corneal radius field. 
 
In order to maximize the efficiency of treatment planning, we include a calculation of the average K in mm as 
part of our nomogram calculator printout (Avg Kmm = 337.5 / Avg KD). In this way, we are able to enter the 
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average K directly into the Corneal radius field, thus saving the extra clicks of opening the K-readings sub-
window and entering both minimum and maximum K values. 
 
 
Figure 6-31: VisuMax software screenshot of the fields to enter the min and max simulated keratometry values in either mm or D. 
 
6.8 Pachymetry 
The next field in the Anatomical parameters section is the Pachymetry, where the minimum corneal 
pachymetry should be entered. This can be manually typed or changed using the up/down buttons in 1 µm 
increments. The pachymetry value is used to calculate the residual stromal thickness (RST), which is displayed 
in the Calculated RST [µm] field within the Treatment information section on the right-hand side. A warning 
will be displayed within the Treatment Wizard section on the right-hand side if the RST falls below the limit set 
in the Settings menu: “Error: the residual corneal thickness is too low.” 
 
6.8.1 Residual stromal thickness limit 
When SMILE was introduced, the first instinct was to apply the same 250 µm residual stromal thickness (RST) 
limit to SMILE that is used for LASIK. Indeed, this limit has been included within the VisuMax software and is 
what the CE approval is based on. This is calculated in the same way as for LASIK as: 
 
Predicted RST = Minimum corneal thickness – Cap thickness – Maximum lenticule thickness 
 
However, because there is no flap created in SMILE, the anterior stromal lamellae remain intact everywhere 
except for the small area of the incision. Therefore, the actual residual stromal thickness in SMILE should be 
calculated as the stromal thickness below the posterior lenticule interface plus the stromal thickness between 
the anterior lenticule interface and Bowman’s layer. In other words, we should consider total uncut stromal 
thickness in SMILE instead of residual stromal thickness as in LASIK. 
 
Predicted total uncut stromal thickness = Minimum stromal thickness† – Maximum lenticule thickness 
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†if an epithelial thickness measurement is not available, the average central epithelial thickness in the normal 
population is 53 µm,
395
 which can be subtracted from the corneal thickness to obtain stromal thickness. 
 
The implications of considering total uncut stromal thickness are discussed in more detail in the following 
section. However, for the purposes of current treatments, the 250 µm limit should be adhered to until there is 
published evidence that lower limits are safe. We are currently undertaking a prospective ethics-approved 
study in which the RST limit is 220 µm, together with a total uncut stromal thickness of 300 µm.
396
 
 
Returning to the calculation of the predicted RST, it is important to remember that the safety calculation is 
only a prediction; the achieved RST will most likely be different due to imprecisions associated with each 
variable. Given this imprecision, the actual RST may be considerably lower than the level predicted.
130, 202, 397
 
This is why when planning a LASIK treatment, it is crucial that this calculation be performed to represent the 
worst case scenario, in order to avoid a nasty surprise of leaving the RST significantly lower than expected. We 
have previously described in detail how to account for the bias and precision of each of corneal thickness, flap 
thickness, and ablation depth.
130, 202
 In LASIK, we routinely apply the following corrections: 
 
 Corneal thickness – based on our studies, we have found that corneal thickness measurement by 
Artemis VHF digital ultrasound and RTVue OCT are on average 15 µm thinner than single point 
handheld ultrasound and Pentacam Scheimpflug tomography.
398
 Therefore, we recommend 
subtracting 10-15 µm from the minimum corneal thickness value as obtained by handheld ultrasound 
or Scheimpflug imaging systems. 
 Flap thickness – it is important to have measured the bias and standard deviation of flap thickness 
with the microkeratome or femtosecond laser being used.
130, 143, 202, 203, 399
 The flap thickness used for 
the safety calculation should be adjusted according to the bias and 2 standard deviations to represent 
the thickest flap that might be created. 
 Ablation depth – usually no adjustment is needed as ablation depth contributes the least error. If a 
published study is available for the excimer laser being used, this can be applied, but in vivo ablation 
depth studies are relatively rare and often unreliable.
204
 
 
However, a slightly more relaxed approach can be taken for SMILE given that the cap remains effectively 
intact. For SMILE, we apply the following adjustments: 
 
 Corneal thickness – as above, no adjustment is required if using VHF digital ultrasound or OCT, but we 
recommend subtracting 10-15 µm from the minimum corneal thickness value as obtained by 
handheld ultrasound or Scheimpflug imaging systems. 
 Cap thickness – given that it has little bearing on safety if the cap is slightly thicker than predicted, we 
do not adjust for the bias and standard deviation of cap thickness. The reproducibility of cap thickness 
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has been shown to range between 4.4-9.0 µm,
134, 400-403
 and the accuracy is between -1.2 and +5.0 
µm.
134, 400-403
 
 Lenticule thickness – using VHF digital ultrasound, we found that the lenticule was 8.2 μm thicker on 
average than the Artemis measured stromal thickness change.
391
 Therefore, we add 8 μm to the 
lenticule thickness shown in the VisuMax treatment planning software. 
 
6.8.2 Total uncut stromal thickness 
It has been reported that the anterior stroma is approximately 50% stronger than the posterior stroma, as 
shown for cohesive tensile strength by Randleman et al
162
 and for tangential tensile strength by Scarcelli et 
al,
164
 due to the greater interconnectivity of collagen fibers in the anterior stroma compared to the posterior 
stroma where the collagen fibers lie parallel to each other.
166
 Therefore, in SMILE, a further 50% of the 
untouched anterior (cap) stromal thickness can be added to the total uncut stromal thickness to get a value 
that is comparable to a LASIK RST (mostly 50% weaker posterior stromal fibers). In reality, we can go further 
than this by basing the calculation on the real stromal tensile strength data. 
 
To evaluate how this affects our thinking about safety calculations in SMILE we developed a mathematical 
model, based directly on the Randleman
162
 depth-dependent tensile strength data to calculate the 
postoperative tensile strength, and compared the results between PRK, LASIK and SMILE.
167
 Given the 
similarity between different studies measuring the different types of tensile strength as described above, the 
assumption was made that cohesive tensile strength is representative of the overall corneal biomechanics. It is 
suggested that this total tensile strength value should replace residual stromal thickness as the limiting factor 
for corneal refractive surgery. 
 
To derive the model, first a non-linear regression analysis was performed on the Randleman
162
 data and it was 
determined that a fourth order curve maximized the fit to the data with a R
2
 of 0.930 demonstrating the very 
high correlation achieved by a non-linear fit. The total tensile strength of the untreated cornea was then 
calculated as the area under the regression line by integration (Figure 6-32). The total tensile strength of the 
cornea after LASIK was derived by calculating the area under the regression line for all depths below the 
residual stromal bed thickness (assuming the flap does not contribute to the tensile strength of the 
postoperative cornea
404
). This value was divided by the total tensile strength of the untreated cornea to 
represent the relative postoperative total tensile strength (PTTS) as a percentage. Similarly, the total tensile 
strength of the cornea after PRK was derived by calculating the area under the regression line for all depths 
below the stromal thickness after ablation. Finally, the total tensile strength of the cornea after SMILE was 
calculated as the area under the regression line for all depths below the lenticule interface added to the area 
under the regression line for all depths above the cap interface, within the stromal cap. This assumes that the 
keyhole incision made in SMILE does not reduce the tensile strength of the anterior region within the stromal 
cap and that this anterior stroma becomes under tension again. This is a reasonable assumption since the side 
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cut is small in length and the many intact lamellae surrounding this incision effectively maintain the integrity of 
the anterior cornea. 
 
 
Figure 6-32: The fourth order polynomial regression equation was integrated to calculate the area under the curve for the relevant 
stromal depths after PRK, LASIK, and SMILE as demonstrated by the green shaded regions. The red areas represent the tissue removed 
(excimer laser ablation/lenticule extraction) and the purple area in LASIK represents the LASIK flap. Reproduced with permission from 
Reinstein DZ, Archer TJ, Randleman JB. Mathematical model to compare the relative tensile strength of the cornea after PRK, LASIK, and 
small incision lenticule extraction. J Refract Surg. 2013 Jul;29(7):454-60. 
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The model was then applied to a variety of different scenarios and a number of conclusions could be drawn 
from the analyses: 
1. The PTTS was greater after SMILE than after PRK – in SMILE, the refractive stromal tissue removal 
takes place in deeper and relatively weaker stroma, leaving the stronger anterior stroma effectively 
intact, meaning that for any given refractive correction SMILE will leave the cornea with greater 
tensile strength than PRK. 
2. The PTTS was greater after SMILE than after LASIK – because the anterior stroma is left effectively 
intact, SMILE will (by definition) leave the cornea with greater tensile strength than LASIK for any 
given refractive correction. 
3. The PTTS increased for SMILE with increasing cap thickness (Figure 6-33) – if SMILE is performed 
deeper in the cornea, more of the stronger anterior stroma will remain and hence the PTTS will be 
greater; this is in contrast to LASIK, where a thicker flap results in lower PTTS given the minimal 
contribution of the flap to corneal biomechanics after healing. 
4. The PTTS decreased for thinner corneas, but the difference between procedures also increased for 
thinner corneas (Figure 6-34) – for example in LASIK, flap stroma plus ablation within the stronger 
anterior stroma would comprise a greater percentage loss of total tensile strength than SMILE. 
 
  
Figure 6-33: Scatter plot of the relative total tensile strength after LASIK (purple) and SMILE (green) plotted against a range of flap/cap 
thicknesses for a fixed central corneal thickness of 550 μm and ablation depth/lenticule thickness of 100 μm (approximately -7.75 D). In 
LASIK, the postoperative relative total tensile strength decreased for greater flap thickness by 0.22%/μm. In SMILE, the postoperative 
relative total tensile strength increased for greater cap thickness by 0.08%/μm. Reproduced with permission from Reinstein DZ, Archer TJ, 
Randleman JB. Mathematical model to compare the relative tensile strength of the cornea after PRK, LASIK, and small incision lenticule 
extraction. J Refract Surg. 2013 Jul;29(7):454-60. 
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Figure 6-34: Scatter plot comparing total tensile strength for a fixed ablation with varying corneal thicknesses after LASIK (purple), PRK 
(blue), and SMILE (green) against a range of central corneal thickness for a fixed ablation depth/lenticule thickness of 100 μm 
(approximately -7.75 D), a LASIK flap thickness of 110 μm, and a SMILE cap thickness of 130 μm. The postoperative relative total tensile 
strength was greatest after SMILE, followed by PRK, and was lowest after LASIK. Reproduced with permission from Reinstein DZ, Archer TJ, 
Randleman JB. Mathematical model to compare the relative tensile strength of the cornea after PRK, LASIK, and small incision lenticule 
extraction. J Refract Surg. 2013 Jul;29(7):454-60. 
 
These results can be quantified in the example scenario represented in Figure 6-35, which shows the relative 
PTTS after LASIK (purple), photorefractive keratectomy (PRK) (blue), and small incision lenticule extraction 
(SMILE) (green) plotted against a range of ablation depths for a fixed central corneal thickness of 550 μm, a 
LASIK flap thickness of 110 μm, and a SMILE cap thickness of 130 μm. The orange lines indicate that the 
relative PTTS reached 60% for an ablation depth of 73 μm in LASIK (approximately -5.75 D), 132 μm in PRK 
(approximately -10.00 D), and 175 μm in SMILE (approximately -13.50 D), translating to a 7.75 D difference 
between LASIK and SMILE for a cornea of the same relative PTTS. The red lines indicate that the relative PTTS 
after a 100 μm tissue removal would be 54% in LASIK, 68% in PRK, and 75% in SMILE. 
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Figure 6-35: This graph shows the relative total tensile strength after LASIK (purple), PRK (blue), and SMILE (green) plotted against a range 
of ablation depths for a fixed central corneal thickness of 550 μm, a LASIK flap thickness of 110 μm, and a SMILE cap thickness of 130 μm. 
The orange lines indicate that the postoperative relative total tensile strength reached 60% for an ablation depth of 73 μm in LASIK 
(approximately -5.75 diopters [D]), 132 μm in PRK (approximately -10.00 D), and 175 μm in SMILE (approximately -13.50 D), translating to 
a 7.75 D difference between LASIK and SMILE for a cornea of the same postoperative relative total tensile strength. The red lines indicate 
that the postoperative relative total tensile strength after a 100 μm tissue removal would be 54% in LASIK, 68% in PRK, and 75% in SMILE. 
Reproduced with permission from Reinstein DZ, Archer TJ, Randleman JB. Mathematical model to compare the relative tensile strength of 
the cornea after PRK, LASIK, and small incision lenticule extraction. J Refract Surg. 2013 Jul;29(7):454-60. 
 
In this model, there are some factors that have not been considered. Firstly, this model only considers the 
central point on the cornea. A full model of the cornea, for example by finite element analysis, that can take 
into account the stromal thickness progression and the volume of the ablation profile would be a significant 
improvement but is likely to provide the same data qualitatively, albeit perhaps more accurately in terms of 
absolute tensile strength changes. 
 
In the analytic model, the assumption was made that the stromal lamellae in the LASIK flap do not contribute 
to the total tensile strength of the cornea at all, an assumption that is supported by published studies 
demonstrating negligible contribution. Schmack et al
404
 found that the mean tensile strength of the central and 
paracentral LASIK wounds was only 2.4% that measured in control eyes. As described earlier, Knox Cartwright 
et al
405
 experimentally demonstrated a LASIK flap depth dependent increase in corneal strain, reporting an 
increase in strain of 9% for a 110 μm flap and 33% for a 160 μm flap. This result is predicted by the analytic 
model that showed the remaining relative total tensile strength would be less for thicker flaps, as would be 
expected. 
 
Another factor not considered is that Bowman’s layer remains intact after SMILE, which is not true in either 
LASIK or PRK. Bowman’s layer has been shown to have very different biomechanical properties to stromal 
tissue as demonstrated by Seiler et al
406
 who showed that removing Bowman’s layer with an excimer laser 
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reduced the Young’s modulus by 4.75%. Leaving Bowman’s layer intact may further increase the corneal 
biomechanical stability after SMILE compared with LASIK and PRK. Finally, the present model in addition does 
not consider the effect of the tunnel-incision on tensile strength changes which although small will not be 
zero.  
 
It is important to point out that while SMILE has a benefit associated with corneal biomechanics, the 
procedure does still reduce the overall tensile strength of the cornea; the advantage is that it does so less than 
LASIK and PRK. Following the publication of cases of ectasia
407-410
 after SMILE in eyes with forme fruste 
keratoconus, it has become apparent that this distinction needs to be stressed – keratoconus is and always has 
been a relative contraindication to tissue subtractive procedures which should be only carried out in certain 
special circumstances with concomitant cross-linking and proper informed consent. 
 
In summary, considering the safety of subtractive corneal refractive surgical procedures in terms of tensile 
strength, represents a paradigm shift away from classical residual stromal thickness limits. The residual 
thickness based safety of corneal laser refractive surgery should be thought of at least in terms of total 
residual uncut stroma. Ideally, a parameter such as total tensile strength, which takes the nonlinearity of the 
strength of the stroma into account, seems more appropriate. For example, the residual stromal bed thickness 
under the interface in SMILE could be less than 250 μm due to the additional strength provided by the 
untouched stromal lamellae in the cap, as long as the total remaining corneal tensile strength is comparable to 
that of the post-LASIK 250 μm residual stromal bed thickness standard. In this new case of using remaining 
total tensile strength, the minimum would evidently be defined as the total tensile strength remaining after 
LASIK with a residual stromal bed thickness of 250 μm. 
 
6.9 Contact glass and cap diameter 
The next parameter to select is the contact glass to use, labelled as Treatment pack size in the software (Figure 
6-36), and will initially be set according to the treatment parameters that have been saved as the default using 
the Save as default checkbox. The contact glasses are available in three sizes – small (S), medium (M), and 
large (L) – which are selected according to the patient’s white-to-white diameter, to ensure that suction is 
applied to the cornea. According to the VisuMax user manual, the minimum white-to-white is 11.2 mm for the 
‘S’ contact glass, 11.7 mm for the ‘M’ contact glass, and 12.4 mm for the ‘L’ contact glass. 
 
 
Figure 6-36: VisuMax software screenshot of the fields to enter the contact glass size and cap parameters. 
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After selecting the contact glass size, it is then time to define the Cap parameters, starting with the Diameter 
[mm]. The cap diameter will initially be set according to the treatment parameters that have been saved as the 
default using the Save as default checkbox. The cap diameter can be manually typed to the nearest 0.01 mm, 
or changed using the up/down buttons in 0.05 mm increments. 
 
The maximum cap diameter is defined by size of the contact glass, which is the disadvantage of using corneal 
suction (obviously, the advantages of the curved contact glass and low suction outweigh this disadvantage). In 
general, the maximum cap diameter is 8.00 mm for the ‘S’ contact glass and 8.80 mm for the ‘M’ contact glass. 
However, the corneal curvature and cap thickness also have a small influence on the maximum cap diameter, 
as shown in Figure 6-37. The maximum cap diameter decreases for steeper corneas and thicker caps. If the cap 
diameter entered exceeds the allowed maximum value for that eye, the field will be colored red, and a 
warning message will be displayed in the Treatment Wizard section: “The following parameter is not plausible: 
Radial treatment zone.” 
 
  
Figure 6-37: Tables defining the maximum cap diameter according to the combination of 1) contact glass size, 2) corneal curvature, and 3) 
cap thickness. Reproduced with permission from the VisuMax user manual for ReLEx SMILE. 
 
To resolve this, the cap diameter must be reduced until it is below the maximum value. The user manual tables 
(Figure 6-37) show the maximum cap diameter to the nearest 0.1 mm, and the up/down buttons in the 
software change the cap diameter in 0.1 mm increments, however, the absolute maximum cap diameter for 
an individual eye is actually calculated to the nearest 0.01 mm. To find the maximum cap diameter for an 
individual eye, the user should use the keyboard to manually adjust the value down in 0.01 mm steps until the 
warning disappears and the field turns back to blue. Because we prefer to use thicker caps, the maximum cap 
diameter is 7.95 mm or less for most patients. 
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The choice of cap diameter depends on two elements. Firstly, the cap diameter defines the location of the 
small incision, so it is generally preferable to have this as far outside the visual axis as possible. Secondly, the 
cap diameter consequently defines the maximum lenticule diameter – i.e. combination of optical and 
transition zone – so the cap diameter must be large enough to provide sufficient clearance to identify the 
lenticule interface according to the optical zone desired.  
 
Essentially all myopic SMILE procedures can be performed using an ‘S’ contact glass; the maximum cap 
diameter of 8.00 mm provides sufficient clearance even for a 7.60 mm lenticule diameter (7.50 mm optical 
zone plus 0.10 mm transition zone). In our 4,000 eye SMILE population, we have used an ‘S’ contact glass in all 
eyes except for the one eye with low myopia where an ‘M’ contact glass was used to allow for an 8.25 mm 
optical zone and 8.70 mm cap diameter. The distribution of cap diameter used is shown Table 6-3. 
 
Table 6-3: Distribution of cap diameter used for SMILE in 4,000 procedures. 
Cap diameter (mm) Percentage 
6.80 to 7.40 1.6% 
7.50  5.0% 
7.60 to 7.80 1.1% 
7.90 3.7% 
7.95 87.2% 
8.00 1.5% 
8.70 0.03% 
 
The advantage of this protocol is that there is no real need to consider the white-to-white when deciding on 
which contact glass to use, as there is for LASIK where an ‘M’ contact glass might be used to create a larger 
flap if necessary. The exception is for very small eyes where the white-to-white is less than the 11.2 mm 
minimum recommended for the ‘S’ contact glass in the VisuMax user manual. This obviously represents a very 
small proportion of patients, but it would be a shame to exclude them from SMILE (or to use an ‘L’ contact 
glass). In our myopic SMILE population, we have treated 3 eyes (0.08%) with white-to-white between 10.7 and 
11.0 mm, with no issues with suction. 
 
The other aspect to consider is the angle kappa – i.e. the offset between the visual axis and the entrance pupil 
center. As the centration is on the visual axis, the treatment will not be concentric with the limbus, meaning 
that there is a possibility that suction will be partially applied on the conjunctiva in small eyes with a large 
angle kappa. The contact glass sizing limits based on white-to-white were originally defined under the 
assumption that suction on the conjunctiva would be insufficient and greatly increase the risk of suction loss. 
However, our experience has been that partial suction on the conjunctiva does not pose a problem and this 
was not the cause of any cases of suction loss in our population. 
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The other exception is hyperopic SMILE,
359, 360, 389
 where an ‘M’ contact glass should be used wherever possible 
to maximize the optical zone and incorporate the large transition zone. The ‘L’ contact glass may be needed for 
hyperopic treatments in small eyes. In our hyperopic SMILE study,
359, 360
 the ‘M’ contact glass was used in all 
eyes, including 13% (8/60) where the white-to-white diameter was less than the 11.7 mm recommended 
minimum, and a white-to-white diameter of 10.8 mm in one case. Given the larger angle kappa common in 
hyperopic eyes,
411-413
 there were also some eyes where contact glass eye fixation was achieved with a portion 
of the peripheral suction ports applied on the limbal conjunctiva. However, in this series there were no 
instances of suction loss or significant treatment decentration observed. Therefore, it appears that there is 
some leeway to the recommended minimum white-to-white values. 
 
6.10 Cap thickness  
The second field in the Cap parameters section is Thickness [µm] (Figure 6-36), and will initially be set 
according to the treatment parameters that have been saved as the default using the Save as default 
checkbox. The cap thickness can be manually typed to the nearest 1 µm or changed using the up/down 
buttons in 5 µm increments within the range 100 to 220 µm. 
 
In our practice we prefer to use a relatively thick cap where possible; 145 µm is our current standard. The main 
reason for using a thicker cap is that the major advantages of SMILE of less dry eye and increased relative 
tensile strength both depend on leaving the anterior stroma undisturbed. Therefore, it is in every surgeon’s 
interest to use a thick cap, rather than following the instincts built-up over years of performing LASIK with thin 
flaps. A further consequence of using a thick cap is that there will always be room for a thin flap if a 
retreatment is needed, which is our preferred method. A cap thickness of 135 µm will mean that there is 
always sufficient room to create a 100 µm LASIK flap. 
 
According to our protocol, the cap thickness would only be made thinner in order to accommodate the full 
treatment within the tissue constraints of the RST limit – i.e. in patients with lower pachymetry and/or higher 
myopia. The other disadvantage of a thinner cap is that this increases the potential of perforation, particularly 
if a sharper instrument is being used. 
 
Some studies have formally investigated the influence of cap thickness on visual outcomes and other 
parameters such as wound healing.
414-417
 Guell et al
414
 compared SMILE with cap thicknesses of 130, 140, 150, 
and 160 µm, and found no difference in visual acuity, refractive outcomes, or objective scatter index (OSI). 
 
In a contra-lateral eye study comparing cap thicknesses of 100 and 160 µm, El-Massry et al
415
 found no 
difference in visual and refractive outcomes, but did report the corneal resistance factor (CRF) and corneal 
hysteresis (CH) by Ocular Response Analyzer to be higher in the 160 µm cap group, suggesting superior corneal 
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biomechanics. However, CH and CRF are notoriously poor parameters for evaluating corneal biomechanics.
418, 
419
 
 
Liu et al
416
 also performed a contra-lateral eye study, this time comparing cap thicknesses of 120 and 140 µm. 
As with the other studies, no difference was found for visual and refractive outcomes, including contrast 
sensitivity. However, in vivo confocal microscopy and scanning electron microscopy analysis indicated that the 
140 µm group was associated with smoother lenticule surfaces and a lower level wound healing response. 
 
Finally, He et al
417
 performed a study in rabbits to investigate whether there were biomechanical differences 
between 100 and 160 µm cap thicknesses. Using Pentacam tomography, they found no forward movement of 
the posterior corneal surface and no difference in posterior corneal surface elevation between groups. Using 
the Corvis (Oculus, Wetzlar, Germany), there was a small difference in second applanation time, but no 
difference in first applanation time or deformation amplitude. Young’s modulus by strip extensometry after 
enucleation also showed no difference between groups. 
 
6.11 Location, size and side cut angle of the small incision(s) 
The final aspects of the treatment profile to be selected relate to the small incision(s). The first parameter is 
the Side cut angle, which is somewhat confusingly included as part of the Cap parameters section (Figure 6-
38); this is a legacy from the software having been originally designed for FLEx and the creation of a flap. When 
any of the incision fields are selected, the view on the treatment screen (right) will change to a front-on view 
to show the position of the incisions according to the current settings (Figure 6-38). The side cut angle will 
initially be set according to the treatment parameters that have been saved as the default using the Save as 
default checkbox. The side cut angle can be manually typed to the nearest 1° or changed using the up/down 
buttons in 5° increments within a range from 1° to 179°. There is no reason to set this to anything other than 
90°. 
 
 
Figure 6-38: VisuMax software screenshot of the fields to enter the small incision parameters (left) and the front-on view that is displayed 
on the treatment screen (right) to visualize the incision geometry that has been selected. 
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The rest of the small incision geometry is defined within the Incision parameters section (Figure 6-38). This 
section allows up to three small incisions to be programmed, with the second and third incisions enabled via 
checkboxes. The Position [°], Angle [°], and Width [mm] are required for each incision selected. The Incision 
parameters section will initially be set according to the treatment parameters that have been saved as the 
default using the Save as default checkbox. 
 
The incision Position dictates the location of the inferior end of each cut, while the Angle and Width are two 
different ways to describe the size of the incision. The Angle and Width are linked so that changing one 
automatically changes the other. The Angle represents the angle subtended by a curved incision at the 
diameter of the cap border. On the other hand, the Width represents the length of the chord that would link 
the two ends of the curved incision. Therefore, if the cap diameter is changed, the relationship between the 
Angle and Width will also change. The current software is set up to keep the Angle constant, which means that 
the Width changes by a few hundredths of a millimeter when the cap diameter is changed. Given that the vast 
majority of SMILE surgeons think in terms of small incision width, this field then needs to be adjusted manually 
back to the desired value. 
 
This link between the cap diameter and incision Width also has a knock-on effect on finding the maximum 
allowed cap diameter. When adjusting the cap diameter down in 0.01 mm steps, if the change causes the 
incision Width to become less than 2 mm (the minimum allowed incision width), the cap diameter will be 
indicated as being outside the permitted range. However, this cap diameter can revert to being allowed after 
resetting the incision Width back to the intended value (i.e. at least 2 mm).  
 
SMILE was originally performed using a single superior incision of about 5 mm,
148, 149
 which remains the 
standard for many surgeons and was used for the U.S. FDA study.
159
 From the outset of our SMILE experience, 
we elected to create two small incisions located supero-temporally and supero-nasally (at 30° and 150°), as 
shown in Figure 6-38.
156, 157
 The supero-temporal incision is used as the primary incision, providing improved 
access for the surgical instruments by avoiding the obstruction of the brow ridge and speculum when using a 
superior incision. Supero-temporal and supero-nasal incisions also bring the advantage of making it easier to 
create a LASIK flap with a superior hinge if a retreatment is required. 
 
The second supero-nasal incision is kept in reserve should there be any issue with lenticule interface 
separation through the primary incision. The size of the small incision has been decreased with most surgeons 
now comfortable using a 2 mm incision as collective experience with SMILE advanced.
155-157, 420, 421
 
 
Another common question asked of SMILE is whether the small incision has an astigmatic effect. The creation 
of any corneal incision(s) must have some effect on corneal curvature, the magnitude of which will be defined 
by the combination of incision width, incision depth, and incision location (peripheral/central). Reducing the 
incision width will minimize the astigmatic effect, which is why most surgeons converge on using a 2 mm 
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incision with experience. This incision size is then significantly smaller than commonly used for astigmatic 
keratotomy. The superficial nature of the SMILE incision also acts to reduce the astigmatic effect, whereas 
astigmatic keratotomy requires a 90% depth. However, SMILE incisions are created closer to the center of the 
cornea than peripheral astigmatic keratotomy incisions, which would act to relatively increase the astigmatic 
effect. One final consideration is that creating a second small incision at 90˚ to the primary incision will act to 
compensate for the astigmatic change induced by the primary incision. 
 
Putting all of these factors together, it is unlikely that a 2 mm small incision will have a clinically significant 
astigmatic effect, but this question has not yet been fully answered in the published literature. One study 
investigated the difference between a temporal and superior 2 mm incision and found that astigmatic 
correction was not significantly affected by the incision location using vector analysis, but this study included 
cylinder correction.
422
  
 
In order to investigate this question further, we performed a retrospective analysis including all cases of 
spherical myopia correction by SMILE and LASIK to compare the surgically induced astigmatism. Inclusion 
criteria were preoperative spherical myopia and 1 year follow-up available. Table 6-4 summarizes the main 
outcome measures for the SMILE and LASIK populations. Figure 6-39 presents polar plots of the surgically 
induced astigmatism vector (SIA), for which there was no difference in the vector mean between SMILE and 
LASIK. If there was a systematic astigmatic effect from the incision, this would result in a cluster at a particular 
axis. The presence of a uniform distribution, and the absence of a cluster, therefore demonstrates that there 
was negligible astigmatic effect from the incision. Of the 11 eyes (8.0%) with SIA of 0.75 D or more, the SIA was 
against-the-rule in 9 eyes (82%). However, a similar trend was also seen in the LASIK group; the SIA was 0.75 D 
or more in 27 eyes (5.3%), the SIA was against-the-rule in 18 eyes (67%). Figure 6-40 shows a cumulative 
histogram for the postoperative refractive cylinder; although there was a trend for postoperative refractive 
cylinder to be slightly higher after SMILE (0.04 D), this was not statistically significant (P = 0.063).  
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Table 6-4: Demographic data for spherical myopia correction by SMILE and LASIK 
 SMILE LASIK P value 
Eyes 137 508  
Attempted spherical equivalent refraction (D) 
-4.67±2.05 
-1.00 to -9.63 
-3.74±2.11 
-0.25 to -9.88 
<0.001 
Postoperative spherical equivalent refraction relative 
to intended target (D)  
-0.17±0.33 
-2.13 to +1.25 
-0.14±0.37 
-1.25 to +1.25 
0.383 
Postop SEQ within ±0.50 D 86% 83%  
Postoperative refractive cylinder (D) 
-0.25±0.26 
0.00 to -1.25 
-0.21±0.24 
0.00 to -1.25 
0.063 
Surgically induced astigmatism vector mean (D) 0.09 D Ax 112 0.07 D Ax 98  
Preop CDVA 20/20 or better 97% 98%  
Postop UDVA 20/20 or better 93% 94%  
Postop UDVA same or better than preop CDVA 72% 84%  
Safety loss 2 lines 0.0% 0.0%  
 
 
 
Figure 6-39: Polar plots of the surgically induced astigmatism vector (SIA) for spherical myopia treated by SMILE with two 2 mm incisions 
(left) and LASIK with the VisuMax and MEL 90 (right). There was no statistically significant difference in SIA vector mean (P=0.06). 
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Figure 6-40: Cumulative histogram of postoperative refractive cylinder after SMILE and LASIK treatment for spherical myopia. 
 
The influence of the small incision on astigmatism has also been evaluated internally by Carl Zeiss Meditec 
(data on file) for a population of 143 eyes treated for pure spherical myopia of -4.57±2.00 (range: -1.00 and -
10.00 D). The cap thickness was 120 µm, the cap diameter 7.5 mm, the optical zone 6.5 mm. A superior small 
incision was used with an incision angle of 90°, meaning an incision width of 5.9 mm. Refractive cylinder 1 year 
after surgery was ≤0.25 D in 88%, 0.50 D in 8%, and 0.75 D in 4% of eyes. The vector mean of the induced 
cylinder was 0.025 D Ax 96, indicating that there was no systematic induction of cylinder due to the small 
incision. 
 
Finally, biomechanical simulations using finite element modeling have also confirmed these clinical findings 
(data on file: Harald Studer, Optimo Medical AG, Biel, Switzerland). The amount of surgically induced 
astigmatism in SMILE surgery almost exclusively depends on the size and location of the small incision; SIA 
induction is greater when the small incision is larger and for a smaller cap diameter (i.e. the diameter at which 
the small incision is created). When using our standard protocol of two 2 mm incisions (one at 30° and one at 
150°) with a depth of between 135 and 145 µm, the finite element model predicted that astigmatic effects 
were not clinically relevant.  
 
6.12 Femtosecond energy and scanning parameters 
The surgeon also has some control over the performance of the femtosecond laser, and therefore the quality 
of the lenticule interfaces, by adjusting the energy and stop spacing settings. These settings should initially be 
set and optimized with the help of a Carl Zeiss Meditec applications specialist, as there are usually small 
differences between laser systems. For standard users, two different parameter sets can be saved, selectable 
as Standard mode and Fast mode during the actual treatment process. 
 
If Expert mode is enabled on your device, this will allow the Spot distance, Track distance, Energy offset, Scan 
direction and Scan mode to be adjusted within a certain range (Figure 6-41). Each parameter can be set 
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independently for each interface, labelled in the software as Lenticule (lenticule interface), Lenticule side 
(lenticule side cut), Cap (cap interface), and Cap side (small incision). The parameters can be changed within a 
certain range by selecting the appropriate field and using the + and – buttons on the right hand side. Due to 
the restricted range for these settings, it is useful to discuss with a Carl Zeiss Meditec applications specialist 
what settings to save as Standard mode and Fast mode, to maximize the available options (Figure 6-42). 
However, the two modes are usually used to switch between SMILE and LASIK, given their different energy and 
spot spacing requirements. 
 
 
Figure 6-41: VisuMax software screenshot of the Expert mode window (right) that allows the Spot distance, Track distance, Energy offset, 
Scan direction, and Scan mode to be adjusted by the user within a certain range. The diagram to the left demonstrates how each 
parameter affects the femtosecond laser bubble pattern. Two different parameter sets can be saved, selectable as <Standard> mode and 
<Fast> mode. 
 
 
Figure 6-42: Diagram shows an example setup for Standard and Fast modes, demonstrating the range within which the energy and spot 
spacing settings can be adjusted. 
 
A lot of work has been put into finding the optimal settings for SMILE. The list below describes each parameter 
in turn, including the settings that we have settled on for our current laser system (Figure 6-41). 
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1. Spot distance [µm] – the distance between consecutive femtosecond laser pulses, adjustable in 0.1 
µm increments up to ±0.5 µm from the starting value. In our protocol, a different Spot distance is 
used for each of the four interfaces as there are different requirements for ease of separation: 
o Cap interface – we use a Spot distance of 3.9 µm, which provides a balance between ease of 
separation (easier if spots are closer) and treatment time (longer if spots are closer). 
o Lenticule interface – laser-tissue interaction changes with depth due to energy absorption by 
the stroma. Therefore, we slightly decrease the Spot distance to 3.8 µm for the lenticule 
interface to achieve interface separation equivalent to the cap interface. 
o Lenticule side cut – we set the Spot distance to 1.0 µm for the lenticule side cut so that it is 
as easy as possible to engage the lenticule interface. As this interface is only 10-15 µm, 
increasing the Spot distance only increases treatment time by a second or two. 
o Small incision – similarly, it is preferable for the small incision to be easy to open to minimize 
any trauma to the epithelium during this process. We have settled on a Spot distance of 1.5 
µm for this interface. 
2. Track distance [µm] – the distance that separates adjacent lines within the femtosecond laser spiral 
pattern, adjustable in 0.1 µm increments up to ±0.5 µm from the starting value. Track distance is 
usually set to the same value as Spot distance for each interface. 
3. Energy offset – the femtosecond laser energy, displayed using a scale where each integer change 
adjusts the energy by 5 nJ (a quick way to make the conversion is to halve the value and multiply by 
10, e.g. 26 divided by 2 is 13, so setting 26 is equivalent to 130 nJ). The energy can be adjusted by up 
to ±30 nJ (6 energy scale increments). The energy is usually set to the same value for all four 
interfaces. The energy defines the size of the bubbles created, with lower energy making smaller 
bubbles. Our current preference is to set the energy 2-3 clicks above the plasma threshold, which is 
setting 23-24 (115-120 nJ) for our current laser. 
4. Scan direction – the direction of the spiral, being either spiral in (start in the periphery and spiral into 
the center) or spiral out (start in the center and spiral out to the periphery). The lenticule interface 
should always be set to spiral in, and the cap interface set to spiral out. This is to minimize the time 
between completion of the lenticule interface and creation of the cap interface to avoid opaque 
bubble layer formation in the lenticule interface distorting the anterior stroma.
423
 Scan direction does 
not apply to the lenticule side cut or small incision, so these fields are disabled. 
5. Scan mode – Scan mode can only be set as single in the commercial software, and indicates that the 
complete spiral pattern will be performed in one continuous path. The other option available in the 
study software is double, which means that the spiral pattern is performed in two passes; the first 
spiral is made with twice the normal distance between lines (Track distance), followed by a second 
spiral in the reverse direction in between the lines of the first pass. Scan mode does not apply to the 
lenticule side cut or small incision, so these fields are disabled. 
6. Estimated treatment time – the total time required to complete the interface creation for the 
selected settings is displayed underneath the table. This is a very important factor to consider as a 
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longer treatment time increases the risk of suction loss. Reducing the Spot distance and/or Track 
distance will increase the number of femtosecond laser pulses required, thus increasing the 
treatment time. 
 
6.13 Preparation of images to guide centration 
Centration in SMILE is based on the patient essentially auto-centrating by having them look at the fixation 
light. During the docking process, the surgeon needs to verify that the centration is on the visual axis, using the 
position of the reflex from the green fixation light as a reference in relation to the pupil. To help this process, 
we prepare a printout (Figure 6-43), including the topography eye image and the Hirschberg test, for the 
surgeon to compare to the intraoperative appearance.  
 
We find that the topography eye image is the most useful reference for the angle kappa, and have developed a 
display that includes visual cues to quantify the magnitude and direction of any angle kappa. The docking 
process only takes a few seconds, so it is important for the surgeon to be able to immediately see at a glance 
the expected position of the reflex. The Atlas eye image is not infallible, for example the patient may not have 
been coaxially fixating during acquisition, so this should be kept in mind during treatment. The pupil diameter 
during treatment is also usually smaller than on the eye image, which needs to be mentally adjusted for. 
 
 
Figure 6-43: Example of the printout used as a reference to the expected position of the corneal reflex during docking. The corneal vertex 
(center of the Mires rings) is indicated as a red dot, with red cross-hair guidelines overlaid to visualize the position relative to the pupil 
border. A further visual cue is included in the form of arrows representing the magnitude and direction of the corneal vertex relative to 
the center of the entrance pupil, as defined by the coordinates measured by the Atlas.  
 
To make this printout, we import the preoperative Atlas topography images into a Microsoft PowerPoint 
template. The images are cropped to show only the eye image, rotated by 180˚, and placed with OD to the 
right and OS to the left. This rotation and placement ensures that the images correspond to the patient’s eyes 
from the surgeon’s point of view during surgery. 
 
Next, the shape tool is used to create a set of red crosshairs with a circle at the intersection. The circle is 
placed at the (0, 0) coordinate of the topography eye image that represents the corneal vertex. The horizontal 
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and vertical lines are then extended to reach the pupil border. In this way, the crosshairs visually emphasize 
the position of the corneal vertex relative to the pupil border. 
 
To further assist the surgeon in visualizing the expected position of the reflex, red arrows are added next to 
the eye image to indicate how far the corneal vertex is from the pupil center in the horizontal and vertical 
directions. The arrow length is determined by the pupil center (x, y) coordinate values, labelled as pup. center 
on the Atlas topography printout; the length is set to be 0.5 cm for every 0.1 mm pupil center offset. To 
maximize efficiency when preparing these printouts, we keep a PowerPoint template that includes a set of 
pre-prepared arrows covering the possible range of values and directions, so that the appropriate arrows can 
be dragged and dropped into place for each eye (Figure 6-44). This template is available to download from 
www.londonvisionclinic.com/SMILECentrationTemplate. 
 
 
Figure 6-44: The set of pre-prepared arrows and cross-hair guidelines to use in PowerPoint when setting up the eye image reference 
printout. This template is available to download from www.londonvisionclinic.com/SMILECentrationTemplate. 
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Chapter 7 Conclusion 
 
The five studies as set out in the Introduction were completed and are summarized below. 
 
 
7.1 A method for the safe treatment of high myopia by LASIK 
This study has been published with the following reference: 
171
 
Reinstein DZ, Carp GI, Archer TJ, Lewis TA, Gobbe M, Moore J, Moore T. Long-term Visual and Refractive 
Outcomes After LASIK for High Myopia and Astigmatism From -8.00 to -14.25 D. J Refract Surg. 2016;32:290-
297. 
 
This study set out to retrospectively analyse the outcomes for LASIK from -8.00 D to -14.00 D using the MEL 80 
excimer laser with 1-2 years follow-up. These patients had been treated using a customised aspheric ablation 
profile that included a spherical aberration pre-compensation factor that we developed between 2003-2006. 
The refractive correction was also adjusted according to a multivariate regression derived nomogram including 
sphere, spherical aberration pre-compensation level, cylinder, age, and flap thickness. 
 
These patients had also been treated using a safety protocol to eliminate the risk of excessive keratectomy. In 
this protocol for treating high myopia, the predicted residual stromal thickness (RST) must be greater than 250 
µm. For some eyes, this meant planning the treatment to be performed in two stages, so that the RST available 
for further correction could be accurately assessed before planning the second procedure. RST was calculated 
including safety biases for corneal thickness, flap thickness and ablation depth,
202
 based on our previous 
studies to evaluate the mean bias and reproducibility for each variable.
143, 203, 204
 Retreatments were 
performed if required with the safety confirmed by direct measurement of the postoperative RST using VHF 
digital ultrasound.
424
 
 
The study has now been completed and was published in the Journal of Cataract and Refractive Surgery.
171
 The 
study found the treatment of high myopia using the MEL 80 excimer laser and either the VisuMax 
femtosecond laser or zero compression Hansatome microkeratome to be safe and effective. While there was 
an increase in higher order aberrations, as expected for a high myopic correction, this increase was not 
excessive as demonstrated by no reduction in contrast sensitivity. Safety in terms of change in CDVA was also 
excellent with no eyes losing 2 lines, 3% losing one line, and 50% gaining one line. While night vision 
disturbances were not objectively measured, a topography-guided retreatment was available for any patients 
reporting significant symptoms, but was only used in 8 eyes (1.7%) demonstrating that few patients 
experienced visually significant night vision disturbances. The results also compared favourably to a literature 
search performed for studies published within the last five years reporting results of myopia above -8.00 D 
either by LASIK or phakic IOLs. 
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7.2 A method for the safe treatment of high hyperopia by LASIK 
This study has been published with the following reference: 
172
 
Reinstein DZ, Carp GI, Archer TJ, Buick T, Gobbe M, Rowe EL, Jukic M, Brandon E, Moore J, Moore T. LASIK for 
the Correction of High Hyperopic Astigmatism With Epithelial Thickness Monitoring. J Refract Surg. 
2017;33:314-321. 
 
This study set out to retrospectively analyse the outcomes for LASIK from +4.00 D to +8.33 D using the MEL 80 
excimer laser with 1-2 years follow-up.  
 
These patients had also been treated using a treatment protocol to maximize including the following 
components. Firstly, a large optical zone and transition zone were used to improve the refractive stability 
compared to previous generation excimer laser ablation profiles for hyperopia. The second factor was 
centration on the coaxially sighted corneal light reflex instead of using entrance pupil centration.
83
 Thirdly, the 
safety protocol required the predicted RST to be greater than 250 µm, including direct measurement of the 
postoperative RST by VHF digital ultrasound if a retreatment was required.
424
  
 
Finally, we developed a new protocol for assessing the risk of apical syndrome. It has traditionally been 
assumed that hyperopic LASIK should be limited according to the postoperative curvature because too much 
steepening can result in epitheliopathy or apical syndrome.
238
 However, curvature change is only a proxy for 
this risk, whereas epithelial thickness provides a direct measurement of the viability of the epithelium. We 
have previously shown that the central epithelium thins by approximately 2 μm for every diopter of hyperopic 
correction using the MEL 80.
273
 This can be used to predict the central minimum epithelial thickness after a re-
treatment and ensure that this remains greater than 28 μm. This is sufficient given that epithelial breakdown 
tends to occur for epithelial thicknesses of approximately 21 μm. This method enables us to safely perform 
further steepening in cases that would otherwise have been excluded based on standard keratometry limits, 
thereby extending the safe treatment range. Epithelial monitoring also identifies cases where further 
treatment would lead to excessive thinning despite apparently safe corneal curvature. Therefore, the 
treatment protocol was to use traditional corneal curvature limits to plan the primary treatment, with a 
maximum limit of +6.50 D, followed by epithelial monitoring to assess whether further steepening could be 
performed as a retreatment. 
 
The study found the treatment of high hyperopia using the MEL 80 excimer laser and either the VisuMax 
femtosecond laser or zero compression Hansatome microkeratome to be safe and effective. Although there 
was an increase in higher order aberrations, as expected for a high hyperopic correction, this increase was not 
visually harmful, as demonstrated by only a small decrease in contrast sensitivity and only a 0.4% loss of two 
lines in CDVA. The two-stage treatment protocol enabled a safer and more accurate final correction for high 
hyperopia in cases of undercorrection by regression but also enabled us to capitalize on cases that 
overcorrected after the primary procedure. These results show that LASIK is a safe and effective option for 
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high hyperopia as an alternative to intraocular surgery, although the balance of risks and benefits must be 
carefully considered between these options for an individual patient. The results also compared favourably to 
a literature search performed for studies reporting the treatment of high hyperopia by LASIK, clear lens 
exchange, and phakic IOLs. 
 
7.3 An investigation into the outcomes of LASIK in high astigmatism 
This study has been published with the following reference: 
173
 
Archer TJ, Reinstein DZ, Pinero DP, Gobbe M, Carp GI. Comparison of the predictability of refractive cylinder 
correction by laser in situ keratomileusis in eyes with low or high ocular residual astigmatism. J Cataract 
Refract Surg. 2015;41:1383-1392. 
 
Ocular residual astigmatism (ORA) is the vectorial difference between corneal and refractive astigmatism 
calculated to the corneal plane.
309
 It is the result of the combination of crystalline lens and posterior corneal 
surface astigmatisms with perceptual physiology and has been shown to be between 0 and 1.25 D for the 
majority of eyes in the normal population, but can range up to 2.00 D and beyond in otherwise normal eyes.
312, 
314
 With-the-rule astigmatism is more likely in eyes with low ORA, while oblique and against-the-rule 
astigmatism is related to high ORA.
314 
 
High amounts of ORA have been shown to be a potentially limiting factor for the predictability of refractive 
correction with an excimer laser. Some authors have reported a relationship of the magnitude of ORA with the 
remaining astigmatism after keratorefractive procedures.
310, 319, 320
 In 1997, Alpins introduced the concept that 
the ORA was a relevant factor to be considered when planning corneal refractive surgery to treat astigmatism, 
proposing that the treatment should be planned to also minimize corneal astigmatism.
310
 Kugler et al.
319
 found 
that conventional LASIK was twice as efficacious in terms of correction of refractive astigmatism in a low-ORA 
group (ORA/refractive astigmatism < 1.0) as in a high-ORA group (ORA/refractive astigmatism ≥ 1.0). Similarly, 
Qian and colleagues
320
 demonstrated in a retrospective study evaluating the outcomes of myopic LASIK that 
this procedure was less effective in correcting refractive astigmatism when the astigmatism was mainly located 
at the internal optics. These authors recommend the consideration of both topography and refractive 
astigmatism values in the surgical planning when a significant amount of ORA is detected preoperatively. 
 
This study set out to evaluate the impact of the preoperative magnitude of ORA on the refractive astigmatism 
predictability of LASIK surgery for the correction of myopic astigmatism and to investigate whether the results 
of the previous studies could be replicated. The study also set out to also consider the influence of the 
magnitude of refractive and corneal astigmatism in order to provide a more comprehensive analysis of such 
potential impact. 
 
The study found that the predictability of the correction of refractive astigmatism was better for eyes with a 
lower degree of ORA than eyes with a higher degree of ORA when grouped by ORA/refractive astigmatism, 
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however, this difference was reduced after matching for refractive astigmatism. This demonstrated that the 
previously published studies
319, 320
 had exaggerated the influence of ORA on predictability due to the bias 
introduced by defining the groups according to the ratio of ORA/refractive astigmatism, which meant that the 
two groups were not matched for the astigmatism treated. 
 
Defining the groups according to the magnitude of ORA further reduced the differences such that there were 
no statistically significant differences between the low and high ORA groups although there was a trend for 
better predictability in the low ORA group. This further demonstrated that the analysis method used in the 
previously published studies
319, 320
 had exaggerated the effect. 
 
After dividing the high ORA group further, it was found that eyes with high ORA and low corneal astigmatism 
demonstrated the best predictability of all groups, and the worst predictability was found in the group of eyes 
with high ORA and high corneal astigmatism. This was an interesting finding that isolated the group of eyes 
that were most affected by the presence of ORA. The final conclusion was that ORA can have a detrimental 
effect on refractive astigmatism correction, however, this is much less significant than previously reported and 
applies only to eyes with high ORA and high corneal astigmatism. 
 
7.4 Evaluation of the effectiveness of topography-guided ablation for optical 
zone enlargement and recentration after myopic LASIK. 
This study was published with the following reference: 
174
 
Reinstein DZ, Carp GI, Archer TJ, Stuart AJ, Rowe EL, Nesbit A, Moore T. Incidence and outcomes of optical zone 
enlargement and recentration after previous myopic LASIK by topography-guided custom ablation. J Refract 
Surg. 2018;34:121-130. 
 
This study set out to retrospectively analyse the outcomes of topography-guided custom ablation for optical 
zone enlargement and recentration after previous myopic LASIK with the MEL 80 excimer laser. Atlas corneal 
topography, corneal wavefront and manifest refraction were used to generate the ablation profile using the 
CRS-Master and MEL80 excimer laser. Standard analysis of refractive and visual outcomes was performed. As 
the main goal of a topography-guided treatment is to improve the regularity of the topography, further 
analyses were performed to investigate this. Optical zone centration and diameter were assessed by 
electronically overlaying a set of paracentral rings and central grid onto tangential curvature difference maps, 
with the edge of the optical zone identified as the mid-peripheral power inflection point. The change in corneal 
higher order aberrations was also analysed. 
 
The analysis has now been completed and the results demonstrate a significant improvement with optical 
zone diameter being increased by 11%, optical zone centration 63% closer to the corneal vertex, and a 39% 
reduction in corneal higher order aberrations. The refractive and visual outcomes were also good.  
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7.5 Evaluation of optimal treatment planning parameters for SMILE. 
This study was published as part of a textbook: The Surgeon’s Guide to SMILE, written by D.Z. Reinstein, T.J. 
Archer, and G.I. Carp. Thorofare, NJ: SLACK Incorporated, 2018.
175
 
 
In this book chapter, a series of studies were undertaken to investigate different aspects of the SMILE 
procedure. The first analysis was the development of a nomogram to account for the undercorrection of 
sphere and cylinder. This led to an interesting finding that the astigmatism results were slightly different for 
with-the-rule, oblique, and against-the-rule astigmatism. Based on this analysis, we developed an angular 
dependent nomogram for cylinder correction. 
 
The second analysis was to report the outcomes for low myopia, as low myopic treatments were thought to be 
more difficult with SMILE due to the thin lenticule. These results showed that satisfactory results could be 
achieved by using a large optical zone and increasing the minimum lenticule thickness. 
 
The third analysis investigated the effect of optical zone on spherical aberration, showing that the induction of 
spherical aberration decreased for larger optical zones, as expected. When compared to spherical aberration 
induction by aspherically-optimised LASIK, SMILE was found to induce less spherical aberration for equivalent 
tissue removal. However, as this was achieved without the need for a flap, the optical zone could be increased 
and further reduce the spherical aberration induction, while still retaining more corneal biomechanical 
integrity than after LASIK. 
 
The fourth analysis considered the astigmatic effect of creating two 2-mm small incisions, at 30 and 150 
degrees. Using vector analysis, it was found that there was no systematic induced astigmatism and the results 
were comparable to LASIK. 
 
7.6 Summary of Main Findings 
 Demonstrated method for safe treatment of high myopia up to -14.00 D by corneal laser refractive 
surgery using 
o Aspherically optimized ablation profiles 
o Residual stromal thickness mapping by VHF digital ultrasound for safe treatment planning for 
retreatment 
o Two-stage treatment protocol for high corrections and thin corneas 
o Use of femtosecond laser for more precise flap creation enabling the use of thinner flaps 
 Demonstrated method for safe treatment of high hyperopia up to +7.00 D by corneal laser refractive 
surgery 
o Large optical zones and transition zones to maximize refractive stability 
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o Epithelial thickness monitoring by VHF digital ultrasound for safe treatment planning for 
retreatment to avoid apical syndrome 
o Residual stromal thickness mapping by VHF digital ultrasound for safe treatment planning for 
retreatment 
o Two-stage treatment protocol for high corrections 
 Demonstrated the influence of ocular residual astigmatism on outcomes 
o A high degree of ocular residual astigmatism is associated with slightly reduced predictability 
for cylinder in eyes with high corneal astigmatism preoperatively 
o However, this study demonstrated that this difference was not as large as previously 
reported due to methodological flaws in the previous studies 
o The study also highlighted the importance of calculating the ocular residual astigmatism to 
identify potential errors in the manifest refraction measurement 
 Demonstrated the effectiveness of topography-guided custom ablation for the treatment of regularly 
irregular astigmatism, specifically for decentration and small optical zones 
 Analyzed four aspects of SMILE 
o Demonstrated that cylinder predictability varied according to the cylinder axis and developed 
an angular dependent nomogram 
o Demonstrated that SMILE can achieve equivalent results to LASIK for low myopia by using 
large optical zone and increasing the minimum lenticule thickness 
o Demonstrated the spherical aberration induction decreased for larger optical zones and 
achieved more spherical aberration control compared to aspherically-optimized LASIK 
o Demonstrated that there was clinically negligible astigmatism effect due to the small 
incisions  
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